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Four Ficus species used in African traditional medicine and indigenous to KwaZulu-Natal, 
sansibarica, bizanae, natalensis and glumosa were used in this study, where a phytochemical 
investigation and biological evaluation of the extracts and compounds were carried out.  A 
range of compounds belonging to the triterpenoid, flavonoid, coumarin, polyphenol, 
megastigmane, cinnamic acid and anthraquinone classes of compounds were isolated.  
 
Six compounds; three triterpenoids and three flavonoids; lupeol acetate (P1-1), cycloart-23-
ene-3,25-diol (P1-2), sitosterol (P1-3), 5,7,4'-trihydroxyflavan-3-ol (P1-4), epicatechin (P1-
5) and isovitexin (P1-6) were isolated  from F. sansibarica. This is the first phytochemical 
investigation of F. sansibarica. Cycloart-23-ene-3,25-diol (P1-2), a cycloartane type 
triterpenoid, is reported herein for the first time in the genus Ficus.  The trans configuration 
of the double bond at ∆23 on the side chain of the compound was clearly indicated by 
coupling constants close to 16 Hz.  To the best of our knowledge only the cis isomer has been 
reported previously. The compounds exhibited moderate dose-dependent and selective 
antibacterial activity against both Gram-negative and Gram-positive bacteria. Exposure of the 
flavonoids; 5,7,4'-trihydroxyflavan-3-ol (P1-4), epicatechin (P1-5) and isovitexin (P1-6) at 
varying concentrations, decreased adhesion indicating good anti-biofilm activity against the 
bacteria tested. No previous studies have examined the effect of these compounds on 
microbial adhesion.  
 
A total of fourteen compounds were isolated from F. bizanae, which included two coumarins, 
7-methoxycoumarin (P2-1) and psoralen (P2-2), one anthraquinone, tectoquinone (P2-3), one 
flavonoid glycoside, quercetin-3-O-β-D-glucopyranoside (P2-4), two megastigmane 
derivatives, vomifoliol (blumenol A) (P2-5) and dehydrovomifoliol (P2-6), a cinnamic acid 
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derivative, dihydroferulic acid (P2-7), two polyphenolic compounds, 4-methoxy catechol 
(P2-8) and protocatechuic acid (P2-9) and five triterpenoids, taraxerol (P2-10), 3β-acetoxy-
9(11)-fernene (P2-11), lupeol acetate (P1-1), β-amyrin acetate (P2-12) and sitosterol (P1-3).  
This is the first phytochemical and pharmacological report on F. bizanae.  A strain- and 
extract-specific potentiative synergistic anti-bacterial effect of F. bizanae extracts in 
combination with the antibiotics, azithromycin, gentamicin, sulphamethoxazole, nalidixic 
acid and cephalosporin was observed with all tested bacteria. 
 
A comprehensive phytochemical analysis of F. natalensis yielded four triterpenoids, ergosta-
4,6,8(14),22-tetraene-3-one (P3-1), stigma-4-ene-3-one (P3-2), a hopane triterpenoid, 3β-
hydroxy-21β-H-hop-22(29)-ene (P3-3), sitosterol (P1-3) and an anthraquinone, tectoquinone 
(P2-3). This is the first report of triterpenes and anthraquinones in F. natalensis.  Essential oil 
were previously reported in the plant.  A broad spectrum antimicrobial effect was 
demonstrated by P3-2, P3-3 and P2-3 against the majority of Gram-negative and Gram-
positive strains while only the dichloromethane fruit extract was active against selected 
strains. In the anti-biofilm assay, the methanol leaf extract demonstrated the most potent anti-
adhesion potential whereas compounds P3-2, P3-3 and P2-3 showed the greatest ability to 
decrease adhesion at the lowest concentration tested against selected bacterial strains. 
 
A phytochemical investigation of F. glumosa resulted in the isolation of 13 compounds, three 
polyphenolic compounds, p-hydroxybenzoic acid (P4-1), 3,4-dihydroxybenzoic acid 
(protocatechuic acid)  (P2-9) and vanillic acid (P4-2), two coumarins, peucedanol (P4-3) and 
(-)-marmesin (P4-4)  together with three flavonoid glycosides, quercetin-7-O-
glucopyranoside (P4-5), quercetin-3-O-β-D-glucopyranoside (P2-4) and quercetin-3-O-β-
galactopyranoside  (P4-6). The five triterpenoids isolated were simiarenol (P4-7), 3β-
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hydroxy-21β-H-hop-22(29)-ene (P3-3), α-amyrin acetate (P4-8), stigma-4-ene-3-one (P3-2) 
and sitosterol (P1-3). With the exception of (P4-2), all the compounds were isolated from F. 
glumosa for this first time.  The methanol soluble leaf extract of the plant exhibited the best 
gastroprotective activity when compared with standard drugs. This is the first report of the 
anti-ulcerogenic activity of F. glumosa. 
 
The bioactivity of the isolated compounds and extracts from the Ficus species used in this 
study support the use of the four Ficus species in African traditional medicine.  This work 
suggests that F. bizanae could be considered a potential source of resistance-modifying 
agents (RMA), which if used together with current antimicrobial agents, can improve their 
efficacy.  This work also indicates that the extracts of Ficus glumosa could be potential anti-
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Chapter 1. Introduction 
1.1 Introduction to the genus Ficus 
The genus Ficus is one of the well-known members of the Angiosperms, belonging to the 
Moraceae family (also known as Mulberry family), comprising over 750 species which 
includes woody trees, shrubs, vines, epiphytes, and hemi-epiphytes.  They are collectively 
identified as fig trees or figs distributed in tropical and subtropical regions worldwide.  
Australasia has approximately 500 diverse species, while Madagascar and Africa have 
approximately 110 species (Lansky and Paavilainen, 2011; Burrows and Burrows, 2003).  
The different species can be categorised as rock-splitters, free-standing, terrestrial or 
stranglers (Burrows and Burrows, 2003). Ficus species have the distinctive characteristics of 
having exceptional inflorescence and a unique pollination syndrome with the wasps’ family, 
Agaonidae (Ronsted et al., 2008; Abraham, 1989). 
Ficus leaves are always simple, alternating with visible stipules that envelope the leaf bud, 
though they sometimes have irregular margins and are lobed and incised. They possess male 
and female flowers in the receptacles from which the fruits grow up to 1.5 cm in diameter, 
with or without a stalk on the axils of the leaves, stem or branches.  The fruit (figs) grow as 
heavy fleshly spheres in pairs or dense clusters and are mostly edible (Palgrave, 1983).   
Generally, the bark, leaves, branches and unripe fruits of the different species of Ficus 
produce a rubber-like, non-toxic latex within their vasculatures (Lansky and Paavilainen, 




1.2  Ethnobotanical relevance of Ficus species 
The fruits, twigs, leaves, latex, stem, root and bark of Ficus species have been traditionally 
used as medicine for the treatment and control of many diseases and ailments (Lansky and 
Paavilainen, 2011; Burrows and Burrows, 2003). They are used to treat bacterial, fungal, 
parasitic and gastrointestinal infections, venereal diseases, gynaecological diseases, 
diarrhoea, respiratory disorders, liver problems, malaria, epilepsy, uterine disorders and 
hypertension and are used as anti-poison, and for the control of childhood convulsions (Table 
1-1 on page 30). Some species are used against snake bites as antivenom and others as 
insecticides (Bhalerao and Sharma, 2014; Igoli et al., 2005). In general, the difference in 
ethnomedicinal use of the species vary geographically and with different local populations.  
They are mostly prescribed by traditional healers with no scientific knowledge (Nadembega 
et al., 2011; Bafor et al., 2010; Burrows and Burrows, 2003).   
The plant part preparation depends on the application. For instance, stem bark and leaf 
decoctions of Ficus carica, Ficus exasperata, Ficus ovata and Ficus polita are mostly used 
for the treatment of numerous aliments and in some cases, the decoction is prepared in milk 
or alcohol (Lansky and Paavilainen, 2011).  There have also been reports of the plant parts 
being used in combination (synergistically) with other plants for treatment (Lansky and 
Paavilainen, 2011). Table 1-1 (page 30) depicts the ethnomedicinal uses and biological 
activities of some common species within the genus. 
There have been diverse reports on the biological activity of different species of Ficus, 
ascribing the activities to the variety of phytoconstituents contained in the plant. Anti-
bacterial, synergistic antibacterial, antimycobacterial, antifungal and antioxidant activities of 
a number of species have been reported (Joshi et al., 2014; Madikizela et al., 2012; 2014; 
Dangarembizi et al., 2013; Chauke et al., 2012;  Mbakwem-Aniebo et al., 2012; Ramde-
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Tiendrebeogo et al., 2012; Poumale et al., 2011; Amol and Rajsekhar et al., 2011a;  Chen et 
al., 2010; Young-Soo and Cha 2010; Wang et al., 2010;  Kuete et al., 2008; 2009; Aliyu et 
al., 2008, Mazumder et al., 2008).  F. polita has also shown anti-HIV activity (Ayisi et al., 
2003).  
Some species of Ficus have also been reported to have utertonic activity, which supports their 
ethnomedicinal use of easing childbirth (Bafor et al., 2009; 2010).  Others have been shown 
to increase sperm production (Bafor et al., 2013; Igbokwe et al., 2009). Several Ficus species 
have been used in the management of pain, fever, inflammation, ulcers, sores and wound 
healing (Sabiu et al., 2015;  Bhalerao et al., 2015; Bhalerao and Sharma 2014; Dangarembizi 
et al., 2013; Mawa et al., 2013; Devi et al., 2012; Gregory et al., 2009; Lansky et al., 2008; 
Rao et al., 2002).   
Antiparasitic, antiplasmodial and anthelmintic activities of extracts and isolated 
phytoconstituents of Ficus sycomorus, Ficus sur, Ficus thonningii, Ficus religiosa, F. carica 
and F. polita have been reported in some studies (Dangarembizi et al., 2013; Mawa et al., 
2013; Muregi et al., 2003; 2007; Sanon et al., 2003; Gbeassor et al., 1990). Cytotoxic, 
anticancer and antidiabetic activity of Ficus species and some related symptoms were 
demonstrated by F. carica, F. sycomorus, F. exasperata, Ficus arnottiana, Ficus palmata, F. 
lutea, F. racemosa, Ficus craterostoma, F. glumosa and Ficus benghalensis (Joshi et al., 
2014; Chaturvedi and Murthy 2013; Kazeem et al., 2013; Mawa et al., 2013; Olaokun et al., 
2013; 2014; Tamokou  et al., 2013; Nana et al., 2012; Ahmed and Urooj, 2010; Lansky et  al., 
2008; Mazumder et al., 2008).  
The use of Ficus species for the treatment of coughs, hypertension and the control of body 
water and lipids have been validated by the antitussive, antiasthmatic, expectorant, 
cardioprotective, anti-diuretic and hypolipidaemic activities of some species of Ficus 
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(Bhalerao and Sharma 2014; Dangarembizi et al., 2013; Liu et al., 2009; Rao et al., 2003; 
Ratnasooriya et al., 2003).   The hepatoprotective and nephroprotective ability (protection of 
liver and kidney damage) of Ficus ingens, F. exasperata, F. palmata and Ficus racemosa has 
been documented in the literature (Enogieru et al., 2015; Joshi et al., 2014; Donia et al., 2013; 
Mandal et al., 1999). The anticonvulsant potential observed by the extracts of F. sycomorus, 
Ficus sur and F. religiosa has validated the plants' use in the management of epilepsy (Ishola 
et al., 2013; Patil et al., 2011; Sandabe et al., 2003).   
Other activities such as proteolytic, antispasmodic, anticoagulant, antiplatelet, anti-amnesia, 
nematicidal, insecticidal, genotoxic, anti-mutagenic, chemomodulatory and 
immunomodulatory effects have also been reported for other Ficus species (Table 1-1 on 
page 30).    Studies on crude plant extracts has mostly been used for the validation of the 
efficacy of the various biological activities, however there has been some cases where 
phytoconstituents such as flavonoids and their glycosides, triterpenoids, coumarins, phenolic 
acids, and ceramides and their derivatives have been isolated and found to be active in assays 
related to the plant's use (Table 1-1 on page 30).     
 
1.3 A phytochemical review of 23 South African Ficus species with antibacterial or 
anti-ulcer activity 
Plants from the genus Ficus are rich sources of diverse classes of compounds such as 
polyphenolic compounds (flavonoids, coumarins, phenolic acids, phenylpropanoids and 
anthocyanins), triterpenes, steroids, alkaloids, megastigmanes, lignanoids, ceramides, tannins 
and in some cases stilbenes and volatile compounds. 
This mini review covers 23 South African Ficus plants, selected since they have been 
reported to have antibacterial or anti-ulcer activities. Triterpenoids and polyphenolic 
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compounds such as flavonoids, flavonoid glycosides, coumarins and phenolic acids were the 
major classes of isolated phytoconstituents. Triterpenoids were found in eighteen of the 23 
plants reviewed, while polyphenolic compounds were found in fourteen. The names of the 
species under review are contained in Table 1-1 (on page 30). Table 1-2 (on page 35) 
contains the names and molecular formulae of all the compounds isolated in these 23 plants. 
 
Terpenoids and sterols 
Lupeol (1), lupeol acetate (2), lupenone (3), lupeol hexanoate (4) and betulinic acid (5) with 
different substituents at positions 3 and 28 were found in F. benghalensis, F. carica, Ficus 
cordata, F. glumosa, F. microcarpa, F. nervosa, F. ovata, F. polita, F. racemosa, F. religiosa 
and F. thonningii.  3β-Hydroxy-20-oxo-29(20→19) abeolupane (6), with an added methyl 
group at C-19 compared to compounds 1-5 and 29,30-dinor-3β-acetoxy-18,19-dioxo-18,19-
secolupane (7), with an open cyclopentane ring were also isolated from F. microcarpa. 
 
 
  R1 R2 
1 lupeol OH CH3 
2 lupeol acetate OAc CH3 
3 lupenone O CH3 
4 lupeol hexanoate OCO(CH2)4-CH3 CH3 
5 betulinic acid OH COOH 
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β-amyrin (8), its acetate derivate, β-amyrin acetate (9) and oleanolic acid (10) of the oleanane 
triterpenoids with a double bond at ∆12, and differing in their substituents at positions 3 and 
28 were contained in nine of the nineteen Ficus species, F. benghalensis, F. carica, F. 
cordata, F. glumosa, F. lutea, F. microcarpa, F. nervosa, F. ovata and F. religiosa. A 
dihydroxy ester, methyl maslinate (11) with an extra hydroxy group at C-2 and an ester 
moiety at C-28, an acetylated triterpene, 3β-acetoxy-12,19-dioxo-13(18)-oleanene (12) with a 
double bond at the 13(18) position and 3β-acetoxy-11α-hydroxy-11(12→13)abeooleanan-12-
al (13) with an unusual cyclopentane ring C in the basic oleanane skeleton were found in F. 
carica and  F. microcarpa. 
 
  R1 R2 
8 β-amyrin OH CH3 
9 β-amyrin acetate OAc CH3 
10 oleanolic acid OH COOH 
 
The ursane triterpenoids 14-19 with the same oleanane skeleton but with methyl groups on 
ring E on adjacent carbons (C-19 and C-20) and different substituents at C-3 and C-17 were 
found in five of the Ficus species reviewed (Jain et al., 2013; Ragasa et al., 2013; Singh et al., 
2011; Chiang et al., 2005).  Ficus nervosa and F. religiosa contains α-amyrin (14) with an  
alpha hydroxy group and methyl group attached at C-3 and C-17 respectively. α-Amyrin 
acetate (15) is contained in F. racemosa and F. sur (Singh et al., 2011; Feleke and Brehane 
2005.), while  α-amyrin octacosanoate (16) containing a long chain fatty acid at C-3 was also 
found in F. racemosa (Jain et al., 2013).  The three carboxylic acids, ursolic acid (17), its 
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acetylated derivative, acetylursolic acid (18) and ursonic acid (19) with a keto group at C-3, 
were found in Ficus microcarpa and F. polita (Kuete et al, 2011; Chiang et al., 2005).   
 
  R1 R2 
14 α-amyrin OH CH3 
15 α-amyrin acetate OAc CH3 
16 α-amyrin octacosanoate OCO(CH2)26CH3 CH3 
17 ursolic acid  OH COOH 
18 acetylursolic acid OAc COOH 
 
Taraxarane triterpenoids with a double bond at 20(30) as in taraxasterol (20) and 20(30)-
taraxastene-3β,21α-diol (21) were isolated from F. benghalensis and  F. microcarpa (Patil 
and Patil 2010; Kuo and Chiang 1999). 20-Taraxasten-3β-ol (22), its oxidised form, 20-
taraxastene-3β,22β-diol (23), and the three C-22 ketones, 22-oxo-20-taraxasten-3β-ol (24), 
3,22-dioxo-20-taraxastene (25) and 3β-acetoxy-20-taraxasten-22-one (26), all with a double 





F. microcarpa also contained 3β-acetoxy-19(29)-taraxasten-20α-ol (27) with a double bond 
at position 19(29) and three related epoxides, 20α,21α-epoxytaraxastan-3β-ol (28), 
ptiloepoxide (29), and 3β-acetoxy-21α,22α-epoxytaraxastan-20α-ol (30) (Chiang et al., 2005; 




Taraxar-14-ene (31) and taraxeryl acetate (32) with a double bond at ∆14 and the 11,12-epoxy 
taraxarenes, 3β-acetoxy-11α,12α-epoxy-14-taraxerene (33) and 3β-acetoxy-11α,12α-epoxy-
16-oxo-14-taraxerene (34) were found in F. microcarpa (Chiang et al., 2005).  In addition, a 





Bauerenol (36), a friedoursane triterpenoid was isolated from F. carica and contained a 
double bond at the ∆7 position (Mawa et al., 2013).  Four friedelane triterpenoids (37-40) 
were also isolated within the twenty-three species reviewed.  Friedelin (37) and 3-friedelanol 
(38) were found in F. benghalensis, 3,7-dioxofriedelane (39) with keto groups at C-3 and C-7 
was isolated from F. exasperata and the carboxylic acid, 3-oxofriedelan-28-oic acid (40) was 





The 9,10-cyclopropyl triterpenoids, 27-nor-3β-hydroxy-25-oxocycloartane (41), (23E)-27-
nor-3β-hydroxycycloart-23-en-25-one (42) and (22E)-25,26,27-trinor-3β-hydroxycycloart-
22-en-24-al (43) were isolated from F. microcarpa (Chiang et al., 2001).  Cycloeucalenol 
(44), a common cylcoartane with a 9,19 cyclopropyl group together with the 13,27-
cyclopropyl cycloursanes, 3β-acetoxy-15α-hydroxy-13,27-cyclours-11-ene (45) and 3β-




The tetracyclic triterpenes, 3β-acetoxy-25-hydroxylanosta-8,23-diene (47) and 3β-acetoxy-
25-methoxylanosta-8,23-diene (48) were isolated from F. microcarpa.  The lanosterol 
compounds, lanosta-7,24-dien-3-one (49), lanosta-8,24-dien-3-one (50), lanost-20-en-3β-
acetate (51), 24,25-dihydroparkeol acetate (52) and gluanol acetate (53) were isolated from F. 





Three ubiquitous steroids, stigmasterol (55), sitosterol (56) and sitosterol-3-O-β-D-
glucopyranoside (57) were found in eleven of the twenty-three Ficus species reviewed. 
Daucosterol (58), sitosterol-3-O-(6'-O-heptadecanoyl)-β-D-glucopyranosyl (59), sitosterol-3-
O-(6'-octadecanoyl)-β-D-glucopyranoside (60), 6β-hydroxystigmast-4-en-3-one (61), 6β-
hydroxystigmasta-4,22-dien-3-one (62) were found in F. microcarpa and campesterol (63), 
28-isofucosterol (64), ergosterol peroxide (65)  and dongnoside E (66) were isolated in F. 






Flavonoids were isolated from fourteen Ficus species, forming the second largest class of 
compounds isolated in the review (Table 1-2). Eleven flavonoids (67-77) of the flavonol 
skeleton with different substitution patterns on the A, B and/or C ring of the nucleus with 
hydroxy and/or sugar moieties have been isolated from several of the Ficus species. 
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Patuletin-3′-O-methyl-3-O-rutinoside (75) with methoxy substituents was isolated from F. 
ingens only (Donia et al., 2013) and an ester of isoquercetin, isoquercitrin-6′′-O-4-
hydroxybenzoate (77) from F. exasperata (Taiwo and Igbeneghu 2014).  
 
  R1 R2 R3 R4 R5 
67 kaempferol H H H H H 
68 quercetin OH H H H H 
69 myricetin OH OH H H H 
70 quercetin-3-O-glucoside OH H glucosyl H H 
71 quercetin-3-O-galactoside OH H galactosyl H H 
72 quercetin-3-O-rutinoside (rutin) 
 
OH H rutinosyl H H 
73 quercetin-3-O-β- rhamnoside OH H rhamnosyl H H 
74 quercetin-3-O-β-D-galacto-
pyranosyl(1→6)-glucopyranoside 
OH H galactopyraosyl→ 
glucopyranosyl  
H H 
75 patuletin-3′-O-methyl-3-O-rutinoside OCH3 H rutinosyl OCH3 H 
76 Quercetin-3,7-O-α-L-dirhamnoside OH H rhamnosyl H rhamnosyl 
77 isoquercitrin-6-O-4-hydroxybenzoate OH H hydroxybenzoate H H 
 
The flavones 78-84, all with hydroxy groups at C-5 and C-7 and with either hydroxy or 
glucose moieties at the other positions on the aromatic rings were isolated in F. exasperata, 
F. glumosa, F. microcarpa, F. nervosa and Ficus sarmentosa (Table 1-2).  The glucose 
moieties are substituted at positions 6, 8 or 4′.   Compound 85 contains a prenyl substituent at 
C-6 while 86 has a linear pyran group attached to ring A of the flavone.  
14 
 
  R1 R2 R3 R4 
78 apigenin H H H H 
79 luteolin OH H H H 
80 isosaponarin H Glu H H 
81 apigenin-C-8 glucoside H H Glu H 
82 isovitexin H H H Glu 
83 Luteolin-C-6-β-D-glucopyranoside OH H H Glu 
84 8-C-(2′′-O-β-D-apiofuranosyl)-β-D-
glucopyranosyl apigenin 
H H Glu→apiofuran H 
 
Dihydroflavanols were also present in the species reviewed.  Naringenin (87), eriodictyol 
(88) and homoeriodictyol (89) were found in F. nervosa and F. sarmentosa, while 
dihydroquercetin (90) was isolated from F. thonningii along with aromadendrin (91), a 
3,4',5,7-tetrahydroxyflavanol. The prenylated 6-prenylpinocembrin (92) was obtained from F. 
glumosa, while shuterin (93), (2R,3R)-3,5,4′-trihydroxy-7-methoxy-6-(3,3-dimethylallyl)-







Three common catechins, catechin itself (96), epiafzelechin (97) and epicatechin (98) were 
isolated from F.cordata and F. microcarpa (Table 1-2).   
 
 
  R1 R2 R3 
96 catechin H OH OH 
97 epiafzelechin OH H H 
98 epicatechin OH H OH 
 
Five species of Ficus, F. glumosa, F. microcarpa, F. nervosa, F. ovata and F. thonningii 





  R1 R2 R3 R4 
99 genistein  OH OH H OH 
100 2′-hydroxygenistein OH OH OH OH 
101 2-hydroxyisoprunetin OH OCH3 OH OH 
102 prunetin OCH3 OH H OH 
103 dehydroferreirine OH OH OH OCH3 
104 cajanin OCH3 OH OH OH 
 
The isoflavonoids, 5,7,2′,4′-tetrahydroxy-3′-(3-hydroxy-3-methylbutyl)-isoflavone 
(thonningiisoflavone) (105), luteone (106) and wighteone (107) contained prenyl or oxidised 
prenyl groups at C-3′ or C-6 while parvisoflavone B (β-isoluteone) (108), alpinumisoflavone 
(109), 4′-O-methylalpinumisoflavone (110) and hydroxyalpinumisoflavone (111) contained a 
pyran ring.  Ficuisoflavone (112) have dihydropyran rings, while compounds 113 and 114 










Simple coumarins, coumarin itself (115), umbelliferone (7-hydroxycoumarin) (116), and 
scopoletin (117) were isolated in F. carica, F. nervosa and F. sarmentosa (Mawa et al., 2013; 
Wang et al., 2011; Chen et al., 2010).  The linear pyranocoumarins, 118-120 were isolated in 
F. nervosa (Chen et al., 2010) and the furano coumarins (121-127) were isolated in a number 
of Ficus species (Alqasoumi et al., 2014a, 2014b; Dongfack et al., 2012; Nana et al., 2012; 
Liu et al., 2011; Singh et al., 2011; Patil and Patil 2010; Deraniyagala et al., 1998).  The 
benzopyranone, 7-hydroxy-2,5-dimethylchromen-4-one (128) and the benzofuran, trans-
psoralenoside (129) were isolated from F. ingens and F. palmata respectively (Alqasoumi et 









Six anthocyanins were found in three of the Ficus species reviewed.  Three of these were the 
polyhydroxylated anthocyanidins, leucodelphinidin (130), and its 3-O-β-D-glycosides, 131-
132, which were isolated from F. benghalensis. The cyanidin-3-rhamnoglucoside (133) was 
reported in F. carica and the anthocyanidin dimers, procyanidin B1 (134) and procyanidin B3 






The Ficus species reviewed also contained several penolic acids.  Protocatechuic acid (136), 
gallic acid (137), vanillic acid (138) and 2,4,5-trihydroxybenzoic acid (139) were found in F. 
glumosa, F.microcarpa, F. ovata F. sycomorus and F. palmata.  The cinnamic acid 
derivative, ferulic acid (140) was isolated in F. carica and F. microcarpa along with three 
caffeoyl acid derivatives, 3-O-caffeoylquinic acid (141), methyl chlorogenate (142) and 5-O-
caffeoylquinic acid (143). The phenylpropanoid, syringin (144) was also found in F. 
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Three phenylpropanoids, (7S,8R)-syringoylglycerol (146) and its glucoside derivatives, 
syringoylglycerol-7-O-β-D-glucopyranoside (147) and 2′,7-epoxysyringoylglycerol-8-O-β-D-
glucopyranoside  (ficuscarpanoside B) (148) were isolated from F. microcarpa, together with 
an aromatic glycoside, icariside D2 (149).  A macrolide, lasiodiplodin (150) together with the 
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benzaldehydes, 4-hydroxybenzaldehyde (151) and vanillin (152) were found in F. nervosa 
and a prenylated stilbene, chiricanine A (153) and a glucosidic stilbene, (E)-3,5,4'-
trihydroxystilbene-3,5-O-β-D-diglucopyranoside (154) were isolated from F. glumosa and F. 




Five lignans, ficusal (155), polystachyol (156), lyoniresinol-2a-O-β-D-xylopyranoside (157)   
ficusesquilignan A (158) and ficusesquilignan B (159) were found in F. glumosa and F. 





Apart from the classes of compounds mentioned above, six ceramides, ficusamide (160), 
glumoamide (161), glumoside (162), benjaminamide (163), lutaoside (164) and politamide 
(165) were found in F. exasperata, F. glumosa, Ficus lutea and F. polita.  The two 
anthraquinones, chrysophanol (166) and aloe emodin-O-glucoside (167) were isolated from 
F. ingens. Pheophorbide-a (168), pheophorbide-b (169) and pyropheophorbide-a (170) were 






Five megastigmanes, 4,5-dihydroblumenol (171), (3S,5R,6R,7E,9S)-megastigman-7-ene-
3,5,6,9-tetraol (172), bridelionoside B (173), dihydroalangionoside A (174), ficumegasoside 
(175), two apo carotenoids, ficusone (176) and (7E,9Z)-dihydrophaseic acid-3-O-β-D-
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glucopyranoside (177), three γ-lactone derivatives, ficuspirolide (178), ficusolide (179) and 
ficusolide diacetate (180), three vitamin E like α-tocopheroids (181-183), an ether, 2,2′-
dihydroxyl ether (184) and an acid, ficuscarpanic acid (185) were all isolated from F. 








Some long chain fatty acids or fatty acid esters (186-188), alkanes (189-190), ketones and 
aldehydes (191-194), alcohols (195-198), esters (199-201) together with monoterpenes (202-
204), sesquiterpenes (205-209) and some other miscellaneous compounds (210-214) were 











1.4 A brief introduction to the plants used in this study 
The phytochemical investigation of four Ficus species, sansibarica, bizanae, natalensis and 
glumosa was carried out in this study and the isolated compounds tested for their bioactivity, 
focussing on their antibacterial activity.  These plants were chosen since all were found in 
KwaZulu-Natal in South Africa and were easily accessible.  Although Ficus glumosa and 
Ficus natalensis had been studied phytochemically previously, these studies did not seem 
comprehensive and hence these plants were reinvestigated.  
1.5 Methodology used in this study 
 The fresh leaves, stem bark and fruits of Ficus sansibarica, Ficus bizanae, F. natalensis and 
F. glumosa were collected from the province of KwaZulu-Natal in South Africa, identified, 
and voucher specimens deposited in the herbarium.  The different parts of the plants were air 
dried, ground and extracted sequentially with organic solvents of increasing polarity (hexane 
˂ dichloromethane ˂ ethyl acetate ˂ methanol).  The crude extracts were fractionated and 
purified using chromatographic techniques with the aim of isolating pure phytoconstituents.  
The isolated pure phytoconstituents were subjected to different spectroscopic techniques, 
mainly nuclear magnetic resonance spectroscopy (1D and 2D NMR), mass spectrometry, 
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infrared (IR) and ultra violet (UV) spectroscopy to identify the structures of the isolated 
phytoconstituents. Once identified, the phytoconstituents were verified by comparison with 
NMR and mass spectral data in the literature.   
 
Appropriate bioassays were carried out on both the crude and isolated phytoconstituents in an 
attempt to support the indigenous medicinal uses of the plants.  In particular, antibacterial 
studies were carried out on the isolates as well as anti-ulcerogenic studies.  The cost of health 
care in Africa is in many cases unaffordable and inaccessible, especially to the indigenous 
population living in the rural areas.  Plants with antibacterial constituents and extracts which 
offer gastroprotective effect can be used as substitutes for expensive antibiotics and anti-ulcer 
drugs which in many cases are inaccessible to the rural population. 
 
This thesis reports the phytochemical investigation of four South African species, F. 
sansibarica, F. bizanae, F. natalensis and F. glumosa and the antibacterial and anti-
ulcerogenic activity of the crude extracts and some isolates from the plants.  
 
1.6 Hypothesis used in this study 
Many species of the genus Ficus have long been used in African indigenous medicine for the 
treatment and management of many disease conditions. It is therefore hypothesised that these 
plants must therefore contain active extracts or phytoconstituents responsible for the 




The research objectives were: 
1. To extract and isolate the phytoconstituents from extracts of the various morphological 
parts of F. sansibarica, F. bizanae, F. natalensis and F. glumosa. 
2. To identify and characterise the isolated phytoconstituents using 1D and 2D NMR, IR, 
UV and MS spectroscopic techniques. 
3. To identify appropriate bioassays based on the isolated phytoconstituents present in the 
plants and to test the extracts and phytoconstituents for their biological activity in these 
assays and validate their ethnomedicinal uses.  
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Table 1-1 Species of some African Ficus used in ethnomedicine and their biological activities 
No Plant species Plant Part  Ethnomedicinal Uses Biological activity Reference (s) 
1. F. arnottiana Miq. 
 
leaves, bark demulcent (relief of burning 
sensations), inflammation, wounds and 
skin diseases, leprosy scabies, 
astringent (shrinkage of body tissues) 
aphrodisiac (sexual stimulantion),  
fertility. 
anti-inflammatory, analgesic, 
hypoglycaemic, antioxidant, ulcer 
preventive  
 
Amol and Rajsekhar 2011a, 
2011b, Gregory et al., 2009; 
Mazumder et al., 2008; Singh 
2006 
2. F. benghalensis Linn seed, fruit, 
latex, leaves, 
bark 
diabetes, inflammation, ulcers (gastric 
problems), healing of wounds and 
sores, ringworm, leprosy, scabies, 
blood clots, diarrheoa, 
dysentery,gonorrhea, haemorrhoids 
(piles), leucorrhea (viginal complaints) 
aphrodisiac (sexual stimulantion), 
astringent (shrinkage of body tissues), 
antiseptic, toothache, obstinate hiccup 
antidiabetic, anti-inflammatory, 
antitumor, antibacterial, anthelmintic 
(parasitic infections), antidiarrhoeal, 
antioxidant, antiatherogenic (arteries 
protection), ameliorative effect 
(bearable), anti-stress 
Bhalerao et al., 2015; 
Chaturvedi and Murthy 2013; 
Patil and Patil 2010; Nair and 
Chanda, 2007; Burrows and 
Burrows, 2003 
3. F. bizanae Hutch. & 
Burtt-Davy. 
None None None None 
4. F. carica Linn fruits, leaves, 
latex, root 
tumours, anti-inflammatory, 
gastrointestinal, respiratory and 
cardiovascular disorders, diuretic, 
expectorant (mucus drainage from 
lungs), mild laxative 
anticancer, hepatoprotective, 
hypoglycamic, antituberculosis, irritant 
potential (inflammations), antibacterial, 
anthelmintic (parasitic), antipyretic 
(fever), antifugal, anti-mutagenic 
(prevention of genes damage), 
oxidative stress, nematicidal, 
antispasmodic (suppresses muscle 




Mawa et al., 2013; Liu et al., 
2011; Young-Soo and Cha, 
2010; Gilania et al., 2008; Duke 





No Plant species Plant Part  Ethnomedicinal Uses Biological activity Reference (s) 
5.  F. cordata Thunb. 
 
Stem bark tuberculosis, diarrhoea, filariasis 
(parasitic infection) 
 
antimicrobial, hepatoprotective effect 
and antioxidant 
Donfack et al., 2011; Kuete et 
al., 2008;  
Khare, 2007 
6. F. craterostoma Mildbr 
& Burret 
leaves stomach pains antibacterial, anti-inflammatory, 
antidiabetic and antioxidant 
Olaokun et al., 2013; 
Madikizela et al., 2012; Bhat 
and Jacobs 1995 
7. F. exasperata Vahl. leaves, bark, 
root, seed 
hypertension, respiratory tract 
infections, ulcers, intestinal pains, 
stomach and chest pains, wounds, 
bleeding, gonorrhoea, uterine 
disorders, anti-abortifacient, 
rheumatism, arthritis, epilepsy, itching, 
colic, insecticide 
antidiabetic (mellitus), hypoglycaemic 
and hypotensive, hepatoprotective, 
antiulcer, antioxidant, antimicrobial, 
antifungal, anticonvulsant, uterotonic 
and uterine stimulatory effect 
(fertility), oxytocin inhibiting effect 
(sexual reproduction), pesticidal  
Enogieru et al., 2015; Sabiu et 
al., 2015; Taiwo and Igbeneghu 
2014; Bafor et al., 2013, 2011, 
2010, 2009; Kazeem et al., 
2013; Musa and Opadiran 2013; 
Lawal et al., 2012; Mbakwen-
Aniebo et al., 2012; Adewole et 
al., 2011; Woode et al., 2011;  
Igoli et al., 2005; Mashana et 
al., 2000; Akah et al., 1998; 
Adjanahoun et al., 1991 
8. F. glumosa (Miq.) Delile aerial parts diabetes mellitus, hypertension, 
oedema, treating sores, upset stomach, 
menstrual pains, skin diseases, 
rheumatism, conjunctivitis, headache, 
as a mouthwash for toothache. 
anticancer, antidiabetic, 
hypoglycaemic, anti-atherosclerotic 
(prevention of artery wall thickness), 
diuretic (control of body water), anti-
diarrhoeal, hypolipidaemic (lipid- 
lowering), antioxidant, antidiarrhoea 
Ntachapda et al., 2015; Onoja et 
al., 2014; Ntchapda et al., 2014, 
Olaokun et al., 2013; 2014; 
Nana et al., 2012; Madubunyi et 
al., 2012; Tanko et al., 2012; 
Burkill, 1985 
9. F. ingens (Miq.) Miq. aerial parts anaemia, diuretic, diarrhoea, piles, 
laxative 
antiprotozoal, antinociceptive (inhibits 
pain sensation), anti-inflammatory, 
hepatoprotective effect, antibacterial, 
radical scavenging activity 
Donia et al., 2013; Al-Musayeib 
et al., 2012; Chauke et al., 2012; 
Aliyu et al., 2008; Ibrahim et 
al., 2006; Burrows and Burrows, 






No Plant species Plant Part  Ethnomedicinal Uses Biological activity Reference (s) 
10. F. lutea Vahl leaves, bark, 
fruits, root, 
wood 
sores, boils, wound healing, rabies and 
madness in livestock 
antidiabetic and hypoglycaemic 
activity, antimicrobial, antioxidant 
Olaokun et al., 2014; 2013; 
Poumale et al., 2011; Marwah et 
al., 2007; Chifundera, 1998 
 
11. F. microcarpa L. leaves, aerial 
root and bark 
bfever, pain relief, reduce perspiration cytotoxic, analgesic, anti-
inflammatory, antioxidant, 
antibacterial, hyaluronidase inhibitor 
effect (permeability of fluids), 
antitussive (relieves cough), 
expectorant effect, anti-asthmatic  
Shripad et al., 2012; Kiem et al., 
2011; Ao et al., 2010, 2008; Liu 
et al., 2009; Chiang et al., 2005; 
Bich et al., 2004 
 
12.  F. natalensis Hochst.  malaria, influenza, ulcers,  whooping 
cough, dysentery, treating wounds, 
warts and septic ears (skin conditions), 
irregular and painful menstruations, to 
ease childbirth, induces lactation, 
arthritis, eye cataract, headache, as an 
antivenom 
antidiabetic, antibacterial Olaokun et al., 2013; Burrows 
and Burrows, 2003; 
Kamatenesi-Mugisha et al., 
2007; Rabe and Staden, 1997; 
Hutchings et al., 1996 
13. F. nervosa Heyne ex 
Roth 
 
bark, root diabetes, ulcers, rheumatism antimycobacterial, anti-ulcer, 
hepatoprotective effect 
Devi et al., 2012; Shireesha et 
al., 2012; Chen et al., 2010; 
Kokate et al., 1991 
14.  F. ovata Vahl. stem bark, 
leaves, latex 
Infectious and gastrointestinal diseases, 
ring worm, anti-poison 
antimicrobial Kuete et al., 2009; Burrows and 









No Plant species Plant Part  Ethnomedicinal Uses Biological activity Reference (s) 
15. F. palmata Forsk. 
 
all parts anti-diabetic, anti-tumour, lung and 
bladder diseases, lipid lowering effect, 
ulcers, gastrointestinal, constipation, 
antifungal activities, warts 
anti-diabetic, antiplasmodial, anti-
ulcer, anti-coagulant, antioxidant, anti-
calcinogenic,  
hepatoprotective (prevention of liver 





Alqasoumi et al ., 2014a; Joshi 
et al., 2014; Iqbal et al., 2014; 
Singh et al., 2014; Al-Musayeib 
et al., 2012; Parmar and 
Kaushal, 1982 
16. F.  polita Vahl fruit, leaves, 
bark, roots 
malaria, microbial infections, 
abdominal pain, dyspepsia 
(indigestion) 
 
antiviral (HIV-1, HIV-2), antimalarial, 
anti-infammatory, antimicrobial 
Kuete et al., 2011; Kubmarawa 
et al., 2007; Ayisi and 
Nyadedzor, 2003; Recio  et al., 
1995; Gbeassor et al., 1990 
17.  F. racemosa Linn all parts fever, ulcers, dysentery, asthma, 
urinary diseases, gleet (gonorrhoea 
infections), piles, leucorrhea (vaginal 
disorders), menorrhagia (heavy 
menstration), skin diseases, antiseptic, 
vermicidal 
cytotoxic effect (brine shrimp), radical 
scavenging activity, antioxidant, 
wound-healing, anti-inflammatory, 
antiulcer, antitussive (relieves cough), 
anti-pyretic (fever), hypoglycaemic, 
hypolipidaemic, hepatoprotective, 
antidiuretic, chemomodulatory effect 
(renal anticarcinogensis) 
antidiarrrrhoeal, larvicidal, 
anthelmintic and antifilarial (parasitic 
infection), antifungal, antibacterial, 
analgesic 
Rao et al., 2015, 2003, 2002; 
Mehta et al., 2012; Jain et al., 
2013; Hamid et al., 2011; 
Shiksharthi and Mittal, 2011; 
Ahmed and Urooj, 2010; Abdul-
Rahuman et al., 2008; Khan and 
Sultana, 2005; Ratnasooriya  et 
al., 2003; Mandal et al., 1999; 
Deraniyagala et al., 1998 
18.  F. religiosa Linn. all parts antiviral, antiprotozoal, inflammation, 
ulcers, fever, asthma, epilepsy, nervous 
disorders, unconsciousness, drug 
addiction, sexual disorders, skin 
diseases, antivenom 




healing, proteolytic (protein 
breakdown),  
nootropic effect (mental function), 
immunomodulatory, parasympathetic 
Gregory et al., 2013; Patil et al., 
2011; Singh et al., 2011; 
Chandrasekar et al., 2010 
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modulatory effect (sympathetic 
nervous system), anti-amnesic, 
antiasthmatic, antioxidant, anthelmintic 
(fever), antimicrobial, anti-ulcer 
No Plant species Plant Part  Ethnomedicinal Uses Biological activity Reference (s) 
19.  F.  sansibarica Warb. fruits None antioxidant Daniel and Topo, 2012 
20. F. sarmentosa var. 
henryi  
Leaves, stem Acesodyne (pains), detumescence 
(subsiding tension) 
antifungal, insecticidal Wang et al., 2011; 2010; Lu, 
2002 
21. F. sur Forssk 
 
Fruit, leaves, 
stem bark, root 
bark, twigs 
a&gtuberculosis(pulmonary), influenza 
(flu), antifungal, diarrhoea, wound 
healing, skin diseases, gonorrhoea, 
sterility (men), infertility (women), 
leprosy, epilepsy, memory loss,, 




anti-cholinesterase, mutagenic and 
genotoxic, sedative effect, 
anticonvulsant; antioxidant 
 
Madikizela et al., 2014; Ishola 
et al., 2013; Ramde-
Tiendrebeogo et al., 2012; 
Nadembega et al., 2011; Muregi 
et al., 2007, 2003; Eldeen et al., 
2005; Igoli et al., 2005; Watt 
and Breyer-Brandwijk, 1962; 
Hutchings et al, 1996;  
22.  F. sycomorus L stem bark, 
fruits, leaves, 
latex 
malaria, fever, tuberculosis, liver 
problems, diarrhoea, uterine disorders, 
to treat coughs, chest pains, skin 
disease, boils, scabies, ringworm, 
epilepsy, toothache, fatigue, hiccups 
antiplasmodial, antifungal; 
antioxidative, sedative and 
anticonvulsant effects, sperm 
producing effect 
Nadembega et al., 2011; El-
Sayed et al., 2010; Igbokwe et 
al., 2009; Hassan et al., 2007; 
Njoroye and Bussmann, 2007; 
Burrows and Burrows 2003; 
Sandabe et al., 2003; Sanon et 
al., 2003 
23. F. thonningii Blume all parts malaria, pneumonia and gingivitis 
(inflammation), urinary tract infections, 
liver disorders, cough (tuberculosis) 
and chest pains, emphysema, 
antiabortion, sore throat, bronchitis, 
jaundice, skin diseases, athlete’s foot, 
hip disorders 
cytotoxicity, reno- and cardioprotective 
effects, antiprotozoal, anti-
inflammatory,  hypoglycaemic, 
antidiarrheal, toxicity (short-term), 
antifungal, analgesic, anthelmintic, 
antimicrobial and antioxidant 
Fongang et al., 2015; 
Dangarembizi et al., 2013; 
Lansky and Paavilainen 2011; 
Nadembega et al., 2011; Aniagu 
et al., 2008; Musabayane et al., 
2007; Njoroge and Kibunga, 
2007; Burrows and Burrows 
2003. 
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Table 1-2  Compounds isolated from the 23 Ficus species reviewed 
No. Name of compound Molecular 
formular 
Plant species isolated 
from 
References 
 TRITERPENOIDS    
1. Lupeol  C30H50O F. benghalensis,  
F. cordata,  
F. glumosa,  
F. nervosa,  
F. polita,  
F. religiosa 
Bhalerao et al., 2015; 
Ragasa et al., 2013; Nana et 
al., 2012; Singh et al., 2011; 
Donfack et al., 2011; Kamga 
et al., 2010 
2. Lupeol acetate C32H52O2 F. carica,  
F. racemosa,  
F. thonningii 
Fongang et al., 2015; Mawa 
et al., 2013; Jain et al., 2013;  
3. Lupenone C30H48O F. nervosa,  
F. religiosa 
Ragasa et al., 2013; Singh et 
al., 2011. 
4.  Lupeol hexanoate C32H60O2 F. thonningii Fongang et al., 2015 
5. Betulinic acid C30H48O3 F benghalensis,  
F. lutea,  
F. microcarpa,  
F. ovata,  
F. polita 
Bhalerao et al., 2015; 
Poumale et al., 2011; Kamga 
et al., 2010; Kuete et al., 
2009;  
Chiang et al., 2005 
6. 3β-Hydroxy-20-oxo-
29(20→19) abeolupane 




C32H52O4 F. microcarpa Chiang and Kuo, 2002 
8. β-Amyrin C30H50O F benghalensis,  
F. cordata,  
F. glumosa,  
F. lutea,  
F. nervosa,  
F. religiosa 
Bhalerao et al., 2015; 
Ragasa et al., 2013;  
Nana et al., 2012;  
Poumale et al., 2011;  Singh 
et al., 2011;  
Kuete et al, 2008 
9. β-Amyrin acetate C32H52O2 F. cordata,  
F. lutea,  
F. racemosa,  
F. sur,  
F. thonningii 
Fongang et al., 2015; 
Jain et al., 2013;  Donfack et 
al., 2011; Poumale et al., 
2011; Feleke and Brehane, 
2005  
10. Oleanolic acid C30H48O3 F. carica,  
F. microcarpa,  
F. nervosa,  
F. ovata 
Mawa et al., 2013; 
Chen et al., 2010;  
Kuete et al., 2009; 
Chiang et al., 2005 
11. Methyl maslinate C31H50O4 F. carica Mawa et al., 2013 
12. 3β-Acetoxy-12,19-dioxo-
13(18)-oleanene 




C32H52O4 F. microcarpa Chiang and Kuo, 2002 
14. α-Amyrin C30H50O F. nervosa,  
F. religiosa 
Singh et al., 2011; 
Chen et al., 2010 
15. α-Amyrin acetate C32H52O2 F. racemosa,  
F. sur 
Jain et al., 2013; Feleke and 
Brehane 2005 
16. α-Amyrin octacosanoate C58H104O2 F. racemosa Jain et al., 2013 
17. Ursolic acid C30H48O2 F. microcarpa,  Kuete et al, 2011; 
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F. polita Chiang et al., 2005 
18. Acetylursolic acid C32H50O4 F. microcarpa Chiang et al., 2005 
19. Ursonic acid C30H48O3 F. microcarpa Chiang et al., 2005 
20. Taraxasterol C30H50O F. benghalensis Patil and Patil, 2010 
21. 20(30)-Taraxastene-3β,21α-
diol 
C30H50O2 F. microcarpa Kuo and Chiang, 1999 
22. 20-Taraxasten-3β-ol C30H50O F. microcarpa Kuo and Chiang, 1999 
23. 20-Taraxastene-3β,22β-diol C30H50O2 F. microcarpa Kuo and Chiang, 1999 
24. 22-Oxo-20-taraxasten-3β-ol C30H48O2 F. microcarpa Kuo and Chiang, 1999 
25. 3,22-Dioxo-20-taraxastene C30H46O2 F. microcarpa Chiang  et al., 2005 
26. 3β-Acetoxy-20-taraxasten-
22-one 
C32H50O3 F. microcarpa Kuo and Chiang, 1999 
27. 3β-Acetoxy-19(29)-
taraxasten-20α-ol 
C32H52O3 F. microcarpa Chiang  et al., 2005 
28. 20α,21α-Epoxytaraxastan-
3β-ol 
C30H50O2 F. microcarpa Kuo and Chiang, 1999 
29. Ptiloepoxide C30H48O2 F. microcarpa Kuo and Chiang, 1999 
30. 3β-Acetoxy-21α,22α-
epoxytaraxastan-20α-ol 
C32H52O4 F. microcarpa Chiang  et al., 2005 
31. Taraxar-14-ene C30H50O F. polita Kuete et al., 2011 
32. Taraxeryl acetate C32H52O2 F. ovata Kuete et al., 2009 
33. 3β-Acetoxy-11α,12α-epoxy-
14-taraxerene 
C32H50O3 F. microcarpa Chiang  et al., 2005 
34. 3β-Acetoxy-11α,12α-epoxy-
16-oxo-14-taraxerene 
C32H48O4 F. microcarpa Chiang  et al., 2005 
35. Germanicol acetate C32H52O3 F. palmata Alqasoumi et al., 2014a. 
 
36. Bauerenol C30H50O F. carica Mawa et al., 2013 
37. Friedelin (3-friedelanone) C30H50O F benghalensis,  
F. ovata,  
F. thonningii 
Fongang et al.,2015;  
Bhalerao et al., 2015; Kuete 
et al., 2009 
38. 3-Friedelanol C30H52O F. benghalensis,  
F. nervosa 
Bhalerao et al., 2015; 
Ragasa et al., 2013 
39. 3,7-Dioxofriedelane C30H48O2 F. exasperata Dongfack et al., 2012 
40. 3-Oxofriedelan-28-oic acid C30H48O3 F. microcarpa Chiang  et al., 2005 
41. 27-Nor-3β-hydroxy-25-
oxocycloartane 




C29H46O2 F. microcarpa Chiang  et al., 2001 
43. (22E)-25,26,27-Trinor-3β-
hydroxycycloart-22-en-24-al 
C27H42O2 F. microcarpa Chiang  et al., 2001 
44. Cycloeucalenol C30H50O F. nervosa Ragasa et al., 2013 
45. 3β-Acetoxy-15α-hydroxy-
13,27-cyclours-11-ene 
C32H50O3 F. microcarpa Chiang  et al., 2001 
46. 3β-Acetoxy-12α-formyloxy-
13,27-cycloursan-11α-ol 
C33H52O5 F. microcarpa Chiang  et al., 2001 
47. 3β-Acetoxy-25-
hydroxylanosta-8,23-diene 
C33H56O3 F. microcarpa Chiang  et al., 2005 
48. 3β-Acetoxy-25-
methoxylanosta-8,23-diene 
C33H54O3 F. microcarpa Chiang  et al., 2005 
49. Lanosta-7,24-diene-3-one C31H52O F. glumosa Nana et al., 2012. 
50. Lanosta-8,24-diene-3-one C31H52O F. glumosa Nana et al., 2012. 




C34H60O2 F. racemosa Jain et al., 2013 
53. Gluanol acetate C33H56O2 F. racemosa Jain et al., 2013; 
Abdul-Rahuman et al., 2008 
54. Euphol-3-O-cinnamate C39H58O2 F. polita Kuete et al., 2011 
55. Stigmasterol C29H48O F. cordata,  
F. exasperata,  
F. nervosa,  
F. polita,  
F. religiosa 
Dongfack et al., 2012;  
Donfack et al., 2011 
Singh et al., 2011; 
Kamga et al., 2010;  
Chen et al., 2010 
56. Sitosterol C29H50O F. cordata,  
F. exasperata,  
F. ingens,  
F. lutea,   
F. microcarpa,  
F. nervosa,  
F. polita,  
F. racemosa,  
F. religiosa,  
F. thonningii 
Fongang et al., 2015; 
Alqasoumi et al., 2014b; 
Donia et al., 2013; 
Ragasa et al., 2013; 
Jain et al., 2013; 
Dongfack et al., 2012; 
Kiem et al., 2011; 
Singh et al., 2011; 
Poumale et al., 2011; 
Kuete et al., 2011 
57. Sitosterol-3-O-β-D-
glucopyranoside 
C35H60O6 F. cordata,  
F. exasperata,  
F. ingens,  
F. lutea,  
F.  polita,  
F. racemosa,  
F. religiosa,  
F. sycomorus,  
F. thonningii 
Fongang et al., 2015; 
Donia et al., 2013;  
Jain et al., 2013; 
Dongfack et al., 2012 
Poumale et al., 2011; 
Singh et al., 2011; 
Kuete et al, 2011; 
Kamga et al., 2010; 
El-Sayed et al., 2010 








C53H94O7 F. microcarpa Kiem et al., 2011 
61. 6β-Hydroxystigmast-4-en-3-
one 
C29H48O2 F. nervosa Chen et al., 2010 
62. 6β-Hydroxystigmasta-4,22-
dien-3-one 
C29H48O2 F. nervosa Chen et al., 2010 
63. Campesterol C28H48O F. religiosa Singh et al., 2011 
64. 28-Isofucosterol C29H48O F. religiosa Singh et al., 2011 
65. Ergosterol peroxide C28H44O3 F. nervosa Chen et al., 2010 
66. Dongnoside E C50H80O23 F. gluomosa Nana et al., 2012 
 FLAVONOIDS    
67. Kaempferol C15H10O6 F. religiosa Singh et al., 2011 
68. Quercetin C15H10O7 F. ingens,  
F. religiosa,  
F. sarmentosa,  
F. sycomorus 
Donia et al., 2013; Singh et 
al., 2011; 
Wang et al., 2011b; 
El-Sayed et al., 2010 
69. Myricetin C15H10O8 F. religiosa Singh et al., 2011 
70. Quercetin-3-O-glucoside 
(isoquercetin) 
C21H20O12 F. carica,  
F. sycomorus 
Mawa et al., 2013; 
El-Sayed et al., 2010 





C27H30O16 F. benghalensis,  
F. carica,   
F. cordata,  
F. ingens,  
F. sycomorus 
Alqasoumi et al., 2014b; 
Donia et al., 2013; 
Mawa et al., 2013; 
Patil and Patil 2010; 
El-Sayed et al., 2010 
73. Quercetin-3-O-β- 
rhamnoside (quercitrin) 




C33H40O21 F. sycomorus El-Sayed et al., 2010 
75. Patuletin-3′-O-methyl-3-O-
rutinoside 




C27H30O15 F. sycomorus El-Sayed et al., 2010 
77. Isoquercitrin-6-O-4-
hydroxybenzoate 
C28H24O15 F. exasperata Taiwo and Igbeneghu, 2014 
78. Apigenin C15H10O5 F. sarmentosa Wang et al., 2011 
79. Luteolin C15H10O6 F. glumosa,  
F. sarmentosa 
Nana et al., 2012; 
Wang et al., 2010 
80. Isosaponarin C27H30O15 F. microcarpa Kiem et al., 2011 
81. Apigenin-C-8 glucoside C21H20O10 F. exasperata Taiwo and Igbeneghu, 2014 
82. Isovitexin C21H20O10 F. microcarpa Kiem et al., 2011 
83. Luteolin-6-C-β-D-
glucopyranoside 




C61H28O14 F. microcarpa Kiem et al., 2011 
85. 6-Prenylapigenin C20H18O5 F. glumosa Nana et al., 2012 
86. Carpachromene C20H16O5 F. nervosa Chen et al., 2010 
87. Naringenin C15H12O5 F. nervosa Chen et al., 2010 
88. Eriodictyol C15H12O6 F. sarmentosa Wang et al., 2010 
89. Homoeriodictyol C16H14O6 F. sarmentosa Wang et al., 2010 
90. Dihydroquercetin C15H12O7 F. sarmentosa,  
F. thonningii 
Fongang et al., 2015; Wang 
et al., 2010 
91. Aromadendrin C15H12O6 F. thonningii Fongang et al., 2015 
92. 6-Prenylpinocembrin C20H20O4 F. glumosa Nana et al., 2012 






C21H22O6 F. thonningii Fongang et al., 2015 
95. Conrauiflavonol C20H18O6 F. thonningii Fongang et al., 2015 
96. Catechin C15H14O6 F. cordata,  
F. glumosa,  
F. microcarpa 
Nana et al., 2012; 
Donfack et al., 2011;  
Kiem et al., 2011 
Kuete et al., 2008 
97. Epiafzelechin C15H14O5 F. cordata Donfack et al., 2011; 
Kuete et al., 2008 
98. Epicatechin C15H14O6 F. microcarpa Kiem et al., 2011 
99. Genistein C15H10O5 F. glumosa, 
F. nervosa 
Nana et al., 2012; 
Chen et al., 2010 
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100. 2′-Hydroxygenistein C15H10O6 F. nervosa Chen et al., 2010 
101. 2-Hydroxyisoprunetin C16H12O6 F. ovata Kuete et al., 2009 
102. Prunetin C16H12O5 F. nervosa Chen et al., 2010 
103. Dehydroferreirine C16H12O5 F. thonningii Fongang et al., 2015 
104. Cajanin C16H12O6 F. nervosa,  
F. ovata 
Chen et al., 2010; 





C20H20O7 F. thonningii Fongang et al., 2015 
106. Luteone C20H18O6 F. thonningii Fongang et al., 2015 
107. Wighteone C20H18O5 F. glumosa,  
F. thonningii 
Fongang et al., 2015; Nana 
et al., 2012; 
 
108. Parvisoflavone  
(β-Isoluteone) 
C20H16O6 F. nervosa, 
F. thonningii 
 
Chen et al., 2010 
109. Alpinumisoflavone C20H16O5 F.glumosa,  
F. nervosa 
Nana et al., 2012; 
Chen et al., 2010 
110. 4′-O-Methyl 
alpinumisoflavone 




C20H16O6 F. thonningii Fongang et al., 2015 
112. Ficuisoflavone C20H16O6 F. microcarpa Li and Kuo, 1997 
113. 6,7-(2-Isopropenyl furo)-
5,2,4-trihydroxyisoflavone 
C20H16O6 F. ovata Kuete et al., 2009 
114. Isolupinisoflavone E C25H26O7 F. microcarpa Li and Kuo, 1997 
 COUMARINS    
115. Coumarin C9H6O2 F. carica Mawa et al., 2013 
116. Umbelliferone (7-
hydroxycoumarin) 
C9H6O3 F. nervosa Chen et al., 2010 
117. Scopoletin C10H8O4 F. nervosa Chen et al., 2010 
118. Xanthyletin C14H12O3 F. nervosa Chen et al., 2010 
119. 3-Hydroxyxanthyletin C14H12O4 F. nervosa Chen et al., 2010 
120. 3-Methoxyxanthyletin C15H14O4 F. nervosa Chen et al., 2010 
121. Psoralen C11H6O3 F benghalensis,  
F. carica,  
F. cordata,  
F. palmata,  
F. racemosa 
Alqasoumi et al., 2014a, 
2014b; 
Liu et al., 2011; 
Patil and Patil, 2010; 
Deraniyagala et al., 1998. 
122. Bergaptol C11H6O4 F. religiosa Singh et al., 2011 
123. Bergapten C12H8O4 F benghalensis,  
F. carica,  
F. exasperata,  
F. glumosa,  
F. palmata,  
F. religiosa 
Alqasoumi et al.,2014a; 
Mawa et al., 2013; 
Dongfack et al., 2012; 
Nana et al., 2012; 
Singh et al., 2011; 
Patil and Patil, 2010 
124. Hydroxyisoimperatorin C16H14O5 F. cordata Alqasoumi et al., 2014b 
125. Oxypeucedanin hydrate C16H16O6 F. cordata,  
F. exasperata 
Alqasoumi et al., 2014b; 
Dongfack et al., 2012 
126. Marmesin C14H14O4 F. nervosa Chen et al., 2010 
127. Dorsteniol C14H14O5 F. cordata Alqasoumi et al., 2014b 
128. 7-Hydroxy-2,5-dimethyl-
chromen-4-one 
C11H10O3 F. ingens Donia et al., 2013 
129. Trans-psoralenoside C17H18O9 F. palmata Alqasoumi et al., 2014a 
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 ANTHOCYANINS    
130. Leucodelphinidin C15H14O8 F. benghalensis Bhalerao et al., 2015; 
Patil and Patil, 2010 
131. 5,7-Dimethyl ether of 
leucoperalgonidin-3-O-α-L-
rhamnoside 
C23H28O10 F. benghalensis Bhalerao et al., 2015; 
Patil and Patil, 2010 
132. 5,3′-Dimethyl ether of 
leucocyanidin 3- O-β-D-
galactosylcellobioside 
C37H52O21 F. benghalensis Bhalerao et al., 2015; 
Patil and Patil, 2010 
133. Cyanidin-3-
rhamnoglucoside 
C27H31O15 F. carica Solomon et al., 2006 
134. Procyanidin B1 C30H26O12 F. microcarpa Ao et al., 2010 
135. Procyanidin B3 C30H26O12 F. microcarpa Ao et al., 2010 
 PHENOLIC 
COMPOUNDS 
   
136. Protocatechuic acid C7H6O4 F. glumosa,  
F. microcarpa,  
F. ovata 
Nana et al., 2012; 
Ao et al., 2010; 
Kuete et al., 2009 
137. Gallic acid C7H6O5 F. sycomorus El-Sayed et al., 2010 
138. Vanillic acid C8H8O4 F. palmata Alqasoumi et al., 2014a 
139. 2,4,5-Trihydroxy benzoic 
acid  
C7H6O5 F. glumosa Nana et al., 2012 
140. Ferulic acid C10H10O4 F. carica Mawa et al., 2013 
141. 3-O-Caffeoylquinic acid C16H18O9 F. carica,  
F. microcarpa 
Mawa et al., 2013; 
Ao et al., 2010 
142. Methyl chlorogenate C17H20O9 F. microcarpa Ao et al., 2010 
143. 5-O-Caffeoylquinic acid C16H18O9 F. carica Mawa et al., 2013 
144. Syringin C17H24O9 F. microcarpa Kiem et al., 2011 
145. Bergenin C14H16O9 F. racemosa Jain et al., 2013 
146. (7S,8R)-Syringoylglycerol C11H16O6 F. microcarpa Ouyang and Kuo, 2006 
147. Syringoylglycerol-7-O-β-D-
glucopyranoside 





C17H23O10 F. microcarpa Ouyang and Kuo, 2006 
149. Icariside D2 C14H20O7 F. microcarpa Ouyang and Kuo, 2006 
150. Lasiodiplodin C17H24O4 F. nervosa Chen et al., 2010 
151. 4-Hydroxybenzaldehyde C7H6O2 F. nervosa Chen et al., 2010 
152. Vanillin C8H8O3 F. nervosa Chen et al., 2010 




C27H34O12 F. polita Kuete et al., 2011 
155. Ficusal C18H18O6 F. microcarpa Li and Kuo, 2000 
156. Polystachyol C22H28O8 F. glumosa Nana et al., 2012 
157. Lyoniresinol-2α-O-β-D-
xylopyranoside 
C27H36O12 F.glumosa Nana et al., 2012 
158. Ficusesquilignan A C31H36O11 F. microcarpa Li and Kuo, 2000 
159. Ficusesquilignan B C31H36O11 F. microcarpa Li and Kuo, 2000 
 MISCELLANEOUS 
COMPOUNDS 
   
160. Ficusamide C44H87NO6 F. exasperata Dongfack et al., 2012 
161. Glumoamide C42H83NO5 F. glumosa Nana et al., 2012 
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162. Glumoamide C48H93NO10 F. glumosa Nana et al., 2012 
163. Benjaminamide  C42H83NO5 F. lutea Poumale et al., 2011 
164. Lutaoside C40H75NO9 F. lutea Poumale et al., 2011 
165. Politamide C50H97NO11 F. polita Kamga et al., 2010 
166. Chrysophanol C15H10O4 F. ingens Donia et al., 2013 
167. Aloe emodin-O-glucoside C21H20O10 F. ingens Donia et al., 2013 
168. Pheophorbide-a C35H36N4O5 F. exasperata Bafor et al., 2013 
169. Pheophorbide-b C35H34N4O6 F. exasperata Bafor et al., 2013 
170. Pyropheophorbide-a C33H34N4O3 F. exasperata Bafor et al., 2013 




C13H24O4 F. microcarpa Kiem et al., 2011 
173. Bridelionoside B C19H34O9 F. microcarpa Kiem et al., 2011 
174. Dihydroalangionoside A C19H36O8 F. microcarpa Kiem et al., 2011 
175. Ficumegasoside C24H38O11 F. microcarpa Kiem et al., 2011 




C21H32O10 F. microcarpa Ouyang and Kuo, 2006 
178. Ficuspirolide C13H20O4 F. microcarpa Kuo and Li, 1999 
179. Ficusolide C11H20O4 F. microcarpa Kuo and Li, 1999 
180. Ficusolide diacetate C15H24O6 F. microcarpa Li and Kuo, 2000 
181. α-Tocopherol C29H50O2 F. microcarpa Chiang and Kuo, 2003 
182. α-Tocospiro A C29H50O4 F. microcarpa Chiang and Kuo, 2003 
134. α-Tocospiro B C29H50O4 F. microcarpa Chiang and Kuo, 2003 
184. 2,2′-Dihydroxyl ether C4H10O3 F. microcarpa Ouyang and Kuo, 2006 
185. Ficuscarpanic acid C10H18O6 F. microcarpa Ouyang and Kuo, 2006 
186. Hexadecanoic acid C16H32O2 F. ovata Sonibare et al., 2009 
187. Glycerol-1,3-dilinolein C37H64O5 F. exasperata Bafor et al., 2013 
188. 2,3-Dihydroxy 
propylpalmitate 
C19H38O4 F. exasperata Dongfack et al., 2012 
189. Nonane C11H24 F. religiosa Singh et al., 2011 
190. n-Hexacosane C26H54 F. racemosa Jain et al., 2013 
191. 3-Pentanone C5H10O F. carica Mawa et al., 2013 
192. 6,10,14-Trimethyl-2-
pentadecanone 
C18H36O F. natalensis,  
F. ovata 
Sonibare et al., 2009 
193. 2-Methylbutanal C5H10O F. carica Mawa et al., 2013 
194. (E)-2-Hexenal C6H10O F. carica Mawa et al., 2013 
195. 3-Methylbutanol C5H12O F. carica Mawa et al., 2013 
196.  (Z)-3-Hexenol C6H12O F. religiosa Singh et al., 2011 
197. (E)-Phytol C20H40O F. natalensis Sonibare et al., 2009 
198. n-Octacosanol C26H54O F. religiosa Singh et al., 2011 
199. Methyl butanoate C5H10O2 F. carica Mawa et al., 2013 
200. 3-Hexenyl acetate C8H14O2 F. religiosa Singh et al., 2011 
201. 3-O-Glycerolacetate C5H10O4 F. exasperata Bafor et al., 2013 
202. Limonene C10H16 F. carica Mawa et al., 2013 




C10H18O2 F. thonningii Fongang et al., 2015 
205. -Bourbonene C15H24 F. religiosa Singh et al., 2011 
206. Caryophyllene C15H24 F. carica Mawa et al., 2013 
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207. Caryophyllene oxide C15H24O  F. ovata Sonibare et al., 2009 
208. -Elemene C15H24 F. carica Mawa et al., 2013  
209. α-Cubebene C15H24 F. religiosa Singh et al., 2011 
210. Inositol C6H12O6 F. religiosa Singh et al., 2011 
211. Vitamin K C31H46O2 F. religiosa Singh et al., 2011 
212. Perillene C10H14O F. religiosa Singh et al., 2011 
213. Camphene C10H16 F. religiosa Singh et al., 2011 
214. Serotonin C10H12N2O F. religiosa Singh et al., 2011 
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Chapter 2. Antibacterial and anti-biofilm activity of flavonoids 
and triterpenes isolated from the extracts of Ficus sansibarica 
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A phytochemical investigation of Ficus sansibarica Warb. subsp. sansibarica (Moraceae) 
resulted in the isolation of three triterpenes and three flavonoids: lupeol acetate (1); cycloart-
23-ene-3,25-diol (2); β-sitosterol (3); 5,7,4'-trihydroxyflavan-3-ol (4); epicatechin (5); and 
isovitexin (6). The compounds were identified by NMR spectroscopy and by comparison of the 
NMR data against values reported in the literature.  This is the first phytochemical investigation 
of F. sansibarica.  The antimicrobial activity of the crude extracts and isolated compounds 
were weak in comparison to ampicillin and tetracycline.  Antimicrobial activity was observed 
at 8 mg mL-1 for Staphylococcus aureus ATCC 29213 with four of the six isolated compounds, 
with no activity being observed at 1 – 4 mg mL-1 against Escherichia coli ATCC 25922, E. coli 
ATCC 35218 and S. aureus ATCC 43300.  Epicatechin (5) was found to decrease adhesion of 
E. coli ATCC 25922 and S. aureus ATCC 29213.  Decreased adhesion of S. aureus ATCC 
29213 was also observed with 5,7,4'-trihydroxyflavan-3-ol (4) and isovitexin (6).  The results 
of this study provide baseline information on F. sansibarica’s potential validity in the treatment 
of infections associated with Gram-positive microorganisms. 
 





Primary healthcare in Africa is still inaccessible to the vast majority of its population due to 
inadequate transport systems to and from hospitals and clinics, the cost of drugs and the high 
rates charged for in-hospital treatment.  An estimated 80% of the world’s population, rely on 
traditional medicine for the healing and treatment of various ailments from coughs and colds to 
HIV, malaria and tuberculosis (WHO, 1996; Street and Prinsloo, 2013).  In most rural areas, 
traditional medicine is the only form of healthcare available.  Research into the 
pharmacologically active African medicinal plants is being carried out with the aim of 
providing scientific evidence for the use of the plants in traditional medicine, 
commercialization and pharmaceutical application of the active components.  This has 
primarily centered on antimicrobial activity but is now being targeted towards microbial 
virulence mechanisms such as biofilm formation and/or quorum sensing. Microbial biofilm 
formation of microorganisms is associated with persistent tissue and foreign body infections 
which are resistant to treatment with antimicrobial agents. Up to 80% of human bacterial 
infections are biofilm-associated; with infections most frequently being caused by 
Staphylococcus aureus, S. epidermidis, Pseudomonas aeruginosa, and Escherichia coli 
(Römling and Balsalobre, 2012). 
 
In tropical and subtropical regions of the world, the genus Ficus (Moraceae) of the Mulberry 
family constitutes one of the largest genera of angiosperms with over 900 species consisting of 
trees, shrubs and epiphytes (Lansky and Paavilainen, 2011).  Among these, about 110 Ficus 
species are indigenous to Africa (Berg and Wiebes, 1992; Singh et al., 2011).  Many Ficus 
species have been used in African traditional medicine either in the treatment or management 
of a wide variety of ailments and diseases or symptoms of these such as convulsive disorder, 
wound healing, gonorrhea, tuberculosis, diabetes, diarrhoeal infections, dysentery, malaria and 
HIV (Wakeel et al., 2004; Yadav et al., 2006; Parekh and Chanda, 2007; Annan and Houghton, 
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2008; Abdulla et al., 2010: Lamorde et al., 2010; Nadembega et al., 2011). Ficus species have 
also been used in Indian ayurvedic and traditional medicine (Joseph and Justin Raj, 2010).  
Extracts of Ficus species have also been documented to have antioxidant, anti-diabetes, 
antibacterial, antifungal, antiviral, antiprotozoal, anticancer, cytotoxic, anti-ulcer, anti-
inflammatory, anti-hyperglycemic, anti-diarrhoea, hepatoprotective, muco-protective and 
gastro-protective activity (Kuete et al., 2009).  Phytochemical studies on species from the genus 
Ficus have shown these plants to be rich sources of flavonoids, lignans, terpenoids, alkaloids, 
coumarins steroids, and ceramides (Ragasa et al., 1999; Kuete et al., 2008; Ramadan et al., 
2009; Ueda et al., 2009; Chen et al., 2010; Kiem et al., 2011; Naressi et al., 2012).  However, 
although there are many phytochemical and pharmacological reports on species within the 
genus Ficus, there are many species that have not been studied and whose ethnobotanical 
relevance is yet to be investigated.  
 
Ficus sansibarica Warb. subsp. sansibarica is a large tree with a spreading crown which is up 
to 20 × 30 m and is commonly known as the Zanzibar fig, Angola fig or knobbly fig.  It is 
usually without aerial roots and contains milky latex.  The knobbly fig is distributed in South 
Africa (Mpumalanga and Northern Province), Swaziland, Mozambique, Zimbabwe, Zambia, 
Malawi, Tanzania and Kenya. It has also been visually recorded in Zululand (Burrows and 
Burrows, 2003). In Botswana, both adults and children eat the fresh ripe fruits (Daniel and 
Topo, 2012). The ripe fruits are also consumed by birds, fruit bats, baboons, monkeys and other 
animals.  Insectivorous birds which feed upon the wasps that pollinate the figs also eat the 
fruits.  The leaves are browsed by nyala, kudu, elephant and giraffe (Venter and Venter, 1996; 
Boon, 2010).  The only biological study reported so far was the analysis of the fresh ripe fruits 
for its nutrients, total phenols and antioxidant activity (Daniel and Topo, 2012).  This prompted 
us to investigate the phytochemical composition of Ficus sansibarica which to the best of our 
knowledge has not been studied previously, and to test the isolated compounds for 
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antimicrobial and anti-biofilm activity with the aim of providing a scientific rationale for the 
use of the plant in the treatment of some bacterial infections. 
 
2.2. Materials and Methods 
Collection of plant materials 
The fruits, leaves and stem bark of Ficus sansibarica were collected in 2011 in KwaZulu-Natal, 
South Africa. The plant was identified and a voucher specimen (G. V Awolola & H. Baijnath 
1) was deposited in the Ward herbarium at the University of KwaZulu-Natal. 
 
General experimental procedure 
The 1H, 13C and 2D NMR spectroscopy were recorded at room temperature either using 
deuterated chloroform (CDCl3), dimethyl sulfoxide (DMSO) or methanol (MeOH) on a Bruker 
Avance111 400 and 600 MHz spectrometer with tetramethylsilane (TMS) as internal standard.  
All GC-MS analyses of samples were recorded on an Agilent GC-MSD apparatus equipped 
with DB-5SIL MS (30 m × 0.25 mm i.d., 0.25 µm film thickness) fused-silica capillary column. 
The carrier gas was Helium (2 mL min-1). The MS was operated in the EI mode at 70 eV.  The 
LC-MS sample analyses were recorded on an Agilent LC-MSD apparatus equipped with a UV 
detector using a mobile phase of 95% acetonitrile, 10% water, and both containing 1.1% formic 
acid at a flow rate of 1ml min-1. Infrared (IR) spectral data was obtained using a Perkin Elmer 
Spectrum 100 Fourier transform infrared spectroscopy (FT-IR) spectrometer with universal 
attenuated total reflection (ATR) sampling accessory. All UV spectra were obtained using a 
Varian Cary UV-VIS spectrophotometer. Optical rotations were measured at room temperature 
using a 10 cm flow tube in a PerkinElmerTM, Model 341 Polarimeter. Melting points were 
obtained using an Ernst Leitz Wetziar micro-hot stage melting point apparatus. For column 
chromatography, Merck silica gel 60 (0.040-0.063 mm) was used while Merck 20 cm × 20 cm 
silica gel 60 F254 aluminium sheets were used for TLC.  The TLC plates were analysed under 
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UV (254 and 366 nm) before being visualized by spraying the plate with a 10% sulphuric acid 
in MeOH solution followed by heating. 
 
Extraction and Isolation 
Freshly crushed F. sansibarica fruits (516 g) were subjected to cold extraction using MeOH, 
while air-dried and ground leaves (520 g) and stem bark (1.5 kg) were subjected to exhaustive 
extraction using solvents of increasing polarity: hexane, dichloromethane (DCM), ethyl acetate 
(EtOAc) and MeOH by maceration with continuous shaking on an orbital shaker for 48 h each 
time at room temperature. The different solvent extracts were concentrated using a rotary 
evaporator and the obtained crude extracts in each case were stored for further analysis. Using 
suitably sized columns the crude extracts were subjected to column chromatography for 
fractionation and the fractions collected were monitored using TLC. Similar fractions were 
combined and concentrated using a rotary evaporator. 
 
The MeOH extract from the fruits was partitioned with EtOAc and the EtOAc portion 
concentrated yielding 1 g of extract.  This was separated on a 1.5 cm diameter column over 
silica gel (0.040-0.063 mm) using a gradient elution of n-hexane:EtOAc (with 10% increments 
of EtOAc) and finally with 100% MeOH, collecting 20 mL at each stage. The fractions were 
combined on the basis of TLC to afford six main fractions (I-VI). Fraction IV was purified 
using CC over Sephadex LH-20 (MeOH) to afford isovitexin 6 (25 mg), a dark yellow solid.  
 
The crude hexane extract of the leaves (10.3 g) was separated using CC in a similar manner 
with a hexane:EtOAc step gradient (with 10% increments every 100 mL). Compound 2, 
cycloart-23-ene-3,25-diol (13 mg) was eluted with hexane:EtOAc (9:1) and evaporated to a 
white powder.  Lupeol acetate 1 (995 mg) was eluted with hexane:EtOAc (8:2) and 
recrystallized in MeOH to give a white powder. The hexane extract (10.4 g) from the stem bark 
was separated in the same manner and yielded sitosterol 3 (305 mg) with hexane:EtOAc (8:2).   
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Figure 2-1  Chemical structures of compounds isolated from Ficus sansibarica. Lupeol acetate 
(1), cycloart-23-ene-3,25-diol (2), sitosterol (3), 5,7,4'-trihydroxyflavan-3-ol, R = H, (4), 
epicatechin, R = OH (5), isovitexin (6). 
 
The EtOAc extract (20.3 g) from the stem bark afforded two flavonoids using both a 
hexane:EtOAc step gradient and a DCM:MeOH step gradient, collecting 100 mL at each stage 
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as stated above. With hexane:EtOAc (8:2), a brownish solid compound, 5,7,4'-
trihydroxyflavan-3-ol 4 (85 mg) was obtained.  Epicatechin 5 (124 mg) was eluted with 10% 
MeOH in DCM.  The structures of 1-6 are given in Figure 2-1. 
 
Antimicrobial susceptibility testing 
Antimicrobial susceptibility of the crude MeOH leaf and stem bark extracts and compounds 1-6 
were determined using the disk-diffusion method.  Crude extracts and isolated compounds were 
dissolved in chloroform or DMSO to a final concentration of 100 mg mL-1.  Blank discs (6 mm; 
MAST, UK) were impregnated with 10 µL (1 mg), 20 µL (2 mg) and 40 µL (4 mg) and 
allowed to dry.   
 
Bacterial isolates (Gram-negative: Escherichia coli ATCC 25922 and E. coli ATCC 35218; 
Gram-positive: Staphylococcus aureus ATCC 29213 and S. aureus ATCC 43300) were grown 
overnight on tryptic soy agar (TSA) plates. Cell suspensions were prepared with sterile 
deionized water and the turbidity adjusted equivalent to that of a 0.5 McFarland standard.  
These were used to inoculate Mueller-Hinton (MH) agar plates by streaking swabs over the 
entire agar surface followed by the application of the respective phytochemical extract discs 
(CLSI, 2007).   Plates were then incubated for 24 h at 37 °C.  Testing was done in duplicate 
with tetracycline (TE30; 30 µg mL-1) and ampicillin (AMP10; 10 µg mL-1) discs being used as 
standard antimicrobial agent controls, in addition to DMSO and chloroform.   
 
Following the preliminary disk-diffusion assays, the agar-well diffusion assay was also used for 
S. aureus ATCC 29213, in order to accommodate a greater concentration of the isolated 
compounds.  Instead of using impregnated discs, agar wells with a diameter of ~6 mm were cut 
into MH agar plates swabbed with S. aureus ATCC 29213.  Wells were filled with 80 µL of 
100 mg mL-1 stock solutions of compounds 1, 2, 4 and 5 (8 mg mL-1) and 80 µL of 20 mg mL-1 
stock solution of compound 6 (1.6 mg mL-1).  Plates were then incubated for 24 h at 37 °C.  
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Testing was done in duplicate and tetracycline (TE30) and ampicillin (AMP10) discs were used 
as standard antimicrobial agent controls, in addition to DMSO and chloroform as negative 
controls.  Zone diameters were determined and averaged.  The following zone diameter criteria 
were used to assign susceptibility or resistance to the phytochemicals tested: Susceptible (S) ≥ 
15 mm, Intermediate (I) = 11 – 14 mm, and Resistant (R) ≤ 10 mm (Okoth et al., 2013).  
Criteria for assigning susceptibility or resistance to AMP10 was as follows: (S) ≥ 17 mm, (I) = 
14 – 16 mm, (R) ≤ 13 mm, while those for TE30 were: (S) ≥ 19 mm, (I) 15 – 18 mm, (R) ≤ 14 
mm (CLSI, 2007).  
 
Biofilm microtitre plate assays  
In order to ascertain the anti-biofilm potential of the isolated compounds, E. coli ATCC 29922, 
E. coli ATCC 35218, S. aureus ATCC 29213 and S. aureus ATCC 43300 were exposed to 
lupeol acetate 1 (100 mg mL-1 stock; 2, 5, 10 and 15 mg mL-1); 5,7,4'-trihydroxyflavan-3-ol 4 
(100 mg mL-1 stock; 1 and 2.5 mg mL-1); epicatechin 5 (100 mg mL-1 stock; 1, 2.5, 5 and 7.5 
mg mL-1); and isovitexin 6 (20 mg mL-1  stock; 0.2 and 0.5 mg mL-1) using microtitre plate 
assays (Basson et al., 2008).  The purified cycloart-23-ene-3, 25-diol 2 could not be tested due 
to unavailability of sufficient material.  All isolates were cultured overnight in tryptic soy broth 
(TSB) and centrifuged for 2 min at 12000 rpm. Cell pellets were washed and re-suspended to a 
turbidity equivalent to a 0.5 McFarland standard.  Each well of the sterile 96-well U-bottomed 
polystyrene microtitre plates contained 90 µL of TSB medium and 10 µL of culture after 
standardization.  To investigate the effect on adherence, respective volumes of extracts were 
added to the TSB medium at the time of inoculation in the microtitre plate assays and volumes 
were standardised to 200 µL with sterile distilled water.  Positive control wells contained TSB 
broth and respective cultures without the tested compounds whilst the negative control wells 
contained un-inoculated TSB broth only to test for sterility and non-specific binding of media. 
Plates were incubated aerobically for 24 h with agitation on an Orbit P4 microtitre plate shaker 
(Labnet), at 37 °C to allow cell attachment and biofilm formation (Basson et al., 2008).   
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Following incubation, the crystal violet assay was performed.  The contents of each well were 
aspirated.  Microtitre plates were washed three times with sterile deionised water to remove 
loosely attached cells.  The remaining cells were fixed with 200 µl of MeOH for 15 min and 
air-dried. Following drying, the wells were stained with 150 µl of 2% Hucker’s crystal violet 
for 5 min.  Thereafter, wells were rinsed gently with water, air-dried and 150 µl of 33% (v/v) of 
glacial acetic acid was added for re-solubilisation of dye bound to adherent cells. Plates were 
then read using the GloMax®-Multi+ Detection System (Promega) at an optical density of 600 
nm.  Tests were done in triplicate on two separate occasions and the results were averaged 
(Basson et al., 2008). OD600 nm values of treated cells were compared to untreated cells to 
investigate the increase or decrease in adhesion as a result of phytochemical exposure. Treated 
and untreated samples were compared statistically using Paired t-tests (SigmaStat V3.5, Systat 
Software, Inc). 
    
2.3. Results and discussion 
The phytochemical investigation of the leaves, stem bark and fruits of F. sansibarica yielded 
six compounds: three triterpenoids and three flavonoids. The non-polar hexane extract of both 
the leaves (1 and 2) and the stem bark (3) contained triterpenoids while the flavonoids were 
isolated from the more polar EtOAc extract of both the stem bark (4 and 5) and the fruits (6).  
The isolated compounds were identified based on their 1H and 13C NMR spectra and 2D NMR 
spectra and compared with literature values.  Thus, they were identified as lupeol acetate 1 
(Mahato and Kundu, 1994), cycloart-23-ene-3,25-diol 2 (Khan et al., 2006; Abdel-Monem et 
al., 2008; Escobedo-Martínez et al., 2012), sitosterol 3 (Chaturvedula and Prakash, 2012), 
5,7,4'-trihydroxyflavan-3-ol 4 (Dafalla, 2005; Iida et al., 2007), epicatechin 5 (Hubert et al., 
2011; Markham and Ternai, 1976) and isovitexin 6 (Lin et al., 2009).  
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Epicatechin 5 has been isolated from several Ficus species like F. microcarpa and F. 
spragueana (Kiem et al., 2011; Ragab et al., 2013).  In contrast, isovitexin 6 was only 
reportedly isolated from F. microcarpa (Kiem et al., 2011), while 5,7,4'-trihydroxyflavan-3-ol 
4 was isolated from F. capensis and F. spragueana (Owolabi et al., 2009; Ragab et al., 2013).  
Lupeol acetate 1 and sitosterol 3 are ubiquitous to plants.  To the best of our knowledge, this is 
the first report of cycloart-23-ene-3,25-diol 2, a cycloartane type triterpenoid with molecular 
formula C30H50O2 in the genus Ficus.  Furthermore, a comparison of the NMR data obtained 
for 2 with that published in the literature (Abdel-Monem et al., 2008; Escobedo-Martinez et al., 
2012, Khan et al., 2006) matched the NMR data of the cycloartane backbone only and there 
were discrepancies in the NMR data of the side chain, which we have unambiguously assigned 
from HMBC data.    The cis isomer of 2 is also reported (Gherraf et al., 2010) and is also 
included here for comparison.  We speculate that the reports of 2 in Abdel-Monem et al. 
(2008), Escobedo-Martinez et al. (2012) and Khan et al. (2006) are also that of the cis isomer as 
the H-23 and H-24 resonances were always reported as overlapping multiplets at δH 5.60.  In 
our spectra, we were able to clearly define the trans nature of the ∆23 double bond by clear 
coupling constants.  A full NMR structural elucidation is given below and a comparison with 
that in the literature given in Table 2-1. 
 
The 1H-NMR spectrum of compound 2 displayed two pairs of doublets with resonances at δH 
0.55 (1H, d, J = 3.4 Hz, H-19a) and at 0.30 (1H, d, J = 3.4 Hz, H-19b), characteristic of 
cycloartane-type triterpenes. In addition, there were the presence of seven methyl groups at δ 
0.82 (s, CH3-29), 0.89 (d, J = 6.5 Hz, CH3-21), 0.90 (s, CH3-28), 0.99 (s, CH3-30, CH3-18), 
1.36 (s, CH3-26/27), the typical H-3 resonance for triterpenoids at δ 3.26, a doublet of doublet 
of doublets (ddd) at δH 5.71 (1H,  J = 15.7, 8.5, 6.1 Hz, H-23),  a doublet at δH 5.53 (1H, J = 
15.7 Hz, H-24) and one proton of the H-22 methylene group at δ 2.26 which could clearly be 
distinguished.  The 13C NMR spectrum was able to be resolved into 7 methyl, 10 methylene, 7 
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methine and 6 singlet carbon resonances, including two olefinic methine resonances for the 
double bond in the side chain, an oxygenated singlet resonance at δC 82.3 and an oxygenated 
methine resonance at δC 78.8, indicating two hydroxy groups in the molecule.  
 
The splitting pattern of the two olefinic protons, which appeared as a ddd at δH 5.71 (J = 15.7, 
8.5, 6.1 Hz, H-23) and doublet at δH 5.53 (J = 15.7 Hz, H-24) arose as a result of H-23 coupling 
with H-24, and H-23 coupling with the two diastereotopic H-22 methylene protons.  These 
coupling constants clearly indicated that the double bond at ∆23 was trans because of the large 
J23,24 value of 15.7 Hz, typical of trans olefinic protons.  Coupling in the COSY spectrum 
between H-23 and H-24 and between H-23 and the two H-22 proton resonances at δH 2.26 and 
1.81, both multiplets was also present.  The corresponding carbon resonances of C-23 and C-24 
were identified at δC 130.74 and 134.45 respectively.  The C-23 carbon resonance was used to 
identify the 3H-26/27 methyl resonances through a HMBC correlation with δH 1.36 and in turn 
the C-25 oxygenated singlet resonance at δC 82.30 through a HMBC correlation between δH 
1.36 and δC 82.30.  The H-23 proton resonance also showed a HMBC correlation to C-25.  The 
doublet of 3H-21 at δH 0.89 showed HMBC correlations to C-17, C-22 and C-20 at δC 52.07, 
39.36 and 36.29 respectively, completing the side chain assignment and linking it to the core 
skeleton. 
 
The rest of the proton and carbon resonances were confirmed by COSY and HMBC 
correlations and matched well with that in Escobedo-Martinez et al. (2012). 
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Table 2-1  
1H and 13C NMR data of cycloart-23-ene-3,25-diol (2) (600 MHz, CDCl3) 
Pos. 1Ha 1Hb,c 1H (2)* 13Ca 13Cb 13C (2)* 
1 1.56 (m), 1.24 (m) 1.30 (m), 0.90 (m) 1.58 (m), 1.26 (m) 31.98 31.93 31.96 
2 1.76 (m), 1.56 (m) 1.40 (m), 1.23 (m)  1.78 (m), 1.58 (m) 30.40 30.33 30.38 
3 3.24 (m) 3.10 (m) 3.26 (m) 78.86 78.80 78.84 
4 - - - 40.50 40.45 40.48 
5 1.30 (m) 0.91 (m) 1.30 (m) 47.11 47.10 47.09 
6 1.59 (m), 0.79 (m) 1.26 (m), 0.45 
(dd, 12.5, 8) 
1.60 (m), 0.80 (m) 21.12 21.08 21.09 
7 1.33 (m), 1.08 (m) 1.65 (m), 1.40 (m) 1.35 (m), 1.10 (m) 26.02 28.04 25.99 
8 1.51 (m) 1.16 (dd, 5, 13) 1.51 (m) 47.98 48.00 47.94 
9 - - - 20.02 20.00 19.98 
10 - - - 26.11 25.96 26.10 
11 1.99 (m), 1.20 (m) 0.77 (m, 2H) 2.00 (m), 1.15 (m) 26.46 26.07 26.45 
12 1.61 (m, 2H) 0.93 (m, 2H) 1.63 (m, 2H) 32.80 35.55 32.80 
13 - - - 45.32 45.29 45.33 
14 - - - 48.83 48.80 48.83 
15 1.30 (m, 2H 1.27 (m, 2H) 1.30 (m, 2H) 35.59 32.76 35.56 
16 1.91 (m), 1.30 (m) 1.60 (m, 2H) 1.90 (m), 1.30 (m) 28.09 26.42 28.08 
17 1.57 (m) 1.24 (m) 1.58 (m) 52.02 52.00 52.07 
18 0.97 (s, 3H) 0.62 (s, 3H) 0.99 (s, 3H) 18.10 18.04 18.07 
19 0.57 (d, 4.2), 0.34 
(d, 4.2) 
0.22 (d, 4.5), 0.01 
(d, 4.5) 
0.57 (d, 3.9), 0.35 
(d, 3.9) 
29.90 30.00 29.86 
20 1.46 (m) 1.10 (m) 1.50 (m) 36.40 36.66 36.29 
21 0.86 (d, 6.5, 3H) 0.53 (d, 3.5, 3H) 0.89 (d, 6.5, 3H) 18.30 18.25 18.22 
22 2.18 (m), 1.74 (m) 1.88 (m) 2.26 (m), 1.81 (m) 39.05 39.00 39.36 
23 5.59 (m) 5.26 (d, 8.0) 5.71 (ddd, 15.7, 
8.5, 6.06) 
125.63 139.31 130.74 
 
24 5.60 (m) 5.26 (d, 8.0) 5.53 (d, 15.7) 139.36 125.57 134.45 
25 - - - 70.77 70.75 82.30 
26 1.31 (s, 3H) 0.98 (s, 3H) 1.36 (s, 3H) 30.00 29.66 24.40 
27 1.32 (s, 3H) 0.98 (s, 3H) 1.36 (s, 3H) 29.90 29.83 24.34 
28 0.89 (s, 3H) 0.56 (s, 3H) 0.89 (s, 3H)  19.31 19.26 19.30 
29 0.81 (s, 3H) 0.42 (s, 3H) 0.82 (s, 3H) 14.02 13.9 13.99 
30 0.97 (s, 3H) 0.62 (s, 3H) 0.98 (s, 3H) 25.45 25.41 25.43 
a Escobedo-Martinez et al. (2012); b  Gherraf et al. (2010), ∆23 cis isomer; c It is highly likely 
that the 1H NMR spectrum in Gherraf et al. (2010) is offset by approximately δ 0.33; coupling 
constants are given in parenthesis; * 1H  and 13C NMR data of this work for compound 2. 
 
 
Antimicrobial susceptibility testing 
The isolated compounds and extracts were subjected to antimicrobial screening and the results 
are presented in Table 2-2. Initial disk-diffusion assays with 1 – 4 mg mL-1 of the six isolated 
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compounds, as well as the crude methanolic leaf and stem-bark extracts proved ineffective 
against the four bacterial strains (Gram-negative: β-lactam susceptible E. coli ATCC 25922 and 
β-lactam resistant E. coli ATCC 35218; Gram-positive: methicillin-susceptible S. aureus 
ATCC 29213 and methicillin-resistant S. aureus ATCC 43300) tested, with no zones of 
inhibition being observed (Table 2-2).  However, S. aureus ATCC 29213 demonstrated 
intermediate susceptibility to 8 mg mL-1 for four of the compounds: lupeol acetate 1, cycloart-
23-ene-3, 25-diol 2, sitosterol 3 and epicatechin 5, using the agar-well diffusion assay (Table 
2-2). However, the flavonoids, 5, 7, 4',-trihydroxyflavan-3-ol 4 and isovitexin 6 were not active 
against the bacteria being tested (Table 2-2).  Most phytochemicals work best against Gram-
positive bacteria and there are very limited small-molecule plant-derived antimicrobial 
compounds with high activity against Gram-negative species (Lewis, 2013).   
 
The limited inhibition observed for the crude MeOH extracts is not surprising.  Reports on the 
antimicrobial activity of extracts from other Ficus species have been variable, with differences 
related to the Ficus species tested, the part of the plant sampled, the extraction solvent and the 
method of antimicrobial testing (Salem et al., 2013).  Lawal et al. (2012) observed F. 
exasperata root bark MeOH extract antimicrobial activity against three S. aureus strains at ≥ 
12.5 mg mL-1, while activity against E. coli strains required ≥ 25 mg mL-1.  They also noted the 
potency of the MeOH extract compared to the EtOAc extract.  Murti and Kumar (2011) 
demonstrated that the F. racemosa ethanolic root extract (25, 50 and 75 mg mL-1) showed 
maximum inhibition against S. aureus when compared with F. benghalensis ethanolic root 
extract.  Crude extracts and compounds from Ficus conraui stem barks also demonstrated 
selective antimicrobial activity varying from weak to moderate (Kengap et al., 2011).  In 
contrast, MICs of ≥ 625 µg mL-1 were obtained with F. ovata stem bark MeOH extracts from S. 
aureus and E. coli. (Kuete et al., 2009), while F. polita MeOH root extract and euphol-3-O-
cinnamate and (E)-3,5,4'-trihydroxy-stilbene-3,5-O-β-D-diglucopyranoside MICs ranged from 
32 - ≥512 µg mL-1 against Gram-positive and Gram-negative bacteria (Kuete et al., 2011). 
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The antimicrobial potencies of the two classes (triterpenes and flavonoids) of compounds 
isolated have previously been established (Cowan, 1999).  Akiyama et al. (2001) obtained 
epicatechin MICs of 8 mg mL-1 with 18 clinical S. aureus strains, since it causes limited 
damage to bacterial plasma membranes, while Mahmoud et al. (2013) observed no 
antimicrobial effect against methicillin-susceptible and –resistant S. aureus strains with 32 – 
1024 µg mL-1 of epicatechin.  The reported weak activity of some isolated cycloartane-type 
triterpenoids from the genus Aphanamixis against S. aureus (Wang et al., 2013) was consistent 
with the weak activity observed for cycloart-23-ene-3, 25-diol (2) in this study.  
 
Biofilm microtitre plate assays 
In the face of increasing incidence of antimicrobial resistance and recalcitrance of bacteria to 
current antimicrobial therapy, drug discovery research is focusing on limiting the pathogenecity 
mechanisms demonstrated by bacteria.  Given the focus on biofilms and their role in microbial 
pathogenicity, screening for the anti-biofilm activity of phytochemicals is imperative in 
identifying alternative therapeutic options. The anti-biofilm activity of lupeol acetate 1; 5,7,4'-
trihydroxyflavan-3-ol 4; epicatechin 5 and isovitexin 6 against E. coli ATCC 29922, E. coli 
ATCC 35218, S. aureus ATCC 29213 and S. aureus ATCC 43300 was variable.  Lupeol 
acetate (triterpene) exposures resulted in statistically significant increased adhesion for all 
strains (Figure 2-2) at all concentrations tested (2 – 15 mg/ml).   
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Table 2-2 Antimicrobial susceptibility profile of Staphylococcus aureus ATCC 29213 


















Lupeol acetate (1) 8 0 13.5 (I) 
Cycloart-23-ene-3,25-diol (2) 8 0 11.5 (I) 
Sitosterol (3) 8 0 13 (I) 
5,7,4'-trihydroxyflavan-3-ol (4) 8 0 0 (R) 
Epicatechin (5) 8 0  13.5 (I) 
Isovitexin (6) 1.6 0 0 (R) 
MeOH leaf extract 8 0 0 (R) 
MeOH stem bark extract 8 0 9 (R) 
Ampicillin 10 25 (S) 25 (S) 
Tetracycline 30 28 (S) 28 (S) 
Chloroform  0 0 (R) 
DMSO  0 0 (R) 
* Tested using disk-diffusion assay;  
# Tested using agar-well diffusion assay; and   
S = susceptible (≥ 15mm), I = intermediate susceptibility (11-14mm), and R = resistant (≤ 10mm) (CLSI, 2007).  
 
Epicatechin 5 exposures decreased adhesion of antimicrobial-susceptible E. coli ATCC 25922 
and S. aureus ATCC 29213 at all concentrations tested (1 – 7.5 mg mL-1), with 5 mg mL-1 
being the most effective (Figure 2-3) indicating that epicatechin has the ability to interfere with 
the adhesion ability of these microorganisms to polystyrene surfaces.  El-Adawi (2012) 
obtained a 55-66% decrease in Streptococcus mutans biofilm formation upon exposure to 2-
15% epicatechin.  Previous reports have suggested that epicatechin was unable to inhibit 
biofilm formation as observed for Eikenella corrodens, a periodontopathogenic bacterium 
(Matsunaga et al., 2010) and for P. aeruginosa PAO1 biofilm formation after 18 h of growth 
(Vandeputte et al., 2010).  Similarly, Nyila et al. (2012) observed that epicatechin from Acacia 
karroo did not reduce Listeria monocytogenes biofilms.  The observed anti-biofilm activity of 
epicatechin was, however, strain-specific as adhesion of β-lactam resistant E. coli ATCC 35218 
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and methicillin-resistant S. aureus ATCC 43300 was increased at all concentrations tested 
(Figure 2-3).  Biofilm formation of P. aeruginosa PAO1 was enhanced 3- to 7-fold under the 
action of epicatechin. Epicatechin caused an up to 5-fold enhancement of the P. aeruginosa 
PAO1 biofilm formation at sub-inhibitory concentrations up to 750 µg mL-1 (Plyuta et al., 
2013).  
 
5,7,4',-Trihydroxyflavan-3-ol 4 (1-2.5 mg mL-1) and isovitexin 6 (0.2-0.5 mg mL-1) exposures 
also decreased adhesion of methicillin-susceptible S. aureus ATCC 29213 (Figure 2-4 and 
Figure 2-5).  Exposure to 2.5 mg mL-1 of 4 almost completely inhibited adhesion of S. aureus 
ATCC 29213 and decreased adhesion of β-lactam susceptible E. coli ATCC 25922 (Figure 
2-4).  No previous studies have examined the effect of lupeol acetate, 5,7,4',-trihydroxyflavan-
3-ol 4 and isovitexin 6 on microbial adhesion.  The anti-adhesion activity of 4, 5 and 6 was 
strain-specific, being most effective against S. aureus ATCC 29213, while lupeol acetate (1) 
increased adhesion of all E. coli and S. aureus strains tested.  
2.4.  Conclusion 
The phytochemical investigation of Ficus sansibarica resulted in the isolation of three 
triterpenes and three flavonoids.  The antimicrobial activity of the crude extracts and the 
isolated compounds were weak with a narrow-spectrum activity against Gram-positive bacteria.  
Most phytochemicals work best against Gram-positive bacteria and there are very limited 
small-molecule plant-derived antimicrobial compounds with high activity against Gram-
negative species.  The anti-biofilm activity demonstrated by the flavonoids 5,7,4'-
trihydroxyflavan-3-ol, epicatechin and isovitexin (4-6) is most significant for S. aureus ATCC 
29213. The results of this study provide baseline information on F. sansibarica potential 

















































































































Figure 2-2  Anti-adhesion activity of 1 – 15 mg mL-1 of lupeol acetate (1) on biofilm formation 
































































































Figure 2-3  Anti-adhesion activity of 1 – 7.5 mg mL-1 of epicatechin (5) on biofilm formation 

































































































Figure 2-4  Anti-adhesion activity of 1 – 2.5 mg mL-1 of 5,7,4'-trihydroxyflavan-3-ol (4) on 




































































































0.5 mg/ml  
 
Figure 2-5  Anti-adhesion activity of 0.2 – 0.5 mg mL-1 of isovitexin (6) on biofilm formation 
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A phytochemical investigation of the fruit, leaves and stem bark extracts of Ficus bizanae 
resulted in the isolation of fourteen compounds, 7-methoxy coumarin (1), psoralen (2), 
tectoquinone (3), quercetin-3-O-β-D-glucopyranoside (4), vomifoliol (blumenol A) (5), (+)-
dehydrovomifoliol (6), dihydroferulic acid (7), 4-methoxy catechol (8), protocatehuic acid (9), 
taraxerol (10), 3β-acetoxy-9(11)-fernene (11), lupanyl acetate (12), β-amyrin acetate (13) and 
sitosterol (14).  The resistance-modifying effect of the hexane, dichloromethane, ethyl acetate 
and methanol extracts of the leaves, stem bark and fruit against ceftriaxone, cefotaxime, 
nalidixic acid, sulphamethoxazole, gentamicin and azithromycin was assessed against six 
Gram-positive and Gram-negative strains using a modified disc diffusion method.  Most extract 
combinations demonstrated either potentiation, additive or indifferent interaction effects, in a 
strain- and extract-specific manner, against the tested bacteria with some antagonistic effects.  
Potentiation of azithromycin activity was observed for all Gram-positive and Gram-negative 
strains with varying extract combinations.  Potentiation of gentamicin activity was observed 
with all extract combinations for both Pseudomonas aeruginosa strains tested, and this was not 
observed with any of the other antimicrobial agents tested.  Potentiation of sulphamethoxazole 
and nalidixic acid activity was effective against staphylococci, while potentiation of 
cephalosporin activity was observed for majority of strains tested.  Based on preliminary data, 
F. bizanae extracts could serve as resistance modifying adjuvants to improve efficacy of 
conventionally used antimicrobial agents. 
 






South Africa has a wealth of flora, thus a wide variety of plants are available to be used for 
medicinal purposes (Lall and Kishore, 2014).  Although many of the plants have been 
investigated for their medicinal uses and phytochemistry, there are still many others that are yet 
to be investigated.  Furthermore, the phytochemical investigation of these plants can provide a 
rationale for their use in ethnomedicine.   
 
Ficus bizanae Hutch. & Burtt-Davy, a tree of up to 15-18 m in height belongs to the Moraceae 
(mulberry) family and is one of the plants endemic to South Africa (IUCN 2014).  It is 
commonly known as Pondo Fig or Pondoland Fig.  In South Africa, the Afrikaners know it as 
‘Pondovy’ while the Xhosa call it ‘umthombe’.  It is distributed in the Butterwort district of 
Eastern Cape, and in the Ngoye Forest in KwaZulu-Natal, South Africa.  Thus far, there is no 
record of either ethnobotanical or economic uses for this species.  Ficus bizanae is documented 
to be morphologically similar to Ficus polita (Burrows and Burrows, 2003).  In West Africa, 
the fruits are consumed by the indigenous people and bark cloth can be made from its fig 
(Irvine, 1961).  
 
Various classes of compounds including steroids, triterpenes, coumarins, flavonoids, alkaloids, 
phenolic acids, megastigmanes, pheophytins and pheophorbides have been isolated from 
diverse Ficus species (Singh et al., 2011; Mawa et al., 2013; Salem et al., 2013; Barolo et al., 
2014; Bunawan et al., 2014).  Furthermore, extracts of many Ficus species have a variety of 
bioactivities including antibacterial, anti-diarrheal, antioxidant, antimalarial, anticoagulant, 
hepato-protective, nephro-protective, anti-inflammatory, anti-hyperglycemic, anti-gastric ulcer, 
anti-viral and anti-HIV (Kengap et al., 2011; Singh et al., 2011; Mawa et al., 2013; Barolo et 
al., 2014; Bunawan et al., 2014 ). 
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The search for new antimicrobial agents has increased recently due to the increase in multi-
drug resistance demonstrated by bacterial pathogens globally.  Plants produce a variety of 
structurally diverse bioactive compounds to protect themselves against a range of 
microorganisms including plant pathogens and environmental organisms (phytoalexins).  Plants 
carry out combinatorial chemistry by using the variety of precursors it has at its disposal, 
creating a multitude of organic compounds (Ncube et al., 2012).  Plant-derived compounds, 
while abundant and diverse, demonstrate limited antimicrobial activity compared to antibiotics 
of bacterial or fungal origin.  Additionally, these compounds are more effective against Gram-
positive rather than Gram-negative bacteria.  Since plant-derived antimicrobials are less potent, 
plants adopt a different paradigm, i.e., synergy to combat microbial infections.  Synergism is a 
phenomenon in which two different compounds are combined to enhance their individual 
activity, while if the combination results in a reduced effect; it is called antagonism (Chung et 
al., 2011).   
 
While several bioactive compounds have significant antimicrobial activity, others are 
synergistic enhancers of antimicrobial agents, despite not having any antimicrobial properties 
themselves (Abreu et al., 2012).  Many plant extracts or compounds with no antibacterial 
activity of their own can enhance the activity of antimicrobial agents to which bacteria are 
developing resistance, thus re-sensitising them.  In medicinal chemistry, the “herbal shotgun” 
or “synergistic multi-target effects” strategy involves the use of plant extracts and antimicrobial 
compounds in a multi-targeted approach.   
 
Synergistic interactions between drugs, plants and/or natural extracts can enhance their efficacy 
and bioactivity against a target, when their effectiveness as single agents is reduced/limited.  
Additionally, synergy reduces toxicity, lowers the dose regimen, decreases adverse side-effects, 
and combats antimicrobial resistance (Cottarel and Wierzbowski, 2007).  Potentiation of 
antimicrobial activity can occur through several mechanisms, i.e., synergistic activity between 
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two compounds (antibiotic + antibiotic; antibiotic + non-antibiotic) through serial or orthogonal 
inhibition of vital physiological pathways; inhibition of resistance enzymes that degrade or 
covalently modify an antimicrobial agent to a non-active form; compounds that block 
antimicrobial efflux or enhance uptake into the cell; and/or dispersal of a biofilm to 
planktonically growing cells, resulting in increased susceptibility to an antimicrobial agent 
(Kalan and Wright, 2011).   
 
Positive interactions that intensify the potency of a bioactive product are called potentiation, 
while additive and synergistic effects are subsets of potentiation when it is experimentally 
characterized and quantified.  Negative interactions occur when certain components of the 
extract inhibit full biological activity of pharmacologically-active compounds by reducing their 
stability or bioavailability or by enhancing their metabolism (Lila and Raskin, 2005).  Synergy 
indicates that the compounds in the extract act via different mechanisms and/or targets (Lila 
and Raskin, 2005).  Potentiation may also be initiated by combined bioactivity interactions 
resulting in safety, stability, improved solubility, absorption rate, enhanced active constituent 
bioavailability or resistance-modifying effects i.e. mechanisms of bacterial resistance being 
either modified or inhibited (Abreu et al., 2012; 2014).  
 
There are many examples of synergistic effects between plant extracts and/or their phyto-
constituents and antimicrobial agents documented in the literature (Hemaiswarya et al., 2008; 
Biavatti, 2009; Abreu et al., 2012).  Combinations of mono or multi-extracts not only affect a 
single target but several targets simultaneously in an agonistic-synergistic way (Hemaiswarya 
et al., 2008; Wagner and Ulrich-Merzenich, 2009). Thus combinational therapy (synergism) of 
plant extracts or its phyto-constituents with antimicrobial agents is being investigated for the 
development of new resistance-modifying agents (RMA), which can improve the efficacy of 
currently used antimicrobial agents (Biavatti, 2009; Abreu et al., 2012).   
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We herein report the isolation, identification and synergistic potential of secondary metabolites 
isolated from F. bizanae leaf, stem bark and fruit extracts to enhance the activity of six 
commonly used antimicrobial agents against Gram-positive and Gram-negative bacteria. 
 
3.2 Results and discussion 
The phytochemical investigation of various parts of F. bizanae led to the isolation of 
compounds 1-14 (Figure 3-1) which were characterised by 1D (1H and 13C) and 2D NMR, IR 
and mass spectrometry and confirmed by comparison with data in the literature as the 
coumarins, 7-methoxy coumarin (1) (Mejia-Barajas et al., 2012) and psoralen (2) (Alqasoumi 
et al., 2014), an anthraquinone, tectoquinone (3) (Cheng et al., 2008; Endale et al., 2013), a 
flavonoid glycoside (quercetin-3-O-β-D-glucopyranoside 4) (Liu et al., 2008), two 
megastigmane derivatives, vomifoliol (5) (Afifi et al., 2014) and dehydrovomifoliol (6) (Serra 
et al., 2007), a reduced cinnamic acid derivative, dihydroferulic acid (7) (Cho et al., 2013), the 
polyphenols, 4-methoxycatechol (8) (Saito and Kawabata, 2005; Bernet and Seifert, 2006) and 
protocatechuic acid (9) (Ramadan et al., 2009), the sterol derivatives, taraxerol (10) 
(Viswanadh et al., 2006), 3β-acetoxy-9(11)-fernene (11) (Kathirgamanathar et al., 2006),  
lupanyl acetate (12) (Mahato and Kundu, 1994; Jamal et al., 2008), β-amyrin  acetate (13) 
(Mahato and Kundu, 1994; Fingolo et al., 2013) and sitosterol (14) (Patra et al., 2010).   
Compounds 4, 10-11, 14 were isolated from the leaf, 1-3, 5-8 and 12 from the stem bark and 9 
and 13 from the fruit.  The spectroscopic data for the isolated compounds is contained in the 
supplementary material.  
 
To the best of our knowledge, this is the first report of compounds 3, 6-8 and 11 in the genus 
Ficus. Tectoquinone (3) was reported in Cryptomeria japonica (Cupressaceae) (Cheng et al., 
2008), dihydroferulic acid (7) from Suaeda japonica (Chenopodiacea) and Bulbophyllum 
vaginatum (Orchidaceae) (Leong et al., 1999; Cho et al., 2013) and 3β-acetoxy-9(11)-fernene 
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(11) from Picris hieracioides (Compositae) (Shiojima et al., 1989), Leproria atrotomentosa 
(Stereocaulaceae) lichen powder (Kathirgamanathar et al., 2006) and Polypodium 
subpetiolatum (Polypodiaceae) (Anderson et al., 1979).  DellaGreca et al. (2004) and Leu et al. 
(2012) reported the isolation of dehydrovomifoliol (6) from Chenopodium album 
(Chenopodiaceae) and Vigna vexillata (Fabaceae), respectively, while 4-methoxycatechol (8) 
was reported in Wedelia trilobata (Asteraceae) (Qiang et al., 2011).  The other compounds 
have been isolated previously in the genus Ficus (Table 3-1). 
 
Table 3-1  Occurrence of compounds isolated from F. bizanae within the genus Ficus  
Name Ficus species Reference 
7-methoxy coumarin (1) Ficus ramentaceae 
Ficus radicans 
Yarosh and  Nikonov (1973)  
Naressi et al. (2012)  
Psoralen (2) Ficus beecheyana 
Ficus formosana 
Ficus carica  
Ficus palmata 
Lee et al. (2004),  
Huang et al (2013), Marrelli et 
al. (2014), Alqasoumi et al. 
(2014) 
Quercetin-3-O-β-D-glucopyranoside (4) Ficus auriculata El-Fishawy et al. (2011) 
Vomifoliol (5) Ficus platypoda Afifi et al. (2014) 
Protocatechuic acid (9) Ficus ovata 
Ficus pandurata  
Ficus mucuso 
Kuete et al. (2009) 
Ramadan et al. (2009) 
Bankeu et al. (2010) 
Taraxerol (10) Ficus thunbergii 
Ficus foveolata 
Ficus tsiangii 
Kitajima et al. (1994) 
Somwong et al. (2013) 
Wang et al. (2014) 
Lupanyl acetate (12) Ficus cordata 
Ficus mucuso 
Ficus bengalensis 
Poumale et al. (2008) 
Bankeu et al. (2010) 
Riaz et al. (2012) 
β-amyrin acetate (13) Ficus sur 
Ficus conraui 
Feleke and  Brehane (2005) 
Kengap et al. (2011) 




Bankeu et al. (2010) 
Naressi et al. (2012) 
Ragasa et al. (2013) 










Since the compounds isolated in this work were all known compounds, where the antimicrobial 
activity has been extensively studied, only the antimicrobial susceptibility testing of the plant 
extracts of F. bizanae were assessed.  All 10 crude plant extracts (4 mg mL-1) were ineffective 
against both P. aeruginosa strains ( 
Table 3-2).  With the exception of the HLX extract, the β-lactamase-producing Escherichia 
coli ATCC 35218 was resistant to all extracts tested.  E. coli ATCC 25922 was similar, with 
resistance to all extracts except HSX ( 
Table 3-2).  The leaf extracts were not effective against both methicillin-sensitive 
Staphylococcus aureus ATCC 29213 (MSSA) and methicillin-resistant S. aureus ATCC 43300 
(MRSA).  However, both S. aureus strains demonstrated inhibition zone diameters ranging 
from 11-15 mm with stem bark and fruit extracts ( 
Table 3-2), suggesting intermediate susceptibility.  The HFX extract was the most potent of the 
crude extracts, demonstrating activity against both S. aureus and E. coli strains, even though 
the concentration tested was 1.84 mg mL-1, which was ~5.4 × less concentrated than other 
tested extracts.  The low antimicrobial activity of F. bizanae extracts is not surprising since 
other studies have reported antimicrobial inhibition zones with 2-250 mg mL-1 of extracts from 
diverse Ficus species including F. carica (Olufemi and Olusegan, 2013), F. exasperata (Takon 
et al., 2013) and F. pseudopalma (De Las Llagas et al., 2014).  Since the crude extracts are a 
mixture of active and non-active compounds, inhibition is observed at much higher 
concentrations compared to conventional antimicrobial agents (Silva et al., 2013). 
 
The 14 isolated compounds were not tested for their antibacterial activity alone in this work.  A 
literature survey indicated that 10 of the 14 compounds isolated were reported to have 






Table 3-2 Zones of inhibition (mm) of crude extracts of Ficus bizanae against six bacterial 
strains 
*HLX, DLX, ELX, MLX = hexane, dichloromethane, ethyl acetate and methanol leaf extracts, respectively. 
#HSX, DSX, ESX, MSX = hexane, dichloromethane, ethyl acetate and methanol stem bark extracts, respectively. 
§HFX, EFX = hexane and ethyl acetate fractions of the methanol extract of the fruit, respectively.  
Concentration of extracts = 4 mg mL-1; HFX concentration = 1.84 mg mL-1. 
S = susceptible (≥ 15 mm), I = intermediate susceptibility (11 – 14 mm), and R = resistant (≤ 10 mm).  
 
For the two coumarins, 7-methoxy coumarin (1) and psoralen (2), MIC values of 9.76 µg mL-1 
and 156.25 µg mL-1 were obtained against Bacillus subtilis and Bacillus megaterium, 
respectively (Kuete et al, 2007).  Quercetin glycoside (4) inhibited the growth of different 
Staphylococcus strains with MICs ranging from 1.2-2.5 mg mL-1 (Abedini et al., 2013).  Pretto 
et al. (2004) demonstrated MICs of 100-1000 µg mL-1 for the phenolic protocatehuic acid (9) 
against both Gram-negative and Gram-positive bacteria.  The triterpenes also demonstrated 
good activity, with MICs of 0.12-1 mg mL-1 for lupanyl acetate (12) and β-amyrin acetate (13) 
against nine bacterial strains (Kiplimo et al., 2011).  This study was also aimed at exploring 
extracts that could potentiate the antibacterial activity of commonly used antimicrobial agents, 
which could easily be practiced as a home remedy to supplement the effect of these drugs.  The 
coumarins, flavonoids, triterpenes and phenolic acid compounds isolated from this plant have 








     DLX
*
     ELX
*
     MLX
*
     HSX
#
      DSX
#
      ESX
#
     MSX
#
     HFX
§
      EFX
§ 
S. aureus ATCC 29213 0
(R) 0(R) 10(R) 10(R) 11(I) 11(I) 12(I) 12(I) 12(I) 15(S) 
S. aureus ATCC 43300 0
(R) 8(R) 10(R) 8(R) 8( R) 11(I) 13(I) 12(I) 11(I) 13(I) 
E. coli ATCC 25922 8
(R) 0(R) 8(R) 8(R) 14(I) 8(R) 0(R) 0(R) 10(R) 8(R) 
E. coli ATCC 35218 11
(I) 10(R) 0(R) 0(R) 10(R) 0(R) 0(R) 0(R) 8(R) 8(R) 
P. aeruginosa ATCC 27853 0
(R) 0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 
P. aeruginosa ATCC 35032 0
(R) 0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 0(R) 
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Table 3-3 Literature survey of antibacterial activity attributed to 10 of the 14 isolated 
compounds as reported in the literature.  
Name Bacterial species active against Reference 
7-methoxy coumarin (1) B. megaterium , B. subtilis, Escherichia coli, P. 
aeruginosa, S. aureus, 
Kuete et al. (2007) 
Souza et al. (2005) 
 
Psoralen (2) B. cereus, B. megaterium, B. subtilis, Citrobacter 
freundii, Enterococcus cloacae, Shigella flexneri, 
Streptococcus faecalis 
Kuete et al. (2007) 
Tectoquinone (3) E. coli, P. aeruginosa, S. aureus, S. epidermidis Verdan et al. (2010) 
Quercetin-3-O-β-D-
glucopyranoside (4) 
Enterococcus faecalis, P. aeruginosa, S. 
epidermidis, S. warneri, Stenotrophomonas 
maltophilia 
Abedini et al. (2013) 
 
 
Dihydoferulic acid (7) B. subtilis, S. aureus Chou et al. (2008) 
Protocatehuic acid (9) B. cereus, E. cloacae, E. coli, P. aeruginosa, 
Proteus mirabilis, Salmonella typhimurium, S. 
aureus, S. saprophyticus, Strep. agalactiae, Strep. 
faecalis 
Kuete et al. (2009) 
Pretto et al. (2004) 
 
Taraxerol (10) E. faecalis, E. coli P. aeruginosa, S. aureus  Mokoka et al. (2013) 
Amir et al. (2013) 
Lupanyl acetate (12) B. subtilis, E. faecium, E. coli Klebsiella 
pneumoniae, P. aeruginosa, S. aureus, S. 
epidermidis, S. saprophyticus, Stenotrophomonas 
maltophilia 
Kiplimo et al. (2011) 
β-amyrin acetate (13) B. subtilis, E. faecium, E. coli, K. pneumoniae, P. 
aeruginosa, S. aureus, S. saprophyticus, S. 
epidermidis, S. maltophilia 
Kiplimo et al. (2011) 
β-sitosterol (14) Bacillus subtilis, Corynebacterium 
diphtheriae, S.  typhii, Shigella  dysenteriae, S. 
aureus, Vibrio cholerae 
Kiprono et al. (2000) 
Awolola et al. (2014) 
 
Potentiation, additive or negative interactions were identified according to criteria described by 
Abreu et al. (2014) using a modified disk diffusion method (DDM).  The DDM method was 
selected as Abreu et al. (2014) obtained good agreement between the checkerboard, Etest, and 
DDM assays (77.5%), as well as 86.3% agreement between checkerboard and DDM, and 
82.5% between Etest and DDM.  In addition to DDM having a good correlation with the other 
methods, it is a low-cost, easy, and rapid way of determining synergism between an extract and 
an antimicrobial agent (Abreu et al., 2014).  The criteria for potentiation, additive and negative 
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was calculated as follows:  Potentiation (IZDa+p – IZDa) ≥ 6 mm, additive 4 ≤ (IZDa+p – IZDa) < 
6 mm, negative (IZDa – IZDa+p) ≥ 6 mm,  indifferent interactions are considered between the 
limits imposed for additive and negative interactions, where a = antibiotic and p = 
phytochemical or extract (Abreu et al., 2014). 
 
The antimicrobial susceptibility of the tester strains to the selected six antimicrobial agents is 
shown in Table 3-4.  The data for the combined synergistic effect of the ten F. bizanae extracts 
and antimicrobial agents (ceftriaxone (CRO) 30 µg mL-1; cefotaxime (CTX) 30 µg mL-1; 
nalidixic acid (NA): 30 µg mL-1; sulphamethoxazole (SXT): 25 µg mL-1; gentamicin (CN): 10 
µg mL-1; azithromycin (AZM): 15 µg mL-1) is shown in Table 3-4.   
 
Most of the F. bizanae extracts demonstrated synergistic and/or antagonistic interactions with 
the antimicrobial agents in a strain- and extract-specific manner (Table 3-4).  Extracts on their 
own had limited activity (Table 3-2) and tested strains were variable in their susceptibility to 
the six antimicrobial agents (Table 3-4), since susceptible and resistant strains were compared. 
 
Staphylococcus: Potentiation of CRO, AZM and SXT activity was observed with the fruit 
extract HFX for methicillin-susceptible S. aureus ATCC 29213 (MSSA), while HFX had an 
additive effect with CTX and NA (Table 3-4).  No potentiation of CN and CTX activity was 
observed with any of the extracts (Table 3-5).  Potentiation of NA and SXT activity was 
observed with three (HLX, MLX and HSX) and six (HLX, DLX, MLX, HSX, DSX and HFX) 
extracts, respectively (Table 3-5).  Negative interactions were observed primarily for CN when 




Table 3-4 Antimicrobial susceptibility of tester strains to antimicrobial agents and difference in 
inhibition zone diameter (IZD) of antimicrobial agents (AA) alone and antimicrobial agents 
combined with F. bizanae extracts.   
Test 
Strains 





























CRO30 24(S) 1(I) 1(I) 1(I) 1(I) 1(I) 4(I) 4(I) 4(I) 11(P) 3(I) 
CTX30 26(S) 2(I) 1(I) 11(N) 1(I) 0(I) 1(I) 4(I) 4(I) 4(A) 1(I) 
NA30 12(Int) 10(P) 12(N) 12(N) 10(P) 6(P) 3(I) 12(N) 12(N) 5(A) 12(N) 
SXT2.5 0(R) 17(P) 20(P) 0(I) 27(P) 13(P) 15(P) 0(I) 0(I) 25(P) 0(I) 
CN10 23(S) 8(N) 23(N) 9(N) 3(I) 3(I) 3(I) 23(N) 8(N) 13(N) 6(N) 




CRO30 13(Int) 3(I) 2(I) 13(N) 13(N) 6(P) 6(P) 2(I) 2(I) 8(P) 6(P) 
CTX30 14(Int) 6(P) 6(P) 7(P) 8(P) 11(P) 6(P) 5(A) 5(A) 9(P) 8(P) 
NA30 14(Int) 14(N) 14(N) 6(P) 14(N) 1(I) 14(N) 14(N) 14(N) 14(N) 14(N) 
SXT2.5 0(R) 19(P) 22(P) 0(I) 15(P) 0(I) 16(P) 0(I) 0(I) 15(P) 15(P) 
CN10 9(R) 9(N) 9(P) 9(N) 6(P) 10(P) 9(N) 9(N) 9(N) 1(I) 9(N) 





CRO30 26(S) 6(P) 6(P) 6(P) 7(P) 5(A) 2(N) 6(P) 10(P) 10(P) 11(P) 
CTX30 14(Int) 19(P) 16(P) 17(P) 22(P) 18(P) 18(P) 19(P) 20(P) 23(P) 21(P) 
NA30 0(R) 25(P) 22(P) 27(P) 27(P) 24(P) 23(P) 25(P) 25(P) 25(P) 27(P) 
SXT2.5 20(S) 10(P) 3(N) 13(P) 6(P) 1(N) 3(N) 3(N) 5(A) 1(I) 4(I) 
CN10 16(S) 12(P) 1(P) 12(P) 9(P) 8(P) 3(N) 6(P) 9(P) 4(I) 10(I) 





CRO30 16(S) 13(P) 14(P) 14(P) 14(P) 9(P) 14(P) 17(P) 14(P) 20(P) 14(P) 
CTX30 27(S) 1(I) 3(I) 5(A) 5(A) 1(I) 1(I) 4(A) 4(A) 10(P) 8(P) 
NA30 24(S) 0(I) 0(I) 0(I) 1(I) 4(I) 10(N) 1(I) 3(I) 1(I) 1(I) 
SXT2.5 23(S) 1(I) 10(N) 5(I) 3(I) 8(I) 9(N) 1(I) 5(I) 2(I) 0(I) 
CN10 23(S) 2(I) 10(N) 4(I) 0(I) 6(I) 7(N) 1(I) 4(I) 11(N) 3(I) 






CRO30 0(R) 26(P) 25(P) 10(P) 17(P) 26(P) 21(P) 20(P) 21(P) 26(P) 24(P) 
CTX30 20(S) 6(P) 4(A) 5(I) 2(I) 5(A) 0(I) 2(I) 5(A) 5(A) 5(A) 
NA30 0(R) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 8(P) 
SXT2.5 0(R) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 
CN10 0(R) 26(P) 22(P) 22(P) 21(P) 25(P) 20(P) 24(P) 23(P) 15(P) 22(P) 





CRO30 25(S) 4(I) 6(N) 10(N) 8(N) 4(I) 4(I) 7(N) 3(I) 5(I) 5(I) 
CTX30 25(S) 2(I) 4(I) 25(N) 10(N) 5(I) 3(I) 6(N) 3(I) 4(I) 3(I) 
NA30 0(R) 0(I) 0(I) 0 (I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 
SXT2.5 0(R) 0(I) 0(I) 0 (I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 0(I) 
CN10 0(R) 21(P) 15(P) 18(P) 18(P) 20(P) 20(P) 18(P) 20(P) 10(P) 17(P) 
AZM15 0(R) 27(P) 0(I) 0 (I) 28(P) 26(P) 26(P) 25(P) 0(I) 0(I) 0(I) 
*AA: Ceftriaxone (CRO30); cefotaxime (CTX30); nalidixic acid (NA30) - 30 µg/ml; sulphamethoxazole (SXT2.5) 
- 25 µg/ml; gentamicin (CN10) - 10 µg/ml; azithromycin (AZM15): 15 µg/ml. 
§R = resistant (≤ 10); Int – intermediate susceptibility (11-14); S = susceptible (≥15) (CLSI, 2007). 
#HLX, DLX, ELX, MLX: hexane, dichloromethane, ethyl acetate, methanol leaf extracts, respectively; HSX, 
DSX, ESX, MSX: hexane, dichloromethane, ethyl acetate, methanol stem bark extracts, respectively; HFX, EFX: 
hexane and ethyl acetate fruit extracts, respectively. Concentration of extracts = 4 mg mL-1; HFX concentration = 
1.84 mg mL-1.  
P = Potentiation (IZDa+p – IZDa) ≥ 6 mm, A = additive (blue) 4 ≤ (IZDa+p – IZDa) < 6 mm, N = negative (yellow) 
(IZDa – IZDa+p) ≥ 6 mm,  I = indifferent (green) indifferent interactions are considered between the limits imposed 
for additive and negative interactions, a = antibiotic; p = phytochemical or extract (Abreu et al., 2014). 
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Potentiation of all antimicrobial agents was observed with as low as one (NA) or as high as 
eight (CTX) of the extracts when the methicillin-resistant S. aureus ATCC 43300 (MRSA) was 
targeted (Table 3-4).  Potentiation of CTX activity was observed with 80% of extracts (HLX, 
DLX, ELX, MLX, HSX, DSX, HFX, and EFX).  This suggests that Ficus extracts have 
potential as adjuvants for cephalosporin-based treatment of MRSA infections.  Negative 
interactions were observed for CRO, NA and CN with 20%, 80% and 60% of extracts (Table 
3-5). 
 
Escherichia: Potentiation of CTX, NA and AZM activity was observed with all 10 extracts 
when susceptible E. coli ATCC 25922 was assessed (Table 3-4).  Potentiation of CRO, SXT 
and CN was also observed with 80%, 30% and 70% of extracts, respectively (Table 3-5).  No 
negative interactions were noted. 
 
CRO activity potentiation was observed with all 10 extracts against the β-lactam-resistant E. 
coli ATCC 35218 (Table 3-4).  CTX potentiation was observed with the fruit extracts HFX and 
EFX and additive interactions were observed with 40% of extracts (Table 3-5).  These 
potentiation/additive interactions with the cell-wall inhibitor cephalosporins suggest that the F. 
bizanae fruit extracts might be suitable to counter β-lactamase-producing Enterobacteriaceae.  
No potentiation of NA, SXT, and CN was observed and negative interactions were observed 
with DLX and DSX extracts. 
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Table 3-5 Summary of interactions obtained when six conventional antimicrobial agents were combined with 10 crude F. bizanae leaf, stem bark and fruit extracts 
Strain Potentiation Additive Negative 
S. aureus ATCC 29213 CRO with HFX - - 
 - CTX with HFX CTX with ELX 
 NA with HLX, MLX, HSX NA with HFX NA with DLX, ELX, ESX, MSX, EFX 
 SXT with HLX, DLX, MLX, HSX, DSX, HFX - - 
 - - CN with HLX, DLX, ELX, ESX, MSX, HFX, EFX 
 AZM with HFX - ELX, MLX, ESX, MSX 
S. aureus ATCC 43300 CRO with HSX, DSX, HFX, EFX - CRO with ELX , MLX 
 CTX with HLX, DLX, ELX, MLX, HSX, DSX, HFX, EFX CTX with ESX, MSX - 
 NA with ELX - NA with HLX, DLX, MLX, DSX, ESX, MSX, HFX, EFX 
 SXT with HLX, DLX, MLX, DSX, HFX, EFX -  
 CN with DLX, MLX, HSX - CN with HLX, ELX, DSX, ESX, MSX, EFX 
 AZM with DLX, MLX, HSX, DSX, HFX - - 
    
E. coli ATCC 25922 CRO with HLX, DLX, ELX, MLX, ESX, MSX, HFX, EFX CRO with HSX - 
 CTX with all 10 crude extracts - - 
 NA with all 10 crude extracts - - 
 SXT with HLX, ELX, MLX SXT with MSX - 
 CN with HLX, ELX, MLX, HSX, ESX, MSX, EFX - - 
 AZM with all 10 crude extracts - - 
E. coli ATCC 35218 CRO with all 10 crude extracts - - 
 CTX with HFX, EFX CTX with ELX, MLX, ESX, MSX - 
 - - NA with DSX 
 - - SXT with DLX, DSX 
 - - CN with DLX, DSX, HFX 
 AZM with MLX, ESX, EFX AZM with MSX - 
    
P. aeruginosa ATCC 
27853 
CRO with all 10 crude extracts - - 
 CTX with HLX CTX HSX, MSX, HFX, EFX - 
 NA with EFX - - 
 CN with all 10 crude extracts - - 
 AZM with HFX - - 
P. aeruginosa ATCC 
35032 
- - CRO with DLX, ELX, MLX, ESX 
 - - CTX with ELX, MLX, ESX 
 CN with all 10 crude extracts - - 
 AZM with HLX, MLX, HSX, DSX, ESX - - 
*HLX, DLX, ELX, MLX: hexane, dichloromethane, ethyl acetate, and methanol leaf extracts, respectively; HSX, DSX, ESX, MSX:  hexane, dichloromethane, ethyl acetate, and methanol stem bark extracts, 
respectively; and HFX, EFX: hexane and ethyl acetate fruit extracts, respectively. 
*Ceftriaxone (CRO30); cefotaxime (CTX30); nalidixic acid (NA30) - 30 µg/ml; sulphamethoxazole (SXT2.5) - 25 µg/ml; gentamicin (CN10) - 10 µg/ml; azithromycin (AZM15): 15 µg/ml.  
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Pseudomonas: Potentiation of CRO and CN activity was observed with all 10 extracts for the 
non-mucoid P. aeruginosa ATCC 27853 (Table 3-4).  CTX, NA and AZM activity was 
potentiated with 1 extract each (Table 3-5).  No potentiation of SXT activity was observed.  
No negative interactions were observed.  No potentiation of CRO, CTX, NA and SXT 
activity was observed for P. aeruginosa ATCC 35032.  However, CN activity was 
potentiated with all 10 extracts (Table 3-4), while potentiation of AZM was observed for 
50% of extracts (HLX, MLX, HSX, DSX and ESX). 
 
Ncube et al. (2012) observed varying efficacies when they targeted diverse plant extract-
antimicrobial agent combinations, with most extract combinations demonstrating either a 
synergistic, additive or indifferent interaction effect against the test bacteria with only a few 
exhibiting antagonistic effects.  Since plant extracts contain multiple diverse chemical 
compounds, their combinational interaction effects are expected to be equally diverse.  The 
observed variations in the activity of the extract-antimicrobial agent combinations against 
susceptible and resistant strains might be indicative of ultrastructural changes, in addition to 
the diverse structures and mechanisms of action of the active substance(s) in the crude 
extracts (Darwish and Aburjai. 2010). 
 
Overall, CRO and CTX (cephalosporins: cell-wall inhibitors) potentiation was observed for 
both Gram-positive and Gram-negative bacteria (susceptible and resistant strains) tested with 
the exception of P. aeruginosa ATCC 35032.  The F. bizanae extracts possibly allowed 
better penetration of the cephalosporin through the outer membrane of Gram-negative E. coli 
and P. aeruginosa ATCC 27853 to the cell wall, which is the target site for the 
cephalosporins (Darwish and Aburjai, 2010).   In the resistant E. coli and P. aeruginosa, the 
extracts could also be acting against β-lactamase enzymes and/or efflux pumps.  Potentiation 
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of NA (DNA gyrase inhibitor) activity with all 10 extracts was only effective for E. coli 
ATCC 25922.  SXT (folic acid inhibitor) activity was potentiated primarily for the Gram-
positive staphylococci tested and no potentiation was observed for resistant Gram-negative 
strains.  It was interesting to note that CN (protein synthesis inhibitor) activity was 
potentiated with all 10 F. bizanae extracts for both P. aeruginosa strains.   
 
Potentiation of AZM (protein synthesis inhibitor) was observed with varying extracts for all 
Gram-positive and Gram-negative strains examined.  The potentiation of gentamicin and 
azithromycin activity suggests the presence of efflux-inhibitory plant-derived compounds or 
RMA.  Aiyegoro et al. (2009) suggested that the methanolic leaf extract of H. pedunculatum 
could contain potential broad-spectrum, efflux pump inhibitors, since the synergistic effect 
was observed against both Gram-positive and Gram-negative organisms.  This could hold for 
the F. bizanae extracts since potentiation of aminoglycoside, macrolide, cephalosporin and 
quinolone activity was observed for Gram-negative and Gram-positive susceptible and/or 
resistant strains.  
 
Jeong et al. (2009) observed the synergistic effects of the F. carica leaf MeOH extract against 
oral bacteria in combination with ampicillin or gentamicin (4-8-fold reduction of MIC).  
Sharma et al. (2014) demonstrated the synergistic effect of the methanolic extract of F. carica 
against E. coli and S. aureus when combined with gentamicin and tetracycline, which they 
attributed to the presence of coumarins and triterpenoids. Documentation of the 
pharmacological activities of the phyto-constituents from the aqueous extract of ripe dried 
fruit of F. carica fig includes classes of compounds such as alkaloids, flavonoids, saponins, 
and terpenes, with the furanocoumarins like psoralen and bergapten, flavonoids like rutin, 
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quercetin, and luteolin, phenolic acids like ferulic acid, and also phytosterols like taraxasterol 
being reported by Lee and Cha (2010). 
 
The MeOH extract in combination with oxacillin or ampicillin, when targeted against MRSA 
induced a ≥4-8-fold reduction in MIC, suggesting a synergistic effect (Lee and Cha, 2010).  
When Odunbaku et al. (2008), examined the synergistic interactions of the ethanol leaf 
extract of F. exasperata on E. coli and S. albus, they observed that the highest inhibitory 
activity was obtained by combining the crude plant extract with protein synthesis inhibitors 
(gentamicin, tetracycline, chloramphenicol and erythromycin), followed by the folic acid 
inhibitor combination, and then with cell wall inhibitors.  These studies thus support the 
potentiation activity observed with F. bizanae extracts in combination with protein synthesis 
inhibitors (azithromycin and gentamicin), cell wall inhibitors (ceftriaxone and cefotaxime), 
DNA gyrase inhibitors (nalidixic acid), with the folic acid inhibitor (sulphamethoxazole) 
combination being the least effective.  The coumarins, triterpenoids, flavonoids and 
polyphenolic compounds isolated from crude extracts have been documented previously to 
possess antimicrobial activity against different bacterial strains (Sato et al., 2004; Cushnie 
and Lamb, 2005; Nitiema et al., 2012; Mawa et al., 2013).  7-methoxy coumarin (1), 
quercetin-3-O-β-D-glucopyranoside (4), protocatechuic acid (9), lupanyl acetate (12) and β-
amyrin acetate (13) isolated from this plant are likely to play a role in the synergistic effect 
experienced with these antimicrobial agents.   
 
The findings mentioned above suggest the possible scientific rationale for F. bizanae to be 
used in ethnomedicine and the efficacy of the combination therapy of the extracts with 
antimicrobial agents as a source of alternative treatment of infections caused by Gram-
negative microbes.  Combination antimicrobial therapy might be the solution in targeting the 
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emergence of resistant bacterial strains, by reducing therapeutic dosages and increasing 
clinical efficacy, thus providing a broader spectrum of antimicrobial activity compared to 
monotherapy. The implications of this are that antibacterial drugs could be used in 
conjunction with some F. bizanae extracts as a natural remedy, resulting in increased efficacy 
and probable reducation of side-effects associated with antimicrobial agents.   
 
3.3 Experimental 
General Experimental Procedures 
Optical rotations were carried out on a Model 341 Polarimeter at room temperature.  Melting 
points were determined on an Ernst Leitz Wetziar micro-hot stage melting point apparatus 
and are uncorrected.  A Varian Cary UV-VIS Shimadzu spectrophotometer was used to 
obtain UV spectra and infrared spectral data was obtained on a Perkin Elmer Spectrum 100 
(FT-IR) spectrometer.  Mass spectra were obtained on a Shimadzu gas chromatograph mass 
spectrometer.  NMR spectra were acquired using tetramethylsilane (TMS) as an internal 
standard on Bruker Avance III 400 and 600 MHz spectrometers. Silica gel 60 (Merck, 70-230 
mesh) and Sephadex LH-20 (Pharmacia) were used as the stationery phase for column 
chromatography (CC).  TLC analysis was carried out on Merck aluminium backed sheets 
precoated with silica gel 60 F254 and visualised using 10% sulphuric acid in MeOH or under 
UV (254 and 366 nm). 
 
Plant material 
Fresh leaf, stem bark and fruit of Ficus bizanae Hutch. & Burtt-Davy, were collected from 
Durban, KwaZulu-Natal, South Africa.  A voucher specimen (G. V. Awolola & H. Baijnath 




Powdered dried leaves (1.1 kg) and stem bark (2.5 kg) of F. bizanae were subjected to cold 
extraction using different organic solvents of increasing polarity: hexane (hex), 
dichloromethane (DCM), ethyl acetate (EtOAc), and methanol (MeOH) sequentially on an 
orbital shaker for 48 hours each. The extracts were evaporated using a rotary evaporator and 
yielded 26.86 g hexane, 18.21 g DCM, 10.59 g EtOAc and 45.56 g MeOH extract for the 
leaves and 9.26 g hexane, 20.43 g DCM, 6.39 g EtOAc and 45.39 g MeOH for the stem bark. 
The MeOH extracts of both the leaves and stem bark were dissolved in methanol and water 
(1:1) and partitioned with DCM and ethyl acetate to yield 4.59 g methanol derived DCM 
extract of the leaves, 3.28 g methanol derived DCM extract of the stem bark, 5.05 g methanol 
derived EtOAc extract of the leaves and 5.00 g methanol derived EtOAc extract of the stem 
bark.   
The dried ground fruits (570 g) were macerated in methanol for 48 hours with continuous 
shaking on an orbital shaker at room temperature. The MeOH extract (85.45 g) was 
redissolved in methanol and water (1:1) and then partitioned with DCM and ethyl acetate to 
yield 3.23 g DCM and 8.24 g EtOAc extract. 
 
Isolation and Purification of compounds 4, 10, 11 and 14 from the leaves 
The hexane and DCM crude extracts of the leaves were combined as a result of similar TLC 
profiles.  A 30.0 g sample of this combined extract was subjected to CC on a 5 cm column 
and eluted with a stepwise gradient of hexane and DCM (10%, 20%, 30%, 50%, 70%, 90% 
and 100% DCM in hexane) and then 20%, 50% and 100% EtOAc in DCM, collecting 
fractions of 100 mL for each step resulting in a total of 280 fractions.  This was further 
combined into 6 fractions (A: fr. 71-78 (150 mg); B: fr. 79-83 (850 mg); C: fr. 84-110 
(920mg); D: fr. 118-127 (1.00g); E: fr.128-141 (1.20g) and F: fr. 153-167 (2.5 g)). 
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Taraxerol (10) (40.1 mg) crystallized out of solution of fraction A as a white powder and was 
recrystallized in methanol.  3β-Acetoxy-9(11)-fernene (11) (10.7 mg) was purified with hex: 
EtOAc (19:1) from fraction B by CC (1 cm column) where 11 eluted in fractions 18-26. 
Fraction F was separated with hex: EtOAc (8:2) on a 2 cm column where sitosterol 14 (40.5 
mg), was obtained as a white powder from fractions 7-17.  
 
The methanol derived EtOAc fraction (5.05 g) partitioned from the MeOH extract of the 
leaves was fractionated on a 3 cm column with a hexane, EtOAc and MeOH gradient elution, 
increasing the polarity by 10% each time gradually to 100% MeOH.  Fractions of 100 mL 
each were collected and similar fractions combined (based on TLC profiles) to afford four 
major fractions (A: 42-78; B: 79-117; C: 118-153 and D: 154-187).  Quercetin-3-O-β-D-
glucopyranoside 4 (90.8 mg) was obtained by purification on a 2 cm column using Sephadex 
LH-20 as the stationary phase and MeOH as the eluent and finally purified on a 1.5 cm 
column using DCM: MeOH (9:1) as the eluent to yield 4 in fractions 82-91.  
 
Isolation and Purification of compounds 1, 2, 3, 5, 6, 7, 8 and 12 from the stem bark 
The hexane and DCM crude extracts of the stem bark showed similar TLC profiles and were 
therefore combined.  A 25.0 g sample of this combined extract was fractionated by CC with a 
gradient elution of hex:DCM and then DCM:EtOAc increasing the polarity by 10%  and 
collecting 10×100 ml fractions for each step to afford six major fractions (A: 1-19; B: 20-23; 
C: 24-42; D: 43-52; E: 64-73; F: 74-89) containing similar compounds as indicated by TLC. 
  
Fraction B (2.00g) was separated by CC on a 1.5 cm column using Hex:DCM (1:9) and 
collecting 20 mL fractions, which yielded 7-methoxy coumarin 1 (480.6 mg), a whitish 
powder in fractions 18-23. Fraction C was separated similarly but using Hex: EtOAc (9:1), 
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which yielded tectoquinone 3 (15.1 mg) as an orange powder in fraction 15-18.  On 
increasing the polarity of the solvent to Hex:EtOAc (8:2), lupanyl acetate 12 (95.8 mg) was 
eluted in fractions 24-35 and was recrystallized from MeOH to obtain a white powder. 
 
The EtOAc extract (6.00 g) of the stem bark was fractionated by CC on a 3cm column using 
hexane, EtOAc and finally MeOH as the eluent, increasing the polarity in a stepwise gradient 
by increments of 10% after each 1L of solvent and collecting 100 mL fractions.  The 
fractions were combined according to TLC analysis as A: 16-36, B: 37-47, C: 48-60, and D: 
61-79. Fraction B (950 mg) was subject to repeated CC with Sephadex LH-20 eluted with 
MeOH, and yielded dihydroferulic acid (7) (140.3 mg) as needle like crystals in fractions 55-
85.  
 
The methanol derived EtOAc fraction (5.00 g) partitioned from the MeOH extract of the stem 
bark was separated as above with hexane, EtOAc and then MeOH after which seven major 
fractions were obtained after fractionation (A: 8-10; B: 11-15; C: 16-18; D: 19-27; E: 36-50; 
F: 51-54; G: 57-80).  Fraction B (40.6 mg) was purified by CC on a 1 cm column and eluted 
with DCM: hex (8:2) to yield psoralen 2 (20.4 mg) in fractions 11-15.  Fraction F (280.2 mg) 
was purified using CC on a 2 cm column and eluted with hex: EtOAc (1:1) where (+)-
dehydrovomifoliol 6 (10.9 mg) was obtained in fractions 4-11 and purified further on 
Sephadex LH-20 with MeOH as the mobile phase to yield 6 as colourless needles in fractions 
27-36.  Fraction G (1.12 g) was separated with EtOAc: Hex (8:2) using a 2.5 cm column 
where vomifoliol (blumenol A) 5 (10.3 mg) was eluted in fractions 15-22 and further purified 
using sephadex LH-20 (eluted with MeOH), to obtain colourless crystals in fractions 41-44.  
4-Methoxy catechol 8 (2.1 mg) was obtained from fractions 3-5 after further purification by 
Sephadex LH-20 (eluted with MeOH) of fractions 25-32 of Fraction G. 
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Isolation and Purification of compounds 9 and 13 from the fruit 
A 2.13 g sample of the methanol derived Hex fraction partitioned from the MeOH extract of 
the fruit was fractionated using CC using Hex:DCM and then DCM:EtOAc in a stepwise 
gradient elution by 10% increments after each 1L of solvent.  A 2 cm column was used for 
the separation and 50 mL fractions were collected.  The fractions were combined as follows, 
A: 13-17; B: 18-20; C: 23-77 and D: 78-120.  β-Amyrin acetate 13 (20.0 mg), a white 
powder, precipitated out of fraction B and was recrystallized with MeOH.  The methanol 
derived EtOAc fraction (8.00 g) partitioned from the MeOH extract of the fruits was 
fractionated in a similar manner and resulted in fractions A: 17-19; B: 20-39; C: 55-61; D: 62 
-85).   Fraction C (1.00 g) was purified using Sephadex LH-20 (eluted with MeOH), which 
yielded an amorphous white powder, protocatehuic acid 9 (80.2 mg) in fractions 29-34.  
 
Antimicrobial susceptibility testing 
Four Gram-negative strains: E. coli ATCC 25922 and ATCC 35218 and P. aeruginosa 
ATCC 27853 and ATCC 35032, and two Gram-positive strains: S. aureus ATCC 29213 and 
ATCC 43300, were selected for the antimicrobial testing.  Four F. bizanae leaf extracts, 
hexane (HLX), dichloromethane (DLX), ethyl acetate (ELX), and methanol (MLX), four F. 
bizanae stem bark extracts, hexane (HSX), dichloromethane (DSX), ethyl acetate (ESX), and 
methanol (MSX), as well as two F. bizanae fruit extracts, hexane (HFX) and ethyl acetate 
(EFX), were assessed for their antimicrobial potential.   
 
Inhibition zone diameters (IZD) of the crude leaf, stem bark and fruit extracts and 
antimicrobial agents individually were determined using the disc diffusion assay (CLSI, 
2007).  Extracts were solubilised in DCM or DMSO to a concentration of 100 mg mL-1.  
Sterile, 6 mm disks (MAST, UK), impregnated with 4 mg mL-1 of each respective extract, 
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were placed on Mueller-Hinton (MH) agar plates swabbed with the respective microbial 
strains.  Discs impregnated with DCM or DMSO were used as negative controls.  Plates were 
incubated at 37 °C for 24 h.  After incubation, IZD (in mm) of extracts were measured and 
their means determined. 
 
Synergistic effect determination  
The resistance modifying effects of F. bizanae extracts with antimicrobial agents were 
assessed using the modified DDM described by Abreu et al. (2014), with some further 
modifications.  Commercially available, 6 mm antimicrobial agent discs (Oxoid, UK) 
[ceftriaxone (CRO30; 30 µg mL-1), cefotaxime (CTX30; 30 µg mL-1), nalidixic acid (NA30; 
30 µg mL-1), sulphamethoxazole (SXT25; 25 µg mL-1), gentamicin (CN10; 10 µg mL-1) and 
azithromycin (AZM15; 15 µg mL-1)] were impregnated with 40 µL (4 mg mL-1) of respective 
crude extracts and placed on MH agar plates seeded with the respective bacteria.  Discs of the 
six antimicrobial agents without extracts were used as positive controls, while discs 
impregnated with DCM and DMSO were used as negative controls.  Following incubation at 
37 °C for 24 h, IZD (in mm) were recorded and interpreted according to criteria (Table 3-6) 
described by Abreu et al. (2014).  There are four possible effects when a combination of 
antibacterial products is used (Abreu et al., 2012): potentiation (when a combination of the 
antibacterial agents exceeds the sum of the effects of the individual products); additive (when 
a combination of antibacterial agents is equal to that of the sum of the effects of the 
individual products); negative (when the combination of antibacterial products promotes a 
reduced effect compared to the effect of the most efficient individual product), and 
indifference (when the combination of antibacterial products promotes equal effects to those 
of the most active product). 
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Table 3-6 Classification of interactions obtained when plant extracts were combined with 
antimicrobial agents (Abreu et al., 2014) 
Interaction Disc diffusion method 
Potentiation (IZDa+p – IZDa) ≥ 6 mm 
Additive 4 mm ≤ (IZDa+p – IZDa) < 6 mm 
Negative (IZDa – IZDa+p) ≥ 6 mm 
a = antibiotics, p = plant extract/phytochemical. 




Fourteen compounds were isolated from the various parts of F. bizanae.  Weak to moderate 
antimicrobial activity was observed against the test strains with crude extracts alone.  
Potentiation was observed when antimicrobial agents were combined with F. bizanae extracts 
in an extract- and strain-specific manner.  While extracts potentiated activity of 
sulphamethoxazole (SXT) against staphylococci, potentiation of ceftriaxone (CRO) was 
effective against both E. coli strains and (gentamicin) CN activity was potentiated against P. 
aeruginosa strains.  The results suggest the potential application of F. bizanae in 
ethnomedicine as resistance-modifying agents for the treatment of bacterial infections.  
Further studies are required to determine the mechanisms of action of this combinational 
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Four triterpenoids, ergosta-4,6,8(14),22-tetraene-3-one 1, stigma-4-ene-3-one 2, 3β-hydroxy-
21β-H-hop-22(29)-ene 3, sitosterol 4 and a quinone, tectoquinone 5, have been isolated from 
the leaf, stem bark and fruit extracts of Ficus natalensis, a medicinal fig found typically in 
South Africa. The pure compounds 1-3 and 5 and crude extracts were tested for their 
antibacterial activity against five Gram-negative and seven Gram-positive strains, and for 
their potential anti-biofilm activity.  Antimicrobial susceptibility was observed with all pure 
compounds tested at 250 µg against the majority of Gram-negative and Gram-positive strains.  
For compounds 2, 3 and 5, broad spectrum antibiotic effects were shown with as much as ten 
of the twelve bacterial strains.  Compound 3, 3α-hydroxy-21α-H- hop-22(29)-ene was active 
against all Gram-positive test organisms.  The crude extracts showed no appreciable 
antimicrobial activity and only the DCM fruit extract was active against sensitive and 
resistant Staphylococcus aureus strains, Enterococcus faecium and Staphylococcus xylosus.  
In the anti-biofilm assay, exposure to EtOAc, MeOH and aqueous MeOH leaf, stem bark and 
fruit extracts decreased adhesion with a biofilm reduction of ≥100% for all three tested 
organisms: Escherichia coli, Pseudomonas aeruginosa and S. aureus.  The MeOH leaf 
extract demonstrated the most potent anti-adhesion potential against E. coli (218.11% biofilm 
reduction).  The greatest ability to decrease adhesion was observed with stigma-4-ene-3-one 
2, 3α-hydroxy-21α-H- hop-22(29)-ene 3 and tectoquinone 5 against P. aeruginosa at the 
lowest concentration tested (100 µg mL-1).   
 




Bacterial adhesion to tissues is one of the initial stages in bacterial infections (Ofek et al., 
2003). When these bacteria colonise and adhere to surfaces, they become more resistant to 
antibiotics.  Further to this, colonisation and adherence make it easier for these microbes to 
gain access to nutrients needed for their survival (Ofek and Doyle., 1994).  As such, 
pharmaceuticals or pharmaceutical extracts capable of preventing the adherence of bacteria to 
surfaces are desirable antibacterial agents.  One source of these are medicinal plants used in 
traditional medicine, since many plant based remedies are known to have antibacterial 
properties (Saranraj and Sivasakthi, 2014; Hemalatha et al., 2013; Cowan, 1999; Rabe and 
van Staden, 1997) and some have even been identified as having anti-adhesion properties 
(Bräunlich et al., 2013; Chusri et al., 2012; Palombo, 2011). 
 
Ficus natalensis Hochst. subsp. natalensis (Moraceae) is a rock splitter tree which grows up 
to almost 20 m in height. It is geographically situated in South Africa, the Democratic 
Republic of Congo, Senegal, Kenya, Angola and Sudan and is well known as the Natal-fig or 
bark-cloth fig, and also known as natalvy, natou, umthombe, umdende and uluzi in South 
Africa (Burrows and Burrows, 2003).  
 
The different parts of the tree have various applications varying from cultural, decorative, and 
commercial applications to folk medicine (Wanyama et al., 2011; Burrows and Burrows, 
2003).  The bark is a major source of bark cloth, as the name implies and a potential source of 
natural dye (Rwawiire et al., 2013; Wanyama et al., 2011; Burrows and Burrows, 2003).  The 
root, bark, latex and leaves are used in several African countries such as Senegal, Uganda, 
Tanzania, Sierra Leone and South Africa to treat a variety of ailments such as lumbago, 
arthritis, headaches, toothaches, cataracts, for irregular and painful menstruations, to induce 
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labour, to ease the pain during childbirth, for retained placenta, and as a galactagogue, as an 
antivenom, to treat malaria, influenza, whooping cough, dysentery, and guinea worm, for 
ulcers, wounds, warts and septic ears and for colic and hiccups (Kamatenesi-Mugisha et al., 
2007; Burrows and Burrows, 2003;  Hutchings et al., 1996).   
 
In previous studies on the plant, antibacterial activity has been reported for the methanol 
extract of the root (Rabe and van Staden, 1997).  Apart from this, Olaokun et al. (2013) also 
reported the anti-diabetic potential of the acetone extract of the leaves.  In a previous 
investigation on essential oils from F. natalensis, (E)-phytol and 6,10,14-trimethyl-2-
pentadecanone were found in the leaves (Sonibare et al., 2009).  In our on-going 
phytochemical and antibacterial research on species belonging to the genus Ficus used in 
African traditional medicine, we have carried out a phytochemical investigation of the leaves, 
stem bark and fruit of F. natalensis and tested both the extracts and pure isolates for their 
antibacterial and anti-adhesion activity against several Gram-positive and Gram-negative 
bacteria. 
 
4.2 Results and discussion 
The fractionation and purification of the leaf, stem bark and fruit extracts led to the isolation 
and identification of five non-polar compounds (Figure 4-1); Ergosta-4,6,8(14),22-tetraen-3-
one 1 (Fangkrathok et al., 2013), stigma-4-en-3-one 2 (Liu et al., 2014), 3α-hydroxy-21α-H- 
hop-22(29)-ene 3 (Sousa et al., 2012),  sitosterol 4 (Rasoanaivo et al., 2014) and tectoquinone 
5 (Cheng et al., 2008) using 1H and 13C  and 2D (COSY, NOESY, HMBC and HSQC) NMR 
spectroscopy and confirmed by comparison with values from the literature. 
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The 1H and 13C NMR spectrum of compound 3 for example revealed the presence of an 
oxygenated methine proton H-3 at δH  3.18 (dd, J = 7.6, 3.2 Hz), two protons at C-29 (m, δH  
4.67-4.64), an isopropenyl methyl group at δH  1.64 (3H, s) and six tertiary methyls between 
δH  0.67-0.96 with corresponding methyl carbon resonances at δC 27.5 (C-23), 215.3 (C-24), 
15.9 (C-25), 16.7 (C-26), 16.6 (C-27) and 15.1 (C-28). HMBC correlations between the 
methyl group proton resonanances of H-23 and H-24 allowed these methyl resonances to be 
assigned two bonds away from C-3. These assignments compare well with that reported in 
literature (Kiem et al., 2004, Sousa et al., 2012). The coupling constant for H-3 double 
doublet (J = 7.64 Hz and 3.16 Hz) at C-3 for H-3 indicated that the stereochemistry of the 
hydroxy group at position 3 must be in the β position. Based on the NMR data and 
comparsion with literature (Kiem et al., 2004, Sousa et al., 2012), compound 3 was confirmed 
as 3β-hydroxy-21α-H- hop-22(29)-ene 3.  
 




Figure 4-1  Structures of isolated compounds from F. natalensis 
 
Antibacterial activity  
The crude hexane, dichloromethane, ethyl acetate and methanol extracts of the leaves, stem 
bark and fruits of F. natalensis were tested along with compounds 1-3 and 5 against both 
Gram-negative and Gram-positive bacterial strains to determine whether or not the crude 
extracts and the pure compounds have any antibacterial activity to substantiate the reported 
use of the plant as an antibacterial agent (Rabe and van Staden, 1997).  Sitosterol 4 has 
previously been tested for its antibacterial properties, and was tested in our laboratory 
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previously and was not tested again in these assays (Kiprono et al., 2000; Awolola et al., 
2014).   
In general, the leaf, stem bark and fruit extracts were relatively ineffective against all Gram-
negative test organisms at 2 and 4 mg mL-1 (Table 4-1).  Several of the extracts had strain-
specific activity at an increased dosage of 4.0 mg; S. sciuri was susceptible to the aq/MeOH 
extract of the leaves, Enterococcus faecalis (ATCC 29212) was susceptible to both the 
EtOAc and MeOH extracts of the stem bark and hexane and DCM extracts of the fruit.  Both 
S. aureus strains and S. xylosus were susceptible to the DCM extract of the fruit.  This extract 
also showed intermediate activity against S. sciuri.  The DCM extract of the fruit was thus the 
most active of all the extracts being active against several of the Gram-positive strains.  This 
is an important point to note as incorporating these fruits into the diet could help fight against 
these pathogens. 
The selective activity toward Gram-positive bacteria and poor activity against Gram-negative 
bacteria was consistent with a study done by Suffredini et al. (2006) on 1220 plant extracts 
from the Amazon and Atlantic rain forests. In their study, only selected extracts showed 
activity against Gram-positive strains while none of the extracts showed any significant 
activity against the Gram-negative bacteria.  The poor activity against Gram-negative bacteria 
is not surprising since they are very resistant to antimicrobial compounds as a result of the 
outer membrane which prevents penetration of antimicrobial compounds (Nikaido, 2001).  
Most phytochemicals are effective against Gram-positive bacteria, however, small molecular 
weight phytochemicals with high activity against Gram-negative species are limited (Lewis, 
2013).  Rabe and van Staden (1997) have previously observed MICs of 4 mg mL-1 for S. 
aureus and S. epidermidis and 8 mg mL-1 for B. subtilis, using methanolic root extracts of F. 
natalensis.  This is in keeping with the inhibition zone results obtained using crude extracts in 
this study.  Varying antimicrobial activity has been reported for other Ficus species extracts, 
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with differences related to the Ficus species tested, part of the plant sampled, the extraction 
solvent and antimicrobial testing assay (Salem et al., 2013). Other Ficus species showing 
antibacterial activity were F. exasperata and F. racemosa; the F. exasperata methanol extract 
of the root showed antibacterial activity against S. aureus and P. aeruginosa and antifungal 
activity against Candida glabrata (Adebayo et al., 2009; Lawal et al., 2012), and the F. 
racemosa methanolic fruit extract showed a broad spectrum of activity against S. aureus, B. 
subtilis, P. aeruginosa and Klebsiella species (Hossain et al., 2014).   
 
Varying antibacterial activity was demonstrated by the compounds tested which ranged from 
resistant to susceptible against both the Gram-negative and Gram-positive organisms (Table 
4-1). The antibacterial activity was dose-dependent, being more active at 250 µg than at 100 
µg. Both sensitive and resistant Gram-negative bacteria demonstrated varying levels of 
susceptibility to compounds 1-3 and 5 at 250 µg (Table 4-1).  Compounds 1-3 and 5 showed 
good activity against β-lactam resistant E. coli ATCC 25922 and the extended spectrum β-
lactamase producing K. pneumoniae ATCC 700603 (being susceptible to all of 1-3 and 5) but 
was only moderately active against P. aeruginosa (both strains being susceptible to only 1 
and showing strain specific susceptibility to 2, 3 and 5).  For the Gram-positive bacteria, the 
best activity was seen against all four staphylococci tested, particularly the MRSA strain 
(ATCC 43300) by all four compounds following 250 µg exposure (Table 4-1).  Bacillus 
subtilis and E. faecalis strains demonstrated varying levels of susceptibility to all four 
compounds.  All the tested compounds, 1-3 and 5, showed broad spectrum antibiotic effects 
where as much as ten of the twelve bacterial strains were susceptible to them.  Tectoquinone 
5 showed high zones of inhibition of 25 mm and 23 mm against S. sciuri and K. pneumoniae 
respectively.  Stigma-4-ene-3-one 2 at 250 µg also demonstrated a high zone of inhibition 
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against S. xylosus of 23 mm. The worst activity was shown against the Gram-negative P. 
aeruginosa and Gram-positive E. faecalis with the lowest recorded zones of inhibition.      
 
Weak to strong activity has been previously reported in the literature for the isolated 
compounds.  Ergosta-4,6,8(14),22-tetraen-3-one 1, previously isolated from a Colletotrichum 
culture has inhibited the growth of S .aureus, P. aeruginosa and B. subtilis at MICs between 
25-75 µg mL-1 (Lu et al., 2000). Stigmast-4-en-3-one 2 isolated from Pycnarrhena 
manillensis showed comparable activity to chloramphenicol against P. aeruginosa, with 
antibacterial activity being demonstrated against E. coli and S. aureus (Ragasa et al., 2009).  
No antibacterial activity for 3β-hydroxy-21β-H-hop-22(29)-ene 3 could be found in the 
literature, however a similar hopane derivative, 22,29-epoxy-30-norhopane-13-ol, isolated 
from Adiantum lunulatum showed moderate activity against Gram-negative Salmonella typhi 
(Reddy et al., 2001).  This is indicative that Gram-negative bacteria must be susceptible to 
this type of skeleton, which is supported by our study since the Gram-negative E. coli, P. 
aeruginosa and K. pneumonia were also susceptible to 3.  Similarly, antibacterial activity for 
tectoquinone (2-methylanthracene-9,10-dione) 5 could not be found in the literature, but 
1,3,8-trihydroxy-6-methylanthracene-9,10-dione, a similar anthraquinone isolated from 
Cassia alata was active against S. aureus and methicillin-resistant S. aureus (MRSA) with 




Table 4-1 Antibacterial activity of isolated compounds and extracts (zones of inhibition in mm) from Ficus natalensis 
*Crude extracts – 100 mg mL-1 – 20 µl = 2 mg; 40 µl = 4 mg. 
# Purified compounds 1 -4: ergost-4, 6, 8(14), 22-tetra-3-one 1, stigmast-4-en-3-one 2, 3α-hydroxy-21α-H- hop-22(29)-ene 3 and tectoquinone 4) – 10 mg mL-1 stock – 10 µl = 100 µg; 25 µl = 250 µg. 
^ nt = not tested; $ R = resistant (≤10 mm); I = intermediate susceptibility (11-14 mm); S= susceptibility (≥ 15 mm); Negative control not used. AMP10 and TE20 refer to10 and 20 µg discs.  
 Zones of inhibition (mm) 



























































































Extracts*                         
Hexane leaves 0R 0R 0R 6R 0R 0R 0R 0R 0R 0R 0R 0R 0
R 0R 0R 0R 0R 0R 0R 9R 0R 0R 0R 9R 
DCM leaves 0R 0R 0R 0R 0R 0R 0R 0R 0R 0R 0R 0R 0
R 0R 0R 0R 0R 0R 0R 0R 0R 9R 0R 0R 
EtOAc leaves 0R 0R 0R 11I 0R 0R 0R 11
I 0R 10R 10R 12I 0
R 10R 0R 9R 0R 10R 0R 10R 8R 141 0R 0R 
MeOH leaves 0R 4R 0R 10R 0R 10R 0R 0R 0R 10R 0R 12I 0
R 0R 0R 0R 0R 11I 0R 10R 0R 11I 0R 0R 
Aq/ MeOH leaves 0R 11I 0R 9R 0R 10R 0R 11
I 0R 11I 0R 0R 0
R 10R 0R 9R 0R 12I 0R 12I 0R 16S 8R 13I 
EtOAc stem bark 0R 0R 0R 6R 0R 10R 0R 0R 0R 0R 5R 11I 15
S 23S 0R 0R 0R 10R 0R 9R 0R 12I 0
R 0R 
MeOH stem bark 0R 0R 0R 0R 0R 0R 0R 0R 0R 0R 0R 0R 8
R 20S 0R 10R 0R 13I 0R 0R 0R 0R 0R 0R 
Hexane fruit 0R 9R 0R 5R 0R 8R 0R 0R 0R 9R 7R 11R 15
S 15S 0R 7R 0R 8R 8R 10R 0R 10R 6R 10R 
DCM fruit 0R 9R 0R 7R 0R 8R 0R 8R 0R 0R 12I 13I 0
R 15S 0R 8R 14I 17S 15S 17S 11I 12I 12I 18S
EtOAc fruit 0R 4R 0R 7R 0R 0R 0R 0R 0R 0R 7R 13I 0 13
I 0R 10R 0R 11I 0R 11I 0R 11I 11I 15S 
MeOH fruit 0R 4R 0R 10R 0R 9R 0R 0R 0R 0R 5R 11I 0
R 11I 0R 10R 0R 10R 0R 10R 0R 0R 0R 0R 


















































1 10R 20S 9R 15
S 7R 15
S 9R 15
S 9R 19S 0R 20S 0
R 13I 0R 13I 9R 16S 9R 15S 9R 15S 11I 16S 
2 10R 18S 9R 16S 0R 15
S 10R 14I 9R 17S 15
S 18S 0
R 14I 0R 16S 10R 18S 8R 22S 10R 19S 0R 23S 
3 0R 16S 0R 15
S 0R 141 0R 18S 7R 16S 0R 0R 0
R 17S 0R 16S 7R 20S 7R 19S 0R 19S 0R 17S 
5 9R 18S 10R 20S 8R 13I 10R 15
S 0R 23S 0R 20S 0
R 16S 0R 111 9R 17S 0R 19S 9R 25S 16S 18S 
Ampicillin 
(AMP10) 
22S 0R 0R 0R 0R 40S nt^ nt^ 25S 20S 34S 0R 
Tetracycline 
(TE20) 




Biofilms in body tissues can be formed by bacteria such as E. coli, P. aeruginosa, 
Haemophilus influenzae and S. aureus (D’Abrosca et al., 2013).  Due to this growing 
research area and in our continuing efforts to identify antimicrobial agents that can prevent or 
treat infections caused by biofilm-forming bacteria, the anti-adhesion potential of crude 
extracts (10 mg mL-1) and isolated compounds (0.1, 0.25 and 0.5 mg mL-1) from F. natalensis 
were evaluated against three bacterial strains, E. coli ATCC 35218, P. aeruginosa ATCC 
27853 and S. aureus ATCC 43300.  
 
Percentage biofilm reduction was calculated as follows: 
Percentage reduction =			 	
 × 100, 
where B denotes the average absorbance per well for blank wells (no biofilm, no treatment), 
C denotes the average absorbance per well for control wells (biofilm, no treatment), and T 
denotes the average absorbance per well for treated wells (biofilm and treatment). 
A negative value therefore indicates that the extract or pure compound increases biofilm 
formation and a positive value indicates reduction of biofilm formation compared to the 
control. 
 
Increased adhesion (p < 0.05) was observed with the Hex and DCM crude leaf and fruit 
extracts (Figure 4-2).  Decreased adhesion was observed for all EtOAc, MeOH and 
aq/MeOH leaf, stem bark and fruit extracts (Figure 4-2; Table 4-2). 
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Figure 4-2  Effect of 2 mg mL-1 crude leaf, stem bark and fruit extracts of F. natalensis on 
biofilm formation of E. coli ATCC 35218, P. aeruginosa ATCC 27853 and S. aureus ATCC 
43300, using microtitre plate assays. Data represents the mean standard deviation of three 
replicates on three separate occasions. 
 
The MeOH leaf extract displayed the greatest anti-adhesion potential against E. coli (Table 
4-2), while most of the extracts except the DCM and hexane extract of the leaves and fruit 
showed reduced biofilm formation by P. aeruginosa.  For S. aureus, the aq/ MeOH leaf, 
EtOAc stem bark and fruit and MeOH stem bark extracts reduced biofilm formation (Table 
4-2).  All the polar extracts (EtOAc, MeOH, aq/MeOH leaf, stem bark and fruit extracts) 
decreased adhesion while the non-polar (Hex and DCM leaf and fruit extracts) increased 
adhesion of the three bacterial strains. The decreased adhesion of E. coli, P. aeruginosa and 
S. aureus of the polar crude extracts suggests interference of the extracts on the ability of 
these microorganisms to adhere to polystyrene surfaces.  The opposite effect was observed 
for the non-polar extracts, which had the ability to promote biofilm formation.  
Unfortunately, no compounds were isolated from these polar extracts to find a link between 
the polar extracts and their anti-biofilm activity. However, Samoilova et al. (2014) observed 
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that extracts from medicinal plants Arctostaphylos uvaursi, Vaccinium vitis-idaea, Tilia 
cordata, Betula pendula and Zea mays stimulated E. coli biofilm formation up to three-fold.  
According to Samoilova et al., (2014), bacteria treated with polyphenol-rich extracts reduced 
more biofilm than with those treated with antibiotics alone.  The differential adhesion activity 
by polar and non-polar crude extracts suggests perhaps differential selection of 
phytochemicals with varying biofilm reduction efficacy.  There are varying reports on anti-
adhesion effects of polar extracts against different bacterial strains in the literature, which 
corroborate our findings.  Anti-adhesion inhibitory effects of polar extracts on E. coli and 
Bacillus cereus (Bräunlich et al., 2013; Tao et al., 2011), the oral bacteria, Streptococcus 
mutans and Streptococcus sobrinus (Song et al., 2006; Rahim and Khan, 2006), both S. 
aureus and methicillin-resistant S. aureus (MRSA) (Chusri et al., 2012; Hobby et al., 2012), 
P. aeruginosa (Sarkar et al., 2014) and Proteus mirabilis (Taqi, 2013) were reported in the 
literature. 
Table 4-2 Percentage biofilm reduction following exposure to 2 mg mL-1 crude leaf, stem 
bark and fruit extracts of F. natalensis   
Extracts Percent biofilm reduction (%) 
 
            E. coli                    P. aeruginosa               S. aureus 
     ATCC 35218               ATCC 27853            ATCC  43300 
Dichloromethane (leaf) -1511.09 -70.94 -540.07 
Ethyl actetate (leaf) 212.57 107.29 125.42 
Hexane (leaf) -1139.56 -6.03 -587.70 
Methanol (leaf) 218.11 106.27 113.13 
Aqueous methanol (leaf) 159.43 105.98 130.46 
Ethyl actetate (stem bark) 200.86 105.83 130.55 
Methanol (stem bark) 210.41 104.56 130.20 
Dichloromethane (fruit) -1293.44 -2.46 -602.69 
Ethyl actetate (fruit) 200.25 107.85 130.28 
Hexane (fruit) -1479.67 -48.26 -705.91 
Methanol (fruit) 199.63 106.87 128.69 
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All four compounds increased adhesion of E. coli ATCC 35218 (p < 0.001) at sub-inhibitory 
(100 µg mL-1, p = 0.047), inhibitory (250 µg mL-1, p < 0.001) and supra-inhibitory (500 µg 
mL-1) concentrations (Figure 4-3).  The results with P. aeruginosa were variable.  Stigmast-
4-en-one (2) decreased adhesion of P. aeruginosa ATCC 27853 at all three concentrations, 
with 100 µg mL-1 being the most effective (Figure 4-4;  
Table 4-3). Ergost-4,6,8(14), 22-tetraen-3-one (1) increased adhesion at 100 µg mL-1, but 
decreased adhesion at inhibitory and supra-inhibitory concentrations (250 and 500 mg mL-1 
respectively) (Figure 4-4).  For 3α-hydroxy-21α-H- hop-22(29)-ene (3) and tectoquinone (5), 
decreased adhesion was only observed at sub-inhibitory (100 µg mL-1) concentrations, while 
increased adhesion was observed at inhibitory and supra-inhibitory concentrations (250  and 
500 µg mL-1) ( 
Table 4-3).  Increased adhesion of S. aureus ATCC 43300 was observed with all four 
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250 µg mL-1 
500 µg mL-1 
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Figure 4-3 Effect of 100 -500 µg mL-1 of ergost-4, 6, 8(14), 22-tetraen-3-one (1), stigmast-4-
en-3-one (2), 3β-hydroxy-21β-H-hop-22(29)-ene (3) and tectoquinone (5) isolated from F. 
natalensis on biofilm formation of E. coli ATCC 35218, using microtitre plate assays. Data 
represents the mean standard deviation of three replicates on three separate occasions. 
 
Table 4-3  Percentage biofilm reduction following exposure to 100-500 µg mL-1 of four 
compounds isolated from F. natalensis. 
Compound E. coli ATCC 35218 
 
100          250          500  
µg/ml 
P. aeruginosa ATCC 
35218  
100          250          500  
µg/ml 
S. aureus ATCC 43300  
 




-315.62 -1456.10 -1176.99 -64.04 28.16 18.05 -445.34 -338.40 -437.78 
Stigmast-4-en-3-
one 
-783.27 -1168.21 -1151.57 59.65 8.59 19.45 -1.81 -330.97 -381.66 
3β-hydroxy-21β-
H- hop-22(29)-ene 
-149.72 -1346.58 -1071.16 39.07 -26.45 -38.54 -54.09 -302.98 -474.39 

























































































































100 µg mL-1  
250 µg mL-1 
500 µg mL-1 
 
Figure 4-4  Effect of 100 -500 µg mL-1 of ergost-4, 6, 8(14), 22-tetraen-3-one (1), stigmast-
4-en-3-one (2), 3α-hydroxy-21α-H- hop-22(29)-ene (3) and tectoquinone (5) isolated from F. 
natalensis on biofilm formation of P. aeruginosa ATCC 27853, using microtitre plate assays. 

























































































































100 µg mL-1 
250 µg mL-1 
500 µg mL-1 
 
Figure 4-5 Effect of 100 -500 µg mL-1 of ergost-4, 6, 8(14), 22-tetraen-3-one (1), stigmast-4-
en-3-one (2), 3α-hydroxy-21α-H- hop-22(29)-ene (3) and tectoquinone (5) isolated from F. 
natalensis on biofilm formation of S. aureus ATCC 43300, using microtitre plate assays. 
Data represents the mean standard deviation of three replicates on three separate occasions. 
 
Variable concentration dependent activity observed with the isolated compounds were in 
accordance with the findings of Kiplomo et al., (2011), where they reported variations in the 
adhesion activities at MIC, sub-MIC (0.5xMIC) and supra-MIC (2xMIC) concentrations with 
some triterpenic class of compounds isolated from Vernonia auriculifera against seven 
different bacterial strains. A low inhibitory concentration (IC50) 16 µg mL
-1 (range of 8 × 
MIC) has also been documented in literature for a pentacyclic triterpenoid, acetyl-11-keto-β-
boswellic acid derived from Boswellia serrata against two oral pathogens, S. mutans ATCC 
25175 and Actinomyces viscocsus ATCC 15987  (Raja et al., 2011). 3,6,16-
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trihydroxylup-20(29)-ene from the plant Combretum leprosum Mart has been reported to 
inhibit the biomass of S. mutans and S. mitis by 97% and 90% respectively at a concentration 
as low as 7.8 µg mL-1 (Evaristo et al., 2014), which further supported our findings. 
Nevertheless, increased adhesion being observed at higher concentrations with some of the 
isolated compounds may probably be as a result of promotion of microbial adhesion caused 
by compounds that provides suitable conditioning film for enhancement of cell attachment 
(Selim et al., 2014). 
 
4.3 Experimental 
General Experimental Procedures 
Silica gel 60 (Merck, 70-230 mesh and 200-300 mesh) was used for vacuum column 
chromatography (VCC) and column chromatography (CC) respectively.  Preparative TLC 
was carried out using glass plates 10 × 20 cm, kieselgel 60 F254 (Merck).  Aluminium sheets 
(20 × 20 cm) pre-coated with silica gel 60 F254 (Merck) were used for TLC analysis and 
visualised with  10% sulphuric acid in MeOH or under UV light at 254 and 366 nm. Melting 
points were determined on an Ernst Leitz Wetziar micro-hot stage melting point apparatus 
and are uncorrected.  IR spectra were obtained on a Perkin Elmer Universal ATR 
spectrometer.  Optical rotation was carried out on a Perkin Elmer™, Model 341 Polarimeter 
at 20 ºC with a 10 cm flow tube.  UV spectra were obtained on a Shimadzu Varian Cary UV-
VIS spectrophotometer. 1H, 13C and 2D NMR spectra were acquired on either Bruker 
AvanceIII 400 or 600 MHz spectrometers at frequencies of 400.22 MHz for 1H and 100.63 
MHz for 13C and referenced to TMS.  GC-MS analysis was carried out on a Shimadzu GC-
MSD apparatus using a fused-silica capillary column DB-5SIL MS (30 m × 0.25 mm i.d., 




The fruits, leaves and stem bark were collected in Durban, KwaZulu-Natal, South Africa in 
December 2012.  The plant was identified at the Ward herbarium of the University of 
KwaZulu-Natal, where a voucher specimen was deposited under the reference number G. V 
Awolola & H. Baijnath 3. 
 
Extraction and purification  
Ground fruits (970 g), ground leaves (1.1 kg) and ground stem bark (1.5 kg) were extracted 
twice by maceration, sequentially with organic solvents of increasing polarity, Hexane (Hex), 
dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH).  Yields of 20.75 g 
(Hex), 9.33 g (DCM), 4.05 g (EtOAc) and 9.97 g (MeOH) of the fruits was obtained after 
evaporation of the organic solvents. For the leaves, 15.05 g (Hex), 12.44 g (DCM), 7.06 g 
(EtOAc) and 14.41 g (MeOH) was obtained while for the stem bark, 8.58 g (Hex), 18.36 g 
(DCM), 10.41 g (EtOAc) and 11.49 g (MeOH) was obtained. 
According to the TLC profile, similar components were observed for both the hexane and 
DCM crude extracts of the leaves. They were both combined and 24.09 g was subjected to 
vacuum column chromatography (VCC) on a silica gel column with a hex:DCM, 
DCM:EtOAc and EtOAc:MeOH step gradient, increasing the polarity each time in 
increments of 20% until 100% MeOH was reached.  Fractions of 250 mL each were collected 
and 2L of solvent were used for each step in the gradient.  A total of 122 fractions were 
eluted.  The fractions were combined into five major fractions after analysis of each of the 
fractions by TLC (A: 28-35; B: 38-52; C: 53-69; D: 70-102 and E: 103-122).  Compound 3, 
3β-hydroxy-21β-H-hop-22(29)-ene (250.6 mg), was obtained from fraction A (1.56 g) after 
washing with hexane and recrystallized in MeOH.  Fraction B (3.60 g) was further purified 
on a column (2 cm in diameter) by elution with hexane:EtOAc (9:1) to obtain 1 ergosta-
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4,6,8(14),22-tetraene-3-one.  Final purification of 1 was achieved by preparative TLC (hex: 
EtOAc; 9:1) to obtain 140.5 mg of 1.  
 
The EtOAc fraction of the leaves (6.50 g) was separated in a similar manner as above, but 
collecting 150 mL fractions and using a volume of 1.2 L for each step in the gradient.  Five 
major fractions were combined after TLC analysis (A: 21-23; B: 24-29; C: 30-48; D: 49-70 
and E: 71-97).  Compound 4, sitosterol (80.6 mg) was obtained from fraction B (210 mg), 
which was eluted with hex:EtOAc (8:2). 
 
Similar to the leaves, the hexane and DCM crude extracts of the stem bark were combined 
based on TLC analysis.  The combined extract (hex and DCM; 26.94 g) was separated similar 
to the leaves to yield six fractions (A: 5-16; B: 17-19; C: 24-26; D: 33-38; E: 50-54 and F: 
66-75). Compound 5, tectoquinone (70.8 mg) was obtained by purification of fraction B 
(280.5 mg) on a silica column and eluted with hex:EtOAc (19:1).  Fraction C (390.9 mg) was 
further purified with a hex:EtOAc (17:3) solvent system, which yielded stigma-4-ene-3-one 
(2) (70.4 mg). 
 
Separation of the different extracts of the fruit was carried out as above, however no 
secondary metabolites were isolated from these extracts.  
 
Microbial strains 
A total of twelve species of microorganisms were used in this study: seven Gram-positive 
strains; Staphylococcus aureus ATCC 29213, S. aureus ATCC 43300, Staphylococcus 
xylosus ATCC 35033, Staphylococcus sciuri ATCC 29062, Enterococcus faecalis ATCC 
51299, Enterococcus faecium ATCC 29212 and Bacillus subtilis ATCC 6633; and five 
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Gram-negative strains; Escherichia coli ATCC 25922, E. coli ATCC 35218, Pseudomonas 
aeruginosa ATCC 27853, P. aeruginosa ATCC 35032 and Klebsiella pneumoniae ATCC 
700603 for antibacterial activity. Bacterial strains were all maintained on tryptic soy agar 
(TSA) at 4 ºC. Prior to the antibacterial tests, the strains were sub-cultured on freshly 
prepared (TSA) plates at 37ºC. 
 
Antibacterial susceptibility testing (AST) 
Using the disc diffusion method, the antibacterial susceptibility of compounds 1-3 and 5 and 
the crude extracts from F. natalensis was determined (CLSI, 2007).  Sitosterol 4 was not 
subjected to the antibacterial tests as this compound has been studied extensively. Stock 
solutions of 10 mg mL-1 for compounds 1-3 and 5 and 100 mg mL-1 for crude extracts were 
prepared using appropriate solvents (DMSO or chloroform).  Sterile, blank discs (6 mm 
diameter; MAST, UK), were impregnated with 100 µg or 250 µg of the isolated compounds 
and 2 mg or 4 mg of the crude extracts.   
Mueller Hinton agar plates were swabbed with bacterial inocula (equivalent to a 0.5 
McFarland standard), and impregnated discs were placed on the inoculated agar surface.  For 
the negative control, chloroform and DMSO-impregnated discs were used while tetracycline 
(TE30) and ampicillin (AMP10) discs (Oxoid, UK) were used as standard antibacterial agent 
controls.  Zones of inhibition, following incubation at 37 °C for 24 h, were measured in mm 
and averaged.  All testing was done in duplicate.   
 
The following zone diameter criteria were used to assign susceptibility or resistance to the 
phytochemicals tested: Susceptible (S) ≥ 15 mm, Intermediate (I) = 11 – 14 mm, and 
Resistant (R) ≤ 10 mm.  Criteria for assigning susceptibility or resistance to TE30 were: (S) ≥ 
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19 mm, (I) 15 – 18 mm, (R) ≤ 14 mm, while those for AMP10 was as follows: (S) ≥ 17 mm, 
(I) = 14 – 16 mm, (R) ≤ 13 mm (CLSI, 2007).  
 
Bacterial adhesion 
Based on the disc diffusion assay, three bacterial strains; E. coli ATCC 35218, S. aureus 
ATCC 43300 and P. aeruginosa ATCC 27853 were selected for the anti-adhesion study. The 
anti-adhesion effect of sub-inhibitory exposure (2 mg mL-1) of F. natalensis crude extracts, as 
well as ergost-4,6,8(14),22-tetraen-3-one 1, stigma-4-ene-3-one 2 , 3β-hydroxy-21β-H-hop-
22(29)-ene 3 and tectoquinone 4 [100 µg mL-1 (sub-inhibitory), 250 µg mL-1 (inhibitory), 500 
µg mL-1 (supra-inhibitory)] were determined using the crystal violet microtitre plate assay 
(Basson et al., 2008).  Bacterial strains were cultured on TSA overnight, and re-suspended in 
sterile distilled water.  Following centrifugation 12000 rpm for 2 min, pellets were washed 
and re-suspended to a turbidity equivalent to a 0.5 McFarland standard.  Each well of the 
sterile 96-well U-bottomed micro-titre plates were filled with 90 µL of tryptic soy broth 
medium and 10 µL of the selected bacterial strains.  Respective volumes of the isolated 
compounds (20, 50, 100 µL of a 1 mg mL-1 stock solution) and crude extracts (40 µL of a 10 
mg mL-1 stock solution) were added to the TSB medium at the time of inoculation in 
microtitre plates and all volumes were standardized to 200 µL with sterile distilled water for 
the investigation of bacterial adhesion. TSB broth inoculated with the respective bacterial 
cultures, but without the tested compounds and extracts were used as positive controls, whilst 
wells containing un-inoculated TSB broth only were used as a negative control to test for 
sterility and non-specific binding of media.  Plates were incubated aerobically at 37 ºC for 24 
h with agitation on an Orbit P4 micro-titre plate shaker (Labnet). 
 
135 
The supernatant in each well, after incubation, was aspirated and the micro-titre plates 
washed three times with 250 µL of sterile distilled water to remove planktonic bacteria.  The 
adherent bacteria were fixed with 200 µL of MeOH for 15 min.  After the removal of 
methanol, the plates were left to air-dry.  Subsequently, 150 µL of 2% Hucker’s crystal violet 
was added to the wells for 5 min.  Thereafter, wells were rinsed gently and thoroughly with 
water for the removal of excess stain, air-dried and 150 µL of 33% (v/v) of glacial acetic acid 
was added for re-solubilization of dye bound to adherent cells (Basson et al., 2008).  Using a 
Fluoroskan Ascent F1 spectrophotometer (Thermolabsystems), the optical density (OD) of 
the destained solution was measured at 600 nm.  Assays were carried out in triplicate, 
performed twice and the data averaged. OD600 values of treated cells were compared to 
untreated cells to investigate the increase or decrease in adhesion as a result of phytochemical 
and crude extract exposure as antimicrobial agents.  Treated and untreated samples were 
compared statistically using Paired t-tests (SigmaStat V3.5, Systat Software, Inc). 
A measure of efficacy called Percentage reduction was calculated from the blank, control, 
and treated absorbance values (Pitts et al., 2003):  
Percentage reduction =			 	
 × 100, 
where B denotes the average absorbance per well for blank wells (no biofilm, no treatment), 
C denotes the average absorbance per well for control wells (biofilm, no treatment), and T 
denotes the average absorbance per well for treated wells (biofilm and treatment). 
 
4.4 Conclusions 
Five non-polar compounds were isolated and identified from extracts of F. natalensis.  
Variable antibacterial activities were reported for both crude extracts and isolated compounds 
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with greater activity against Gram-positive bacteria, albeit at high concentration (4 mg mL-1).  
Decreased adhesion with >100% biofilm reduction was demonstrated by all the crude polar 
extracts against all bacterial strains.  The isolated compounds exhibited strain-specific anti-
adhesion potential. This is the first report of the anti-adhesion potential of crude extracts and 
isolated compounds of F. natalensis.  It is quite possible that the isolates from F. natalensis 
in this work could be responsible for the antibacterial activity experienced by those who use 
the plant for medicinal purposes since most of them have shown good antibacterial activity in 
the assays used in this work.  The same isolates also showed anti-biofilm activity, which 
could also contribute to the antibacterial activity.  Surprisingly though, the crude extracts did 
not show a significant antibacterial effect, however, probably if administered over a period of 
time, the concentrations of the isolates in the patient could increase resulting in the desired 
antibacterial effect shown by them in this study and may possess the potential to be 
developed into agents that can be used be prevent bacterial biofilm formation.  Further 
research is required to identify specific compounds that will be able to inhibit biofilm 
formation by both Gram-negative and Gram-positive bacterial pathogens at sub-inhibitory 
concentrations that will prevent the evolution of antimicrobial resistance. 
 
Acknowledgements 
The authors are thankful to the Research office, University of KwaZulu-Natal (UKZN), 
Westville Campus, Durban for a doctoral research grant.  GVA was awarded a PhD study 
fellowship (study leave) by the University of Ilorin, Nigeria. 
 
137 
4.5 References  
Adebayo, E. A., Ishola, O. R., Taiwo, O. S., Majolagbe, O. N. and Adekeye, B. T. (2009). 
Evaluations of the methanolic extract of Ficus exasperata stem, bark, leaf and root for 
phytochemical analysis and antimicrobial activities. Afr. J. Plant Sci. 3 (12): 283-287.  
Awolola, G. V., Koorbanally, N. A, Chenia, H., Shode, F. O. and Baijnath, H. (2014). 
Antibacterial and anti-biofilm activity of flavonoids and triterpenes isolated from the 
extracts of Ficus sansibarica warb. subsp. sansibarica (Moraceae) extracts. Afr. J. Tradit. 
Complement. Altern. Med. 11(3): 124-131. 
Basson, A., Flemming, L. A. and Chenia, H. Y. (2008). Evaluation of adherence, 
hydrophobicity, aggregation and biofilm development of Flavobacterium johnsoniae-like 
isolates. Microb. Ecol. 55: 1-14. 
Bräunlich, M., Økstad, O. A., Slimestad, R., Wangensteen, H., Malterud, K. E. and Barsett, 
H. (2013). Effects of Aronia melanocarpa Constituents on biofilm formation of 
Escherichia coli and Bacillus cereus. Molecules 18: 14989-14999. 
Burrows, J. and Burrows, S. (2003). Figs of Southern and South-Central Africa. Ed. Steffens, 
F., Umdaus Press, South Africa, p. 176. 
Cheng, S., Huang, C., Chen, W., Kuo, Y. and Chang, Y. (2008). Larvicidal activity of 
tectoquinone isolated from red heartwood-type Cryptomeria japonica against two 
mosquito species. Biores. Technol. 99: 3617-3622. 
Chusri, S., Phatthalung, P. N. and Voravuthikunchai, S. P. (2012). Anti-biofilm activity of 
Quercus infectoria G. Olivier against methicillin-resistant Staphylococcus aureus. Lett.  
Appl. Microbiol. 54: 511-517. 
Clinical and Laboratory Standards Institute (2007). M100-S17. Performance standards for 
antimicrobial susceptibility testing, 17th informational supplement, 27(1): Wayne, PA. 
138 
Cowan, M. M. (1999). Plant products as antimicrobial agents. Clin. Microbiol. Rev. 12 (4): 
564-582. 
D’Abrosca, B., Buommino, E., D’Angelo, G., Coretti, L., Scognamiglio, M., Severino, V., 
Pacifico, S., Donnarumma, G. and Fiorentino, A. (2013). Spectroscopic identification 
and anti-biofilm properties of polar metabolites from the medicinal plant Helichrysum 
italicum against Pseudomonas aeruginosa. Bioorg. Med. Chem. 21: 7038-7046. 
Evaristo, F. F. V., Albuquerque, M. R. J. R., Santos, H. S. D., Bandeira, P. N., Ávila, F. D. 
N., Silva, B. R. D., Vasconcelos, A. A., Rabelo, E. D. M., Nascimento-Neto, L. G., 
Arruda, F. V. S., Vasconcelos, M. A., Carneiro, V.A., Cavada, B. S. and Teixeira, E. H. 
(2014). Antimicrobial effect of the triterpene 3,6,16-trihydroxylup-20(29)-ene on 
planktonic cells and biofilms from Gram positive and Gram negative bacteria. BioMed 
Res. Int. 2014: 1-7.  
Fangkrathok, N., Sripanidkulchai, B., Umehara, K. and Noguchi, H. (2013). Bioactive 
ergostanoids and a new polyhydroxyoctane from Lentinus polychrous mycelia and their 
inhibitory effects on E2-enhanced cell proliferation of T47D cells. Nat. Prod. Res. 27(18): 
1611-1619. 
Hemalatha, M., Thirumalai, T., Saranya, R., Elumalai, E. K., David, E. (2013). A review on 
antimicrobial efficacy of some traditional medicinal plants in Tamilnadu. J Acute Dis. 
99-105. 
Hobby, G. H., Quave, C. L., Nelson, K., Compadre, C. M., Beenken, K. E. and Smeltzer, 
M.S. (2012). Quercus cerris extracts limit Staphylococcus aureus biofilm formation. J. 
Ethnopharmacol. 144: 812-815. 
Hossain, M. S., Sayeed, M. A. and Uddin, M. N. (2014). In-vitro antimicrobial activity of 
methanolic extract of Ficus racemosa Linn. Fruits. J. Sci. Innovat. Res. 3(4): 446-449. 
139 
Hutchings, A., Scott A. H., Lewis G. and Cunningham A. B. (1996). Zulu medicinal plants. 
An inventory. University of Natal Press, Pietermaritzburg, South Africa, p. 1961. 
Kamatenesi-Mugisha, M., Oryem-Origa, H. and Olwa-Odyek (2007). Medicinal plants used 
in some gynaecological morbidity ailments in western Uganda. Afr. J. Ecol. 45(Suppl. 1): 
34-40. 
Kiem, P. V., Minh, C. V., Huong, H. T., Nam, N. H., Lee, J. J. and Kim , Y. H. (2004). 
Pentacyclic triterpenoids from Mallotus apelta. Arch Pharm. Res. 27(11): 1109-1113. 
Kiplimo, J. J., Koorbanally, N. A. and Chenia, H. (2011). Triterpenoids from Vernonia 
auriculifera Hiern exhibit antimicrobial activity. Afr. J. Pharm. Pharmacol. 5(8): 1150-
1156. 
Kiprono, P. C., Kaberia, F., Keriko, J. M. and Karanja, J. N. (2000). The in vitro anti-fungal 
and anti-bacterial activities of β-sitosterol from Senecio lyratus (Asteraceae). Z. 
Naturforsch. 55c: 485-488. 
Lawal, I. O, Borokini, T., Oyeleye, A., Williams, O. A. and Olayemi, J. O. (2012).   
Evaluation of extract of Ficus exasperata Vahl root bark for antimicrobial activities 
against some strains of clinical isolates of bacteria and fungi.  Int. J. Mod. Bot. 2(1): 6-12. 
Lewis, K. (2013). Platforms for antibiotic discovery. Nat. Rev. Drug Discovery 12: 371-387. 
Liu, B., Jian, L., Chen, G., Song, X., Han, C. and Wang, J. (2014). Chemical constituents and 
in vitro anticancer cytotoxic activities of Polyalthia plagioneura. Chem. Nat. Compd. 
49(6): 1171-1174. 
Lu, H., Zou, W. X., Meng, J. C., Hu, J. and Tan, R. X. (2000). New bioactive metabolites 
produced by Colletotrichum sp., an endophytic fungus in Artemisia annua. Plant Sci. 151: 
67-73. 
Mahato, S. B and Kundu, A. P. (1994). 13C NMR Spectra of pentacyclic triterpenoids-A 
compilation and some salient features. Phytochemistry. 37: 1517-1575. 
140 
Nikaido, H. (2001). Preventing drug access to targets: cell surface permeability barriers and 
active efflux in bacteria. Cell Develop. Biol. 12: 215-223. 
Ofek, I., Hasty, D. L. and Doyle, R. J. (2003). Bacterial Adhesion to Animal Cells and 
Tissues. American Society for Microbiology Press, Washington, DC.  
Ofek, I. and Doyle, R. J. (1994). Common themes in bacterial adhesion. In: Bacterial 
Adhesion to Cells and Tissues, Ofek, I. and Doyle, R.J., Eds., Chapman & Hall, New 
York. p. 513-562. 
Olaokun, O. O., McGaw, L. J., Eloff, J. N. and Naidoo, V. (2013).  Evaluation of the 
inhibition of carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic 
content of extracts of ten African Ficus species (Moraceae) used traditionally to treat 
diabetes. BMC Complement. Altern. Med. 13(94): 1-10. 
Palombo, E. A. (2011). Traditional medicinal plant extracts and natural products with activity 
against oral bacteria: potential application in the prevention and treatment of oral 
diseases. Evidence-Based Complement. Altern. Med. 2011: 1-15. 
Pitts, B. M., Hamilton, M. A., Zelver N. and Stewart. P. S.  2003. A microtitre-plate 
screening method for biofilm disinfection and removal. J. Microbiol. Methods 54: 269-
276.  
Promgool, T., Pancharoen, O. and Deachathai, S. (2014). Antibacterial and antioxidative 
compounds from Cassia alata Linn. Songklanakarin J. Sci. Technol. 36(4): 459-463. 
Rabe, T. and van Staden, J. (1997). Antibacterial activity of South African plants used for 
medicinal purposes. J. Ethnopharmacol. 56: 81-87. 
Ragasa, C. Y., Tepora, M. M. and Rideout, J. A. (2009). Antimicrobial activities of sterols 
from Pycnarrhena manillensis. ACGC Chem. Res. Comm. 23: 31-34. 
141 
Rahim, Z. H. and Khan, H. B. (2006). Comparative studies on the effect of crude aqueous 
(CA) and solvent (CM) extracts of clove on the cariogenic properties of Streptococcus 
mutans, J. Oral Sci. 48(3): 117-123.  
Raja, A. F., Ali, F., Khan. I. A., Shawl, A. S. and Arora, D. S. (2011). Acetyl-11-keto-β-
boswellic acid (AKBA); targeting oral cavity pathogens. BMC Res. Notes. 4(406): 1-8. 
Rasoanaivo, L. H., Wadouachi, A., Andriamampianina, T. T., Andriamalala, S. G., 
Razafindrakoto, E. J. B., Raharisololalao, A. and Randimbivololona, F. (2014). 
Triterpenes and steroids from the stem bark of Gambeya boiviniana Pierre. J.  
Pharmacogn. Phytochem. 3(1): 68-72. 
Reddy, V. L. N., Ravikanth, V., Rao, T. P., Diwan, P. V. and Venkateswarlu, Y. (2001). A 
new triterpenoid from the fern Adiantum lunulatum and evaluation of antibacterial 
activity. Phytochemistry 56: 173-175. 
Rwawiire, S., Luggya, G.W. and Tomkova, B. (2013). Morphology, thermal, and mechanical 
characterization of bark cloth from Ficus natalensis. ISRN Textiles 2013:  1-8. 
Salem, M. Z. M., Salem, A. Z. M., Camacho, L. M., and Ali, H. M. (2013). Antimicrobial 
activities and phytochemical composition of extracts of Ficus species: An overview. Afr. 
J. Microbiol. Res. 7: 4207-4219. 
Samoilova. Z., Muzyka, N., Lepekhina, E., Oktyabrsky, O. and Smirnova, G. (2014). 
Medicinal plant extracts can variously modify biofilm formation in Escherichia coli. 
Antonie van Leeuwenhoek 105: 709-722.  
Saranraj, P. and Sivasakthi, S. (2014). Medicinal Plants and its Antimicrobial Properties: A 
Review. Global J Pharma. 8(3): 316-327. 
Sarkar, R., Chaudhary, S. K., Sharma, A., Yadav, K. K., Nema, N. K., Sekhoacha, M., 
Karmakar, S., Braga, F. C., Matsabisa, M. G., Mukherjee, P. K. and Sen, T. (2014). Anti-
142 
biofilm activity of Marula – A study with the standardized bark extract. J.  
Ethnopharmacol.154: 170-175. 
Selim, S. A., Adam, M. E., Hassan, S. M.  and Albalawi, A. R. (2014). Chemical 
composition, antimicrobial and antibiofilm activity of the essential oil and methanol 
extract of the Mediterranean cypress (Cupressus sempervirens L.) BMC Complement. 
Altern. Med. 14(179): 1-8. 
Song, J. H., Kim, S. K., Chang, K. W., Han, S. K., Yi, H. K. and Jeon, J. G. (2006). In vitro 
inhibitory effects of Polygsaonum cuspidatum on bacterial viability and virulence factors 
of Streptococcus mutans and Streptococcus sobrinus, Arch. Oral Biol. 51: 1131-1140. 
Sonibare, M. A., Sonibare, O. O., Akharame, O. E. and Soladoye, M. O. (2009). Chemical 
composition of essential oils of Ficus elasticoidies De Wild., Ficus ovata Vahl and Ficus 
natalensis subsp. leprieurii (Miq.) C.C. Berg from Nigeria. J. Essent. Oil Bearing Plants 
12(3): 282-286.  
Sousa, G. F., Duarte, L.  P., Alcântara, A. F. C., Silva, G. D. F., Vieira-Filho, S. A., Silva, R. 
R., Oliveira, D. M. and Takahashi, J. A. (2012). New triterpenes from Maytenus robusta: 
Structural elucidation based on NMR experimental data and theoretical calculations. 
Molecules 17: 13439-13456. 
Suffredini, I. B., Paciencia, M. L. B., Varella, A. D. and Younes, R. N. (2006). Antibacterial 
activity of Brazilian Amazon plant extracts. Braz. J. Infect. Dis. 10: 400-402. 
Tao, Y., Pinzόn-Arango, P. A., Howell, A. B. and Camesano, T. A. (2011). Oral consumption 
of cranberry juice cocktail inhibits molecular-scale adhesion of clinical uropathogenic 
Escherichia coli. J. Med. Food. 14(7/8): 739-745. 
Taqi, R. A. (2013). Effect of Ficus religiosa phenolics on the formation of biofilm and 
swarming of Proteus mirabilis. Int. J. Biol. Pharm. Res. 4(12): 1147-1150. 
143 
Wanyama, P. A. G., Kiremire, B. T., Ogwok, P.  and Murumu, J. S. (2011). Indigenous plants 
in Uganda as potential sources of textile dyes. Afr. J Plant Sci. 5(1): 28-39. 
  
144 
Chapter 5. The phytochemistry and gastroprotective 








, Seun S. 
Noren
†††
, Neil A. Koorbanally
†* 
†School of Chemistry and Physics and  ††School of Life Sciences, University of KwaZulu-
Natal, Private Bag X54001, Durban 4000, South Africa. 
††† Department of Pharmacognosy, Faculty of Pharmacy, University of Lagos, Nigeria.  
 
*Corresponding author: Tel.: +2731 260 3189; Fax: +2731 260 3091. 
E-mail addresses: Koorbanally@ukzn.ac.za (N.A. Koorbanally), vickyfani@yahoo.com 




Ficus glumosa is reputed for the treatment and management of various health conditions, 
including diarrhoea, dysentery, oedema, headache, stomach ailments and ulcers. Three 
phenolic acids (1-3), two coumarins (4 and 5), three flavonoid glycosides (6, 7a, 7b) and five 
triterpenoids (8-12) were isolated from the aerial parts of F. glumosa. Gastroprotective 
activity of the methanol soluble extract of the leaves was apparent at 200 mg kg-1 with 
significant protection in ethanol, indomethacin and pylorus-induced experimental ulcer in rat 
models. The extract was shown to be non-toxic at 2000 mg kg-1. Quercetin-3-O-β-D-
glucopyranoside (isoquercitrin) 7a, quercetin-3-O-β-D-galactopyranoside 7b and p-
hydroxybenzoic acid 1 isolated from the leaf extract probably play a role in the observed 
gastroprotective activity. The findings in this study validate the use of F. glumosa in the 
treatment of ulcers in African ethnomedicine. 
 




The genus Ficus (Moraceae) comprises over 800 species of woody trees, shrubs and vines, 
with over 100 species found in Africa (Serrato et al., 2004).  F. glumosa (Miq.) Delile is a 
medium sized tree which grows up to 5-10 m and has a smooth pale brown bark.  The 
branches are thick and hairy while the leaves are thick with silky white oblong hairs.  The 
fruit grow into hairy red figs when ripe and grow on the axils of the leaves either singly or in 
pairs (Burrows and Burrows, 2003).  It is commonly known as “African rock fig” and is 
reputed for the treatment and management of various health conditions in African traditional 
medicine, including dysentery, oedema, hypertension, headache, stomach ailments, menstrual 
pains, skin diseases, rheumatism, diabetes mellitus and to treat female sterility (Burkill, 1985; 
Arbonnier, 2000; Orwa et al., 2009; Madubunyi et al., 2012).  A mixture of the latex and bark 
are applied as mouthwash for toothache while the bark decoction is used for the treatment of 
sores and ulcers (Burkill, 1985).  The fruits are eaten when ripe.  
 
Pharmacologically, F. glumosa has been described for its antidiabetic, hypolipidaemic, 
hypoglycaemic and antioxidant properties (Madubunyi et al., 2012; Olaokun et al., 2013; 
2014; Onoja et al., 2014). The methanol leaf extract of the plant had antidiarrheal activity 
(Tanko et al., 2012) and the aqueous leaf extract showed diuretic activity, supporting its 
traditional use in treating hypertension (Ntchapda et al., 2014) as well as hypolipidemic and 
anti-atherosclerotic properties (Ntchapda et al., 2015). Additionally, Nana et al. (2012) 
reported 23 phytochemical compounds from the stem bark including ceramides, flavonoids 
and their glycosides and sterols and their glycosides. One of the compounds isolated, 
dongnoside E showed good cytotoxic activity against the prostate cancer PC-3 cell line (Nana 
et al., 2012).  
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Several plant extracts, including those of Ficus have been shown to have gastroprotective 
effects (Sumbul et al., 2011; Srinivas et al., 2013;  Alqasoumi et al., 2014; Ishikawa et al., 
2014;  Yesilada et al., 2014), which prompted us to investigate the aerial parts of F. glumosa 
for its gastroprotective potential.  Thus far, despite various documented pharmacological 
studies on F. glumosa, there is no report on the gastroprotective activity and detailed 
phytochemical studies of the aerial parts of the plant. We herein report the phytochemical 
study of the stem bark, fruit and leaves and gastroprotective activity of F. glumosa leaves. 
 
5.2 Results and discussion  
The phytochemical investigation of the aerial parts of F. glumosa resulted in the isolation of 
13 known compounds (Figure 5-1), which were identified by their 1H and 13C NMR spectra 
and by comparison of their physical and spectroscopic data with that reported in the 
literature. They were identified as p-hydroxybenzoic acid (1) (Refaat et al., 2015); 3,4-
dihydroxy benzoic acid (2) (Zhu et al., 2010, Nana et al., 2012); vanillic acid (3) (Refaat et 
al., 2015); peucedanol (4)  (Ikeshiro et al., 1994); (-) – marmesin (5) (Znati et al., 2014); 
quercetin-7-O-glucopyranoside (6)  (quercimeritrin) (Shin et al., 2010); quercetin-3-O-β-
glucopyranoside (7a) (Atay et al., 2015); quercetin-3-O-β-galactopyranoside  (7b) (7a & 7b- 
were isolated as a mixture) (Atay et al., 2015); simiarenol (8) (Yoo et al., 2008); 3β-hydroxy-
21β-H-hop-22(29)-ene  (9) (Sousa et al., 2012); α-amyrin acetate (10) (Ali, 2013); stigma-4-
ene-3-one (11) (Tanemossu et al., 2014) and sitosterol (12) (Rasoanaivo et al., 2014). 
Compounds 1, 7a & 7b, 9, 11 and 12 were isolated from the leaves while 2-5, 8 and 10 were 
isolated from the stem bark and 6 was found in the fruits. Eight of the isolated compounds 
have been previously reported in related Ficus species (Chang et al., 2005; Chen et al., 2010;  
Nana et al., 2012; Park et al., 2012; Tsai et al., 2014), including 3β-hydroxy-21β-H-hop-
22(29)-ene (9), which was isolated from Ficus natalensis in this work (Chapter 4).  This is 
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the first report of peucedanol (4), quercetin-7-O-glucopyranoside (6), quercetin-3-O-β-
galactopyranoside (7b) and simiarenol (8) in the genus Ficus. 
 
The structural elucidation was carried out using 1H, 13C, HMBC and NOESY data.  For 
example, the  1H NMR spectrum of 4 indicated two characteristic coumarin doublets at δH 
7.84 and δH 6.18 (H-3, J = 9.2 and H-4, J = 9.4).  Two aromatic one-proton singlets 
indicating their para orientation to each other at δH 7.40 and δH 6.73 (H-5 and H-8) was 
evident. There were three other observable proton signals, two-proton multiplets at δH 2.53, 
δH 3.07 (H-1′a and H-1′b) attributable to a benzylic methylene and a one-proton double 
doublet at δH 3.62 (H-2′).  Two three-proton singlets resonating at δH 1.29 and δH 1.28 (H-4′   
and H-5′) were assigned to the gem-dimethyl groups at C-3'.  The point of attachment of the 
isoprenyl unit was indicated by HMBC correlations between H-1′a and H-1′b to C-5 and C-7. 
The structure of Peucedanol (4) was confirmed by comparison with the data from literature 
and the configuration at C-2' was also determined as R as 4 had an optical rotation similar in 







Figure 5-1 Chemical structures of compounds 1-12 isolated from the aerial parts of F. 
glumosa 
Gastroprotective activity 
There are many different experimental models used in evaluating the gastroprotective activity 
of a plant extract or compound, such as the ethanol and indomethacin induced ulcer models. 
150 
Gastric lesions induced by ethanol results in gastric mucosal injury which is as a result of 
aggressive and protective imbalance (Oliveira et al., 2011; Amandeep et al., 2012). The 
methanol soluble extracts of the aerial parts (leaves, stem bark and fruits) of F. glumosa was 
screened for their gastroprotective potential at the dose of 100 and 200 mg kg-1. The extracts 
showed varying degrees of ulcer inhibition compared to the control (Table 5-1). In particular, 
the gastroprotective activity of the leaf extract (FLM) was found to be very high.  The leaf 
extract reduced ulcer lesions by 75 and 90%, respectively at a dose of 100 and 200 mg kg-1 
significantly (P< 0.01).  Misoprostol, the standard drug used in this experiment, showed 
protection of 85% at a dose of 0.1 mg kg-1 compared to the control.  Since the methanol leaf 
extract showed a gastroprotective effect of 90% at 200 mg kg-1, it was thus selected for 
further studies in the indomethacin and pylorus ligation-induced ulcer models. 
 
The long term administration of non-steroidal anti-inflammatory drugs (NSAID) is another 
important factor in the pathology of gastric ulcers. NSAID such as indomethacin caused 
therapeutic and toxic effects by inhibiting cyclooxygenase and decreasing the levels of 
prostaglandins in the gastric mucosa (Yoshikawa et al., 1993; Takeuchi et al., 1997). In the 
indomethacin induced ulcer assay, the extract showed significant and marked protection with 
50, 61 and 100% protection at doses of 50, 100 and 200 mg kg-1 respectively (Table 5-2). 
The standard drug omeprazole, showed 96% protection at 100 mg kg-1. The results obtained 
suggest that the cytoprotective effect of F. glumosa may be mediated by prostaglandins. 
 
Pyloric ligation is a method used to induce ulcers in experimental rat models.  It does this by 
the accumulation of gastric juice and by interfering with gastric blood circulation (Shay et al., 
1945).  This test allows measurement of parameters such as gastric secretion volume, pH and 
total acidity ([H+]) in the gastric juice (Miranda, et al., 2015). The ulcer index and percent 
protection against ulcers in the pylorus ligated-induced ulcer model are shown in Table 5-3. 
The extract significantly reduced ulcer indices compared to the tween 20 treated pylorus- 
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ligated control group.   The percentages of ulcer protection at doses of 50, 100 and 200 mg 
kg-1 were 56, 60 and 62%, respectively. The gastric volume and gastric acidity were 
significantly (P<0.05, P<0.01)  reduced at the dose of  100 and 200 mg kg-1, while the gastric 
pH was increased at all the three doses, compared to the control. The standard drug, 
cimetidine produced a significant decrease in ulcer index, gastric volume and total acidity 
with significant increase in the pH compared to the control. These findings suggest that the 
gastroprotective effect of the extract could involve anti-secretory action.   
 
The phytochemical profile of the leaves of F. glumosa yielded five compounds including two 
flavonoids (quercetin-3-O-β-D-glucopyranoside (isoquercitrin) 7a and quercetin-3-O-β-D-
galactopyranoside (hyperoside) 7b and a phenolic derivative of benzoic acid, p-
hydroxybenzoic acid 1. These compounds have been reported to have gastroprotective and 
antioxidant activities.  Rodrigues et al. (2012) reported isoquercitrin 7a as one of the 
components in the anti-ulcerogenic active fraction of Byrsonima sericea leaves, while 
Yesilada et al. (2014) identified this compound as the active anti-ulcerogenic compound in 
Sambucus ebulus. Quercetin-3-O-β-D-galactopyranoside has also been reported as one of the 
components of Byrsonima crassa, a medicinal plant used in Brazilian folk medicine for the 
treatment of gastric ulcers (Sannomiya et al., 2005).  
 
Moreover, the flavonoid glycosides and p-hydroxybenzoic acid 1 have been reported to have 
antioxidant activity (Zocoler et al., 2009; Zhang et al., 2014; Cong et al., 2015). Antioxidant 
activity is one of the mechanisms suggested for anti-ulcerogenic effects (Kwiecien et al., 
2002; Repetto and Llesuy, 2002).  Other suggested mechanisms include stimulation of 
prostaglandin, thereby inhibiting leukotriene production, increasing the gastric hexosamine 
level and enhancing the strength of the gastric barrier either physically or by blocking the H+, 
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K+–ATPase pump (Okazaki et al., 2007).  It could therefore be deduced that the presence of 
these phenolic compounds may contribute to the significant gastroprotective activity 
observed in the leaf extract of F. glumosa, which would validate the use of the plant in 
African traditional medicine.    
 
Table 5-1 Effect of the methanol extracts of F. glumosa in rats with ethanol-induced ulcers 
Treatment Dose  (mg/kg)         Mean ulcer score    % Inhibition 
5% Tween 20 10 5.10±0.51 - 
Extract FLM 100 0.50±0.32** 75.49 
FLM 200 0.30±0.20*** 90.20 
FSM 100 3.50±1.19 31.37 
FSM 200 2.10±0.95* 42.35 
FFM 100 3.50±1.19 31.37 
FFM 200 2.60±0.97 36.27 
Misoprostol 0.1 0.60±0.24** 85.29 
Results are mean ± SEM, n=5. Statistical comparison was determined by one way ANOVA 
followed by Dunnett’s multiple comparison post-hoc tests. *P<0.05, **P<0.01, ***P<0.001, 
statistically significant compared to the control (5% Tween 20) 





Table 5-2 Effect of the methanol extract of the leaves of F. glumosa in rats with 
indomethacin-induced ulcers 
Treatment Dose (mg/kg) Mean ulcer score % Inhibition 
5% Tween 20 10 6.20± 0.68 - 
Extract 50             3.10±0.70** 50.00 
100             2.40±0.60*** 61.29 
200             0.00±0.00*** 100.00 
Omeprazole 100             0.10±0.08*** 96.24 
Results are mean ± SEM, n=5. Statistical comparison was determined by one way ANOVA 
followed by Dunnett  multiple comparison post-hoc tests.  **P<0.01, ***P<0.001, 
statistically significant compared to the control (5% Tween 20).  
 















10 3.00±0.76 - 0.82±0.50 3.88±0.06 9.80±0.05 
Extract 50 1.30±0.18* 56.67 0.54±0.05 6.20±0.80** 7.80±0.11 
 
100 1.20±0.12* 60.00 0.35±0.04** 7.36±0.27*** 6.20±0.08* 
 
200 0.90±0.24** 62.50 0.40±0.08** 6.60±0.22** 5.00±0.09** 
Cimetidine 100 0.10±0.04*** 95.83 0.22±0.13*** 7.48±0.05*** 4.00±0.02*** 
Results are mean ± SEM, n=5. Statistical comparison was determined by one way ANOVA 
followed by Dunnett multiple comparison post-hoc tests. *P<0.05, **P<0.01, ***P<0.001, 




General Experimental Procedures 
Reagents and chemicals were purchased from Merck and Sigma-Aldrich, South Africa.  
Organic solvents were redistilled and dried according to standard procedures prior to being 
154 
used. Optical rotation was recorded with a 10 cm flow tube using a Perkin ElmerTM, Model 
341 Polarimeter.  Melting points were recorded on an Ernst Leitz Wetziar micro-hot stage 
melting point apparatus and are uncorrected. IR spectra were determined using a Perkin 
Elmer Spectrum 100 Fourier-Transform Infra-Red (FT-IR) spectrometer with universal ATR 
sampling accessory.  Ultraviolet absorption (UV) spectra were obtained on a Shimadzu 
Varian Cary UV/VIS Spectrophotometer in either methanol or chloroform. 1H and 13C NMR 
spectra were recorded in either CDCl3 or CD3OD on a Bruker Avance
III 400 or 600 MHz 
spectrophotometer at 400.22 MHz for 1H and 100.63 MHz for 13C at room temperature. 
Chemical shifts (δ) are reported in ppm and coupling constants (J) in Hz. The chemical shifts 
of the deuterated solvent were 7.24 and 77.0 for 1H and 13C NMR respectively referenced to 
the internal standard, tetramethylsilane (TMS). For GC-MS analyses, the samples were 
analysed on a Shimadzu GC-MSD apparatus equipped with a fused-silica capillary column 
DB-5SIL MS (30 m × 0.25 mm i.d., 0.25 µm film thickness) at  a flow rate of 2 mL min-1 
using helium as a carrier gas. The MS was operated in the EI mode at 70 eV. The MALDI-
TOF MS spectra were recorded on a Bruker Reflex III (Germany). Chromatography was 
carried out by vacuum column chromatography (VCC) and column chromatography (CC) 
using silica gel 60 (Merck, 70-230 mesh, 200-300 mesh and Sephadex LH-20 (Pharmacia)).  
Analytical TLC was performed on pre-coated silica gel 60 F254 aluminium sheets (Merck 
1.05554) and visualised by spraying with 10% sulphuric acid in MeOH followed by heating 
or under UV light at 254 and 366 nm.  
 
Plant collection and extraction 
Fresh leaves, stem bark and fruit of F. glumosa (Miq.) Del. was collected at Durban, 
KwaZulu-Natal, South Africa during the month of February 2013. The plant was identified 
by Professor Himansu Baijnath, a botanist at the University of KwaZulu-Natal and deposited 
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at the University of KwaZulu-Natal, Ward herbarium (voucher no. G.V. Awolola & H. 
Baijnath 4). The plant parts were air dried (at room temperature) and pulverized in a 
mechanical grinder (Thomas Wiley laboratory mill). 
 
The powdered leaves (1.1 kg), stem bark (3.2 kg) and fruit (1.1 kg) material of F. glumosa 
were sequentially extracted with organic solvents of increasing polarity; hexane (Hex), 
dichloromethane (DCM), ethyl acetate (EtOAc) and methanol (MeOH) on an orbital shaker 
for 48 hours. The extracts were combined, filtered and concentrated to afford 8.27 g (Hex), 
8.16 g (DCM), 5.43 g (EtOAC) and 8.55 g (MeOH) crude extracts for the leaves, 35.26 g 
(Hex), 9.32 g (DCM), 8.72 g (EtOAc) and 13.14 g (MeOH) crude extracts for the stem bark 
and 29.17 g (Hex), 15.54 g (DCM), 10.55 g (EtOAc) and 29.81 g (MeOH) crude extracts for 
the fruits. The MeOH extracts of the leaves, stem bark and fruits were used for the 
gastroprotective assay while phytochemical analysis was conducted on all extracts. 
 
Isolation and purification of the leaf extracts 
A 7.12 g sample of the crude hexane extract was subjected to CC on 2.5 cm column and 
eluted with a stepwise gradient of hexane, dichloromethane, ethyl acetate and methanol, 
increasing the polarity by 20% for each step and collecting 100 mL fractions each. Based on 
their TLC profiles, the fractions were combined into four major fractions (A: 18-27; B: 28-
31; C: 32-49 and D: 50-82).  3β-Hydroxy-21β-H-hop-22(29)-ene 9 (40.56 mg) crystallized 
out of fraction B as a white powder.  The DCM and EtOAc crude extracts were combined 
(12.40 g) based on their TLC profiles and subjected to VCC as above. Similar fractions were 
pooled together to afford five major fractions (A: 11-26; B: 27-31; C: 32-36; D: 62-69 and E: 
70-81). Purification of fraction B (220.67 mg) led to the isolation of stigma-4-ene-3-one 11 
(30.12 mg) (purified with hex: EtOAc (17:3)) and sitosterol 12 (20.92 mg) (purified with hex: 
EtOAc (8:2)).   
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The methanol extract (7.52 g) was partitioned with EtOAc yielding 510.05 mg and was 
separated using Sephadex LH-20 and eluted with MeOH.  Fractions of 10 mL each were 
collected from a 1 cm column. The fractions were combined into four major fractions as 
follows, A: 7-14; B: 15-21; C: 22-30 and D: 31-45.  Purification of fraction B (80 mg) with 
Sephadex LH-20 and using MeOH as the eluent yielded p-hydroxybenzoic acid 1 (9.01 mg).  
Fraction C (100.56 mg) was separated on a 1 cm column and eluted with DCM: MeOH (9:1) 
to yield a mixture of 7a and 7b, which was identified as quercetin-3-O-β-D-glucopyranoside 
7a and quercetin-3-O-β-D-galactopyranoside 7b (40.52 mg of the mixture) in fractions 33-37.   
 
Isolation and purification of compounds from the stem bark 
The hexane and DCM extracts of the stem bark were combined due to similar TLC profiles.  
A 40.23 g sample of this combined extract was fractionated by VCC with a gradient elution 
using hexane, DCM, EtOAc and MeOH, increasing the polarity by 20% each time, collecting 
8 x 250 ml fractions for each step.  Fractionation of the crude extract afforded six major 
fractions (A: 1-6; B: 7-14; C: 15-21; D: 25-27; E: 28-45 and F: 46-63).  α-Amyrin acetate 10 
(5.37 g), crystallised out of fraction A and was recrystallized in hexane.  Simiarenol 8 (20.41 
mg) precipitated out as a white powder from fraction B. Fraction D (1.14 g) was further 
purified on a 1.5 cm diameter column by CC using Hex: EtOAc (3:2), collecting 20 mL 
fractions.  A light yellow powder was obtained from fractions 47-50 as (-)-marmesin 5 (72.20 
mg).  
 
The EtOAc fraction (7.50 g) of the stem bark was fractioned on a 3 cm diameter column and 
eluted with a step gradient of hex: EtOAc (increasing the polarity by 20% for each step) and 
finally with 100% MeOH; 10 x 100 mL fractions were collected at each stage.  Six major 
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fractions were obtained based on similar TLC profiles (A: 1-13; B: 14-23; C: 24-27; D: 28-
39; E: 40-56 and F: 57-72). Further purification of fraction B (460.48 mg) with Hex: EtOAc 
(1:1) yielded vanillic acid 3 (20.17 mg) as a brown powder.   p-Hydroxybenzoic acid 1 (20.35 
mg) was isolated from the same column with (Hex: EtOAc, 2:3) as a yellow powder.  
Fraction C (240.67 mg) yielded tiny brown crystals on elution with Hex: EtOAc (1:9) and 
was identified as 3,4-dihydroxybenzoic acid 2 (20.48 mg).   
 
The MeOH extract was partitioned with EtOAc.  A 3.10 g sample of the EtOAc portion was 
separated using a gradient elution of Hex: EtOAc and MeOH, increasing the polarity by 10% 
at each increment and collecting 10 × 20 mL fractions at each stage.  Four major fractions 
were obtained (A: 10-15; B: 16-30; C: 32-59 and D: 60-72).  Fraction B (460.25 mg) was 
separated with Sephadex LH-20 and eluted with MeOH.  This yielded more of 3,4-
dihydroxybenzoic acid 2 (22.31 mg) and vanillic acid 3 (10.12 mg).  Fraction C (760.12 mg) 
was purified on a 1 cm diameter column using Hex: EtOAc (1:1) and yielded a brown 
powder, identified as peucedanol 4 (30.12 mg).  
 
Isolation and purification of compounds from the fruits 
The methanol extract of the fruits was partitioned as above.  A 870.42 mg sample of the 
EtOAc portion was separated using Sephadex LH-20 with MeOH as the mobile phase, 
collecting 10 mL fractions. Three major fractions were obtained (A: 15-21; B: 22-26 and C: 
27-39). Fraction A (250.34 mg) was purified with sephadex LH-20 (eluted with MeOH) and 
yielded 3,4-dihydroxybenzoic acid 2 (90.78 mg).  Fraction C (330.54 g) was also purified 
using Sephadex LH-20 (eluted with MeOH), and yielded quercetin-7-O-glucopyranoside 6 




Healthy Male Albino Wister rats weighing between 120-140 g were used for the study and 
maintained under standard laboratory conditions in temperature controlled rooms (24-28 ºC), 
under a 12:12 h light–dark cycle, with access to water and food ad libitum until use.  Animal 
care and handling procedures were in accordance with the International Association for the 
Study of Pain guidelines for the use of animals in pain research (Zimmermann, 1983). The 
research protocol was approved by the College of Medicine, Institutional Ethical Committee 
of the University of Lagos, Nigeria (CM/COM/08/VOL.XXVI). 
 
Acute toxicity 
An acute toxicity test was performed according to the Organization of Economic Co-
operation and Development guidelines for chemical testing (OECD, 2001). A single oral dose 
(2000 mg kg-1) of the methanol extract of F. glumosa (leaf, stem bark and fruit extracts) was 
separately administered to 6 male Swiss albino mice, which underwent an overnight fast, by 
gavage using a suitable canula. Animal behaviour was observed from 1 h after the first 
administration of a single extract and monitored daily for 14 days. 
  
Gastroprotective activity in rats 
Preliminary screening using an ethanol-induced gastric ulcer model 
The gastroprotective potential of the methanol extracts of the leaves, stem bark and fruit of F. 
glumosa against superficial haemorrhagic mucosal lesions was investigated in the rats. Male 
rats weighing between 110 and 130 g were fasted for 24 h prior to the experiment. Forty rats 
were divided randomly into 8 groups of 5 rats each and pre-treated orally with the vehicle 
(5% Tween 20, 10 ml kg-1), misoprostol (0.1 mg kg-1) or extract (100-200 mg kg-1).  After 1 h 
of pre-treatment, all the rats were gavaged with l mL of absolute ethanol. The rats were 
159 
sacrificed 1 h later by cervical dislocation and their stomachs were immediately excised, cut 
along greater curvature, rinsed with normal saline and ulcer scored according to the method 
of Galati et al. (2001). 
 
Indomethacin-induced gastric ulcer model 
Rats fasted for 24 h were treated with vehicle (tween 20, 5%) or extract (50, 100 and 200 mg 
kg-1).  After 1 hour, indomethacin was administered orally to the rats at a dose of 80 mg kg-1 
to all the groups (Nwafor et al., 2000). The animals were sacrificed after 6 h by cervical 
dislocation, their stomachs removed, washed gently with saline (0.9%) and ulcer index scored 
as referenced in the ethanol-induced model (Galati et al., 2001).  
 
Pylorus ligation-induced gastric ulcer model 
The evaluation of the gastric anti-secretory potential of the extracts was determined according 
to the method described previously by Asif et al. (2013) with slight modifications. The 
animals were divided into 5 groups, each consisting of 5 rats.  All animals underwent 24 h of 
fasting. Group 1 served as the control (negative) and received 5% tween 20 only. Group II, 
III and IV received the extract at the doses of 50, 100 and 200 mg kg-1 respectively, while 
group V received cimetidine at 100 mg kg-1 (positive control). After 1 h of treatment, pylorus 
ligation was done without causing any damage to the blood supply of the stomach. Six hours 
after the ligation, the animals were sacrificed and the stomach removed. The gastric contents 
were collected into a centrifuge tube, centrifuged for 15 min at 2000 rpm and the supernatant 
volume measured.  The pH value was obtained with a pH meter (Elico, Hyderabad, India) 
and total acidity by titration (phenolphthalein as indicator). The ulcers formed in the gastric 




The results were expressed as the mean ± SEM (Standard error of the mean). Statistical 
analysis was performed with Graph Pad Prism version 5.0 for Windows (GraphPad Software, 
San Diego, CA, USA) using one way ANOVA followed by Dunnett’s multiple comparism 
post-hoc test. The significance level was set at P<0.05.  
 
5.4 Conclusions 
Toxicity and mortality was not observed with the rats in the acute toxicity testing of the 
methanol extracts (2000 mg kg-1) of the aerial parts of F. glumosa. A dose dependent 
gastroprotective effect was observed with the methanol soluble extract of the leaves, stem 
bark and fruits in the ethanol induced ulcer model.  In the indomenthacin induced ulcer 
model, the methanol leaf extract showed 100% gastroprotective activity at 200 mg kg-1.  The 
isolation of the mixture of isoquercitrin 7a and hyperoside 7b as well as p-hydroxybenzoic 
acid 1 in the methanol extract of the leaves of F. glumosa probably contributed to the 
gasteroprotective effects as these compounds were previously reported as having 
gastroprotective activity. These findings substantiate the use of the plant in African 
traditional medicine.   
 
ACKNOWLEDGMENTS 
This study was supported by a doctoral research grant from the Research office, University of 
KwaZulu-Natal (Westville campus), Durban, South Africa. The first author (Gbonjubola V. 
Awolola) is grateful to the University of Ilorin, Kwara State, Nigeria for the award of a PhD 





Ali, N. (2013). Brine shrimp cytotoxicity of crude methanol extract and antispasmodic 
activity of α-amyrin acetate from Tylophora hirsuta Wall. BMC Complement. Altern. 
Med. 13(135): 1-7. 
Alqasoumi, S. I., Basudan, O. A., Al-Rehaily, A. J. and Abdel-Kader, M. S. (2014). 
Phytochemical and pharmacological study of Ficus palmata growing in Saudi Arabia. 
Saudi Pharma. J. 22: 460-471.  
Amandeep, K., Robin, S., Ramica, S. and Sunil, K. (2012). Peptic Ulcer: A review of 
etiology and pathogenesis. Int. J. Pharm. 3(6): 34-38. 
Arbonnier, M. (2000). Arbres, arbustes et lianes des zones sèches d'Afrique de l'Ouest (Trees, 
shrubs and vines in dry areas of West Africa). In: CIRAD-MNHN-UICN (Ed.), 
CIRAD, (Montpellier), p. 752. 
Asif, R., Ansari, J. A., Kannappan, N. and Khan, M. (2013). Gastric antisecretory and 
antiulcer activities of Tabernaemontana divaricata L. Med. Chem. Drug Discovery. 
4(1): 35-40.  
Atay, I., Kirmizibekmez, H., Goren, A. C. and Yesilada, E. (2015). Secondary metabolites 
from Sambucus ebulus. Turk. J. Chem. 39: 34-41.  
Burkill, H. M. (1985). The useful plants of West Tropical Africa, vol. 1, Royal Botanic 
Gardens, Kew, p. 258-259. 
Burrows, J. and Burrows, S. (2003). Figs of Southern and South-Central Africa. Ed. Steffens, 
F., Umdaus Press, South Africa, p. 112.   
Chang, M., Yang, Y., Kuo, Y., Kuo, Y., Chang, C., Chen, C. and Lee, T. (2005). 
Furocoumarin glycosides from the leaves of Ficus ruficaulis Merr. var. antaoensis. J. 
Nat. Prod. 68: 11-13. 
162 
Chen, L-W., Cheng, M-J., Peng, C-F. and Chen, I-S. (2010). Secondary metabolites and 
antimycobacterial activities from the roots of Ficus nervosa. Chem. Biodivers. 7: 1814-
1821. 
Cong, F., Joshi, K. R., Devkota, H. P., Watanabe, T. and Yahara, S. (2015). Dhasingreoside: 
new flavonoid from the stems and leaves of Gaultheria fragrantissima, Nat. Prod. Res. 
29 (15): 1442-1448. 
Galati, E. M., Monforte, M. T., Tripodo, M. M., d’Aquino, A. and Mondello, M. R. (2001). 
Antiulcer activity of Opuntia ficus indica (L.) Mill. (Cactaceae): ultrastructural study. J. 
Ethnopharmacol. 76: 1-9. 
Ikeshiro, Y., Mase, I. and Tomita, Y. (1994). Coumarin glycosides from Peucedanum 
japonicum. Phytochemistry 35: 1339-1341. 
Ishikawa, T., Navarro, L. B., Donatini, R. S., Bacchi, E. M., Kato, E. T. M. Vilegas, W. and 
Yoshida, M. (2014). Gastroprotective property of Plinia edulis (Vell.) Sobral 
(Myrtaceae): The role of triterpenoids and flavonoids. PharmacologyOnLine 1: 36-43. 
Kwiecien, S, Brzozowski, T. and Konturek, S. J. (2002). Effects of reactive oxyen species 
action on gastric mucosa in various models of mucosal injury.  J Physiol. Pharmacol. 
53(1): 39-50. 
Madubunyi, I. I., Onoja, S. O. and Asuzu, I. U. (2012). In vitro antioxidant and in vivo 
antidiabetic potential of the methanol extract of Ficus glumosa Del (Moraceae) stem 
bark in alloxan-induced diabetic mice. Comp. Clin. Pathol. 21: 389-394. 
Miranda, M. A., Lemos, M., Cowart, K. A., Rodenburg, D., McChesney, J. D., Radwa, M. 
M., Furtado, N. A. J. C., Bastos, J. K. (2015). Gastroprotective activity of the 
hydroethanolic extracts and isolated compounds from the leaves of Solanum cernuum 
Vell. J. Ethnopharmacol. 172: 421- 429. 
163 
Nana, F., Sandjo, L. P., Keumedjio, F., Ambassa, P., Malik, R., Kuete, V., Rincheval, V., 
Choudhary, M. I. and Ngadjui, B. T. (2012). Ceramides and cytotoxic constituents from 
Ficus glumosa Del. (Moraceae).  J. Braz. Chem. Soc. 23(3): 482-487. 
Ntchapda, F., Abakar, D., Kom, B., Nana, P., Bonabe, C., Kakesse, M., Talla, E. and Dimo, 
T. (2014). Diuretic activity of the aqueous extract leaves of Ficus glumosa Del. 
(Moraceae) in rats. Scientific World J. 2014: 1-10. 
Ntchapda, F., Djedoubouma, A., Talla, E., Dongmo, S. S., Nana, P., Adjia, H., Nguimbou, R. 
M., Bonabe, C., Gaimatakon, S., Yanou, N. N. and Dimo, T. (2015). Hypolipidemic 
and anti-atherogenic effect of aqueous extract leaves of Ficus glumosa (Moraceae) in 
rats. Exp. Gerontol. 62: 53-62. 
Nwafor, P. A., Okwuasaba, F. K. and Binda, L.G. (2000). Antidiarrhoeal and 
antiulcerogenic effects of methanolic extract of Asparagus pubescens root in rats. J. 
Ethnopharmacol.  72: 421-427. 
OECD, Organization of Economic Co-operation and Development (2001). Guideline for 
Testing of Chemicals: 420 Acute oral toxicity, OECD, France. 
Okazaki, M., Shimizu, I., Ishikawa, M., Fujiwura, S., Yamamoto, H., Shiraishi, T., Horie, T., 
Iuchi, A. and Ito, S. (2007). Gastric mucosal levels of prostaglandins and leukotrienes 
in patients with gastric ulcer after treatment with rabeprazole in comparison to 
treatment with ranitidine. J Med. Investigat. 54: 83-90. 
Olaokun, O. O., McGaw, L. J., Awouafack, M. D., Eloff, J. N. and Naidoo, V. (2014). The 
potential role of GLUT4 transporters and insulin receptors in the hypoglycaemic 
activity of Ficus lutea acetone leaf extract. BMC Complement. Altern. Med. 14(269): 
1-12. 
Olaokun, O. O., McGaw, L. J., Eloff, J. N. and Naidoo, V. (2013) Evaluation of the inhibition 
of carbohydrate hydrolysing enzymes, antioxidant activity and polyphenolic content of 
164 
extracts of ten African Ficus species (Moraceae) used traditionally to treat diabetes. 
BMC Complement. Altern. Med. 13(94): 1-10. 
Oliveira, A. P., Santin, J. R., Lemos, M., Klein-Junior, L. C., Couto, A. G., Meyre da Silva 
Bittencourt, C., Cechinel-Filho, V. and Faloni de Andrade, S. (2011). Gastroprotective 
activity of methanol extract and marrubiin obtained from leaves of Marrubium vulgare 
L. (Lamiaceae). J Pharm. Pharmacol. 63: 1230-1237.  
Onoja, S. O., Omeh, Y. N., Ezeja, M. I. and Chukwu, V. N. (2014). Hypolipidaemic and 
haematological evaluation of the hydromethanolic extract of Ficus glumosa stem bark 
in alloxan-induced diabetic rats. J Complement. Integrat. Med. 11(4): 259-264. 
Orwa, C., Mutua, A., Kindt, R., Jamnadass, R. and Anthony, S. (2009). Agroforestry 
Database: A Tree. Version 4.0. http://www.worldagroforestry.org. 
Park, S. H., Oh, T., Kim, S. S., Kim, J. E., Lee, S. J. and Lee, N. H. (2012). Constituents with 
tyrosinase inhibitory activities from branches of Ficus erecta var. sieboldii King. J 
Enzyme Inhib. Med. Chem. 27(3): 390-394. 
Rasoanaivo, L. H., Wadouachi,  A., Andriamampianina, T. T., Andriamalala, S. G.,  
Razafindrakoto, E. J. B., Raharisololalao, A. and Randimbivololona, F. (2014). 
Triterpenes and steroids from the stem bark of Gambeya boiviniana Pierre. J 
Pharmacogn. Phytochem. 3 (1): 68-72. 
Refaat, J., Samy, M. N., Desouke, S. Y., Ramadan, M. A., Sugimoto, S., Matsunami, K. and 
Kamel, M. S. (2015). Chemical constituents from Chorisia chodatii flowers and their 
biological activities. Med. Chem. Res. 24: 2939-2949. 
Repetto, M. G. and Llesuy, S. F. (2002). Antioxidant properties of natural compounds used in 
popular medicine for gastric ulcers. Braz J. Med. Biol. Res. 35: 523-534. 
Rodrigues, P. A., Morais, S. M., Souza, C. M., Magalhales, D. V., Vieira, I. G., Andrade, G. 
M., Rao, V. S. and Santos, F. A. (2012). Gastroprotective effect of Byrsonima sericea 
165 
DC leaf extract against ethanol-induced gastric injury and its possible mechanisms of 
action. An. Acad. Bras .Cienc. 84: 113-122.  
Sannomiya,  M.,  Fonseca, V. B.,  da Silva, M. A., Rocha, L. R. M., dos Santos, L.C.,  
Hiruma-Lima, C. A., Souza Brito, A. R. M. and Vilegas, W. (2005). Flavonoids and 
antiulcerogenic activity from Byrsonima crassa leaves extracts. J. Ethnopharmacol. 97: 
1-6. 
Serrato, A., Ibarra-Manrique, Z. G. and Oyama, K. (2004). Biogeography and conservation of 
the genus Ficus (Moraceae) in Mexico. J. Biogeogr. 31: 475-485. 
Shay, H., Komarov, S. A., Fels, S. S., Meranze, D., Gruenstein, M. and Siplet, H. (1945).  A 
simple method for the uniform production of gastric ulceration in the rat. Gastroenterol. 
4: 43-61. 
Shin, S., Lee, L., Moon, S. R., Koo, I. H., Hong, H., Shin, E., Lee, M., Park, J. and Chung, H. 
S. (2010). Identification of secondary metabolites with antioxidant and antimicrobial 
activities from Artemisia iwayomogi and Chrysanthemum zawadskii. J. Korean Soc. 
Appl. Biol. Chem. 53(6): 716-723. 
Sousa, G. F., Duarte, L. P., Alcântara, A. F. C., Silva, G. D. F., Vieira-Filho, S. A., Silva, R. 
R., Oliveira, D. M. and Takahashi, J. A. (2012). New triterpenes from Maytenus 
robusta: Structural elucidation based on NMR experimental data and theoretical 
calculations. Molecules 17: 13439-13456. 
Srinivas, T. L., Lakshmi, S. M., Shama, S. N., Reddy, G. K. and Prasanna, K. R. (2013). 
Medicinal plants as anti-ulcer agents. J. Pharmacogn. Phytochem. 2 (4): 91-97. 
Sumbul, S., Ahmad, M. A., Mohd, A. and Mohd, A. (2011). Role of phenolic compounds in 
peptic ulcer: An overview. J. Pharm. Bioallied Sci. 3(3): 361-367. 
166 
Tanemossu, S. A. F., Franke, K., Arnold, N., Schmidt, J., Wabo, H. K., Tane, P. and 
Wessjohann, L. A. (2014). Rare biscoumarin derivatives and flavonoids from 
Hypericum riparium. Phytochemistry 105: 171-177. 
Tanko, Y., Alladey, O., Ahmed, M. K., Mohammed, A. and Musa, K. Y. (2012). The effect 
of methanol leaves extract of Ficus glumosa on gastrointestinal motility and on castor 
oil induced diarrhea in laboratory animals. J. Nat. Prod. Plant Resour. 2 (3): 360-367. 
Takeuchi, K., Kato, S., Nishiwaki, H. and Hirata, T.  (1997). Analysis of pathogenic elements 
involved in gastric lesions induced by non-steroidal anti-inflammatory drugs in rats. J. 
Gastroen. Hepatol. 12: 360-367. 
Tsai, P-W., Castro-Cruz, K. A., Shen, C-C. and Ragasa, C. Y.  (2014). Chemical constituents 
of the stems of  Ficus triangularis.  Der Pharmacia Lettre 6 (5): 130-133. 
Yesilada, E., Gürbüz, I., and Toker, G. (2014). Anti-ulcerogenic activity and isolation of the 
active principles from Sambucus ebulus L. leaves. J. Ethnopharmacol. 153: 478-483. 
Yoo, N. H., Jang, D. S. and Kim, J. S. (2008). Phytochemical constituents of the roots of 
Erigeron annuus. J. Korean Soc. Appl. Biol. Chem. 51(4): 305-308.  
Yoshikawa, T., Naito, Y., Kishi, A., Tomii, T., Kaneko, T., Iinuma, S., Ichikawa, H., 
Yasudaet, M., Takahashi,S. and Kondo,M. (1993).  Role of active oxygen, lipid 
peroxidation, and antioxidants in the pathogenesis of gastric mucosal injury induced by 
indomethacin in rats, Gut 34: 732-737. 
Zhang, Y., Wang, D., Yang, L., Zhou, D. and Zhang, J. (2014).  Purification and 
characterization of flavonoids from the leaves of Zanthoxylum bungeanum and 
correlation between their structure and antioxidant activity. PLoS ONE 9(8): e105725, 
11 pages.  
Zhu, C-C., Wang, K-J, Wang, Z.-Y. and Li, N. (2010). Chemical constituents from rhizomes 
of Curculigo breviscapa. Bull. Korean Chem. Soc. 31 (1): 224-226. 
167 
Zimmerman, M. (1983). Ethical guidelines for investigations of experimental pain in 
conscious animals. Pain 16: 109-110. 
Znati, M., Jannet, H. B., Cazaux, S., Souchard, J. P., Skhiri, F. H. and Bouajila, J. (2014). 
Antioxidant, 5-lipoxygenase inhibitory and cytotoxic activities of compounds isolated 
from Ferula lutea flowers. Molecules 19: 16959-16975. 
Zocoler, A. M. D., Sanches, A. C. C., Albrecht, I. and Mello, J. C. P. (2009). Antioxidant 
capacity of extracts and isolated compounds from Stryphnodendron obovatum Benth. 
Brazilian J. Pharma. Sci. 45 (3): 443-452. 
  
168 
Chapter 6. Conclusion 
This work describes the phytochemical investigation of four South African Ficus species, 
sansibarica, bizanae, natalensis and glumosa and the bioactivities of extracts and isolated 
compounds from these species.  All species are used in African traditional medicine and 
indigenous to KwaZulu-Natal. 
 
There have been no recorded traditional uses of Ficus sansibarica, nevertheless the fruits are 
eaten in some parts of Africa while birds which feed upon the wasps pollinate the figs. Due to 
the vast ethnomedicinal uses of many Ficus species we decided to carry out a phytochemcial 
investigation of F. sansibarica. The phytochemical investigation of F. sansibarica yielded 
sterols and flavonoids, classes of compounds which have been known to have antibacterial, 
antioxidant, antifungal, antimalarial, anti-inflammatory, anti-leishmanial and anti-arthrital 
activity. Both the crude extracts and isolated compounds of F. sansibarica exhibited weak 
antimicrobial activity against Gram-positive bacterial strains.  The flavonoids isolated from 
the plant demonstrated significant anti-biofilm activity suggesting the use of the plant to 
prevent bio-film formation. Our findings also indicate that F. sansibarica could be considered 
a natural source of antibiotics and traditional healers may want to incorporate this plant into 
their traditional medicinal practices.   
 
Similar to F. sansibarica, Ficus bizanae also has no documented reports on its 
ethnomedicinal use. We also examined this plant phytochemically based on the traditional 
uses of other Ficus species.  The phytochemical study of F. bizanae led to the isolation of 
coumarins, anthraquinones, flavonoid glycosides, megastigmane derivatives, cinnamic acid 
derivatives, polyphenols and triterpenoids.  Antibacterial, antioxidant and anti-inflammatory 
activities were reported for the compounds isolated in F. bizanae. The crude extracts 
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exhibited weak to moderate antimicrobial activity against the test strains. However, the 
extracts of F. bizanae were shown to have a synergistic and potentiative effect with currently 
used antibiotics. Azithromycin, gentamicin, sulphamethoxazole, nalidixic acid and 
cephalosporin gave the best potentiative effect with the extracts.  Our studies indicate that 
extracts of F. bizanae can be used to enhance the effect of currently used antibiotics.  Further 
studies are needed to identify the mechanism of action of this combinational therapy and 
dosages needed to be effective. 
 
Various parts of Ficus natalensis is used for aliments such headache, toothache, irregular and 
painful menstruations, as antivenom, to treat malaria, influenza, whooping cough, dysentery, 
for ulcers and wounds.  A phytochemical study of the plant led to the isolation of 
triterpenoids, sterols and an anthraquinone.  Both the crude extracts and isolated compounds 
have shown antibacterial activity against Gram-positive bacteria. The polar crude extracts of 
the plant was shown to decrease antibacterial adhesion. Similarly, stigma-4-ene-3-one P3-2, 
3β-hydroxy-21β-H-hop-22(29)-ene P3-3 and tectoquinone P3-5 showed anti-adhesion 
potential to the bacteria tested against. It is quite possible that these isolates are responsible 
for the antibacterial activity of the plant.  
 
Ficus glumosa is used in African traditional medicine in the treatment and management of 
various health conditions such as stomach ailments and ulcers, diarrhoea, dysentery, oedema, 
hypertension, headache, menstrual pains and skin diseases.  Phytochemical studies showed 
the plant to contain polyphenolic compounds, coumarins, flavonoid glycosides, triterpenoids 
and sterols.  The various extracts of the plant parts of F. glumosa showed a dose dependent 
gastroprotective activity with the methanol of the leaves being the most active from these 
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extracts.  Our findings corroborate the use of F. glumosa in traditional medicine for the 
management of ulcers. 
 
Secondary metabolites belonging to diverse classes of compounds have been isolated from 
the four South African Ficus species studied in this work.  Most of these have previously 
shown pharmacological activity in many biological assays.  This information will be very 
useful for the traditional healers who use these plants in African ethnomedicine in that our 
findings could provide a rationale for their use for certain medical conditions.  In addition, 
these plants are an alternative, easily accessible, less expensive source to synthetic 
pharmaceuticals. 
 
Furthermore, the plants studied in the work have shown that they could be used as 
antibacterial, anti-adhesive, resistant-modifiying and gastroprotective agents.  Future work is 
needed to identify the specific compounds from the active extracts that inhibit biofilm 
formation of both Gram-negative and Gram-positive bacteria.   F. bizanae is a possible 
source for enhancing the activity of antibiotics used in the pharmaceutical industry.  Further 
studies defining the possible mechanisms of action of this combinational therapy may thus be 
required. 
 
